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Predictive genetic testing for hereditary nonpolyposis colorectal cancer 
(HNPCq has been offered to families with kno~ mutations in South Africa 
since 1997. 
Aim 
The aim of this study is to evaluate the beriefits and limitations, as perceived 
by family members, of the current management of inherited colorectal cancer. 
Methodology 
The research population was made up of six families. The 239 individuals live 
along the West Coast of South Africa. During a 10- day trip from Cape Town 
to Port Nolloth, (Map 1.1) (Appendix 10-Itinerary) 119 subjects were 
contacted. (Flow chart 3.1 explains the attrition in the sampling process). 
Sixty four individuals were entered into a cross-sectional descriptive survey 
using a questionnaire provided by the Victorian Ginical Genetic Services 
(Australia) (Appendix 3). The entry criteria included individuals; i) from 
families with HNPCC caused by the inheritance of a hMU-l1 mutation as a 
result of a C to T transversion at nucleotide 1528 in exon 13 on chromosome 
3p(2;3) and; ii) those who had received predictive genetic test results from 
Professor R Ramesar the Professor of Human Genetics, University of Cape 
Town (Appendix 1 - protocol). 
Descriptive and analytical statistics were used to explore the data. 
Results 
The sociodemographics showed a middle to lower socioeconomic group of 
single and two parent families, mostly with dependant children, and a low 
number of high scholastic achievers. 
ill 
Frequent exposure to cancer, knowledge of genetic risk, and a predictive 
genetic test were recalled by most of this group. Their retained knowledge of 
the consequences of HNPCC inheritance and subsequent effects was 
moderate to low except for the question about colonoscopic surveillance. This 
showed a high level of insight into how to prevent colon cancer. The majority 
of this group also had a positive attitude toward predictive genetic testing. 
At the time of the study most of the cohort was not experiencing stress about 
being at-risk for colon cancer but there were those who had experienced 
stressful events. Most of the subjects with a positive genetic mutation had 
experienced a stressful event in the last year and these events were mainly 
caused by death or cancer. Subjects who had both negative and positive 
genetic mutation results had; i) misunderstood their risk, ii) had low colon 
cancer knowledge scores, iii) were Iworried' about colonic and extracolonic 
cancers being detected and iv) had concerns about not coping emotionally 
with their predictive genetic results. Most of the respondents were coping 
psychologically at the time of the study and did not have anxiety or 
depression. 
The cohort was confident that the medical team would find, cure and enable 
survival after a colon cancer was diagnosed. Even though the accuracy of the 
surveillance worried them, they seemed positive about undergoing the 
procedure and were eager to decrease the surveillance intervals. 
Recommendations 
Individuals with both positive and negative genetic results require regular 
information sessions. 
The concepts of preventative colectomy and pre-predictive test screening for 
depression and coping styles, would require further research before 
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GLOSSARY 
Adenomatous polyp: A premalignant lesion found on the mucosal lining of 
the colon. 
Allele: Alternative form of a gene found at the same locus on homologous 
chromosomes( 4). 
APC: Adenomatous polyposis coli gene. 
Autosomal dominant inheritance: A dominant trait is one which manifests in 
a heterozygote and is often possible to trace through many generations(4). 
Autosomal inheritance: The pattern of inheritance shown by a disorder or 
trait, determined by a gene on one of the non-sex chromosomes(4). 
Biliary Tract: The collection of ducts that connect the liver and gall bladder to 
the duodenum (upper small intestine). 
BRCAl: Breast cancer Gene 1. 
Chemotherapy: Drug therapy to rid the body of cancer cells. 
Chromosomes: Thread-like, darkly staining bodies, within the nucleus of the 
cell, composed of DNA and chromatin, which carry genetic information(4). 
Colectomy: Surgical removal of the colon. 
Colonoscopy: A medical procedure that enables visualisation of the inner 
lining of the colon. 
Construct: A concept created by researchers for scientific use(5). 
Construct validity: The extent to which a research tool measures the concept 
or variable that the researcher wants it to measure(5). 
Content validity: Concerned with sampling adequacy. A judgement whether 
the content of the questionnaire is representative of all possible 
questionnaires (5) . 
Cross-sectional design: A design, where data is collected at one point in 
xvi 
tirne(6). 
Descriptive research: The main objective of this type of research is the 
accurate portrayal of characteristics of persons, situations or groups and/ or 
the frequency with which certain phenomena occur. The research is also 
designed to recount, characterise, narrate, describe, or classify 
observations(5;6) . 
Descriptive statistics: A process of summarising and synthesising data from a 
sample(5). 
DNA: Deoxyribonucleic acid. The nucleic acid in chromosomes, in which 
genetic information is coded(4). 
Endometrium: Mucosal lining of the uterus. 
Exon: Region of a gene which is not excised during transcription forming part 
of mRNA and therefore specifying part of the primary structure of the gene 
product(4). 
Face Validity: The extent to which the instrument is judged appropriate by an 
experienced researcher(5). 
FAP: Familial adenomatous polyposis. 
FOB: Faecal occult blood. 
Gene: A part of the DNA molecule of a chromosome, which directs the 
synthesis of a specific polypeptide chain to create protein(4). 
HADS: Hospital Anxiety and Depression Scale. 
Heterozygote: A person possessing both an abnormal or mutant allele and a 
normal aUele(4). 
Homologous chromosome: Chromosomes which pair during meiosis and 
contain identica1loci(4). 
hMLHl: Name of a mismatch repair gene that causes HNPCC (human MutL 
homologue 1). 
xvii 
hMSH2 and hMSH6: Name of a mismatch repair gene that causes HNPCC 
(human MutS homologue ). 
hPSMl and hPSMl: Name of a mismatch repair gene that causes HNPCC 
(human post meiotic segregation). 
HNPCC: Hereditary Nonpolyposis Colorectal Cancer. 
IES: Impact of Events Scale. 
Locus: The site" of a gene on a chromosome(4). 
Median: It is the middle score that divides a set of scores in two equal parts. 
The value above and below which 50 per cent of the score lies(6). 
Mean: A simple descriptive statistic that is a measure of central tendency 
computed by adding all values or scores and dividing it by the total number 
of scores( 6). 
mRNA: A single stranded molecule complementary to one of the strands of 
double-stranded DNA which is synthesised during transcription and 
transmits genetic information in the DNA to the ribosome's for protein 
synthesise 4). 
MBSS: Miller's Behavioural Style Scale. 
Mutation: A change in genetic material, either in a single gene, or in a number 
or structure of the chromosomes(4). 
Nucleic acid: Is composed of a long chain of individual molecules called 
nucleotides(4). 
Nucleotide: Each contains a nitrogenous base, pentose sugar and a phosphate 
group(4). 
Ovary: Female reproductive organs in which ova are produced. 
Pancreas: Glandular organ that produces hormones and digestive juices. 
Penetrance: The proportion of heterozygotes for a dominant gene who 
xviii 
express a trait, even if mildly(4). 
Proband: An affected individual (irrespective of sex) through whom a family 
comes to the attention of an investigator (index case)(4). 
Proctocolectomy: Surgical procedure that removes the colon and rectum. 
Palliative: A procedure that is not curative but attempts to alleviate 
symptoms. 
Radiotherapy: Use of radiation to rid an area of the body of malignant cells. 
Reliability: The extent to which data is consistent, accurate and precise, as 
well as the extent that procedures yield consistent data(5). 
Renal Pelvis: Area of the kidney into which produced urine drains and passes .. 
into the ureter. 
Research population: The whole group of individuals being researched or 
those having common characteristics, sometimes called the universe(7). 
Response set bias: Factors that interfere with measurement of attitude or 
answers to questions(5). 
ST AI: Spielberger State-Trait Anxiety Inventory. 
Survey research: Non-experimental research that focuses on obtaining 
information regarding the activities, beliefs, preferences, and attitudes of 
people via direct questioning of a sample of respondents(6). A collection of 
data by questionnaire or interview(5). 
Trait Any detectable phenotype property or characteristic(4). 
Transversion: the substitution of one nucleotide for another in an exon, 
resulting in a mutation. 
Ureter: Muscular duct that transports urine from the kidney to the bladder. 
X-Linked: Genes carried on the X chromosome(4) 
X chromosome: One of the sex chromosomes. 
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1 CHAPTER 1- INTRODUCfION 
1.1 HNPCC - early history 
In about 1895, Dr Alfred Warthin, the Chairman of Pathology at the 
University of Michigan, identified. the earliest hereditary form of cancer. His 
seamstress predicted. that she would die at an early age of either a gastric, 
colon or uterine cancer as most of her family members had died. of these 
diseases. She died. at an early age of endometrial carcinoma(8;9). Dr. 
Warthin published. two articles on this family, one in 1913(10) and the other 
in 1931(10). 
Dr. H.T. Lynch presented. a family with inherited. colon cancer that was not 
familial, adenomatous polyposis at the 1964 American Society of Human 
Genetics meeting. Dr. Marjorie Shaw was in the audience. She was a 
colleague of Dr. Warthin's successor at the University of Michigan, Dr. A.J. 
French(9). Dr French entrusted. Dr. Lynch with Dr Warthin's detailed. records 
and pathology specimens that had been meticulously collected. over 30 years. 
Dr. Lynch re-published. this information in 1988(11). 
The medical community were sceptical about the possibility of a hereditary 
form of nonpolyposis cancer in the 1 fJ'IO's to mid 1980's, but more and more 
evidence was published.(9) until in 1989 the 'International Collaborative 
Group on HNPCC (ICG-HNPCq was established. by a group of interested. 
physicians who drew up uniform diagnostic criteria called. 'The Amsterdam 
Criteria'(12;13) (Table 2.2). 
It took until 1993 before a definite genetic mutation was found for 
HNPCC(9;14;15). 
1.2 South African background 
In the mid 1980's Dr. Neville Polley worked. in Kleinsee. This is a smaIl, 
remote diamond-mining town on the northwestern coast of South Africa, 
close to the Namibian border. In casual conversion, Dr. Polley's 23-year-old 
1 
gardener complained of cramping abdominal pain. The gardener predicted 
that he had the same condition that had killed his father. The gardener was 
correct He had an obstructing colon caitcer(2). 
Dr. Polley constructed a family pedigree and when it became obvious that 
this disorder was inherited, he contacted Dr. M. Madden of the deparbnent 
of Surgery of the University of Cape Town. Dr. Madden arranged a trip with 
Dr. Goldblatt, from the Department of Human Genetics, to the area. They 
found a family living in Kommagas with 16 men from three generations who 
had developed colon cancer and they thought that they were dealing with a 
X-linked inherited colon cancer(16). Kommagas at the time was a tiny village 
clustered around a Moravian mission. These people had settled here because 
, 
it was a perennial source of surface water in a semi-desert environment. 
It subsequently became apparent, as more data was collected, that the 
condition was HNPCC. The initial data was skewed because; i) many of the 
male family members stayed in the area and worked for the mines whilst 
their sisters moved away and married men from the surrounding towns and; 
il) in HNPCC the penetrance in men is higher than in women (17). 
Colonoscopic surveillance had been commenced biennially in 1988. Genetic 
material was collected for a formal research project to identify the causative 
mutation in 1991(3). 
Professor R. Ramesar identified the causative mutation as a hMLHl genetic 
mutation (C to T transversion at nucleotide 1528 in exon 13 on chromosome 
3p) in 1995(2;3). 
This family was the first South African family entered into predictive genetic 
testing and a colonoscopic surveillance outreach program (Appendix 1). A 
registered nurse, Christina Harocopos, from the family colorectal cancer unit 
at St. Marks Hospital, London was recruited to Cape Town to establish a 
similar program for this family. The local program was established in 
1997/1998. 
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1.3 Personal involvement 
In January 1999, I took over the co-ordinating role from Sr. C. Harocopos. By 
December 2002, nine families had entered predictive genetic testing 
(Appendix 1) whilst 21 others had known HNPC:C mutations (fable 1.1). 12 
of these families had the same genetic mutation as the original family but 
there is as yet no established genealogical connection. To date, six of these 
families are being actively managed for HNPC:C and a total of 414 
individuals from these six families have received their predictive genetic test 
results (fable 3.1 and Flow Chart 3.1). 
Table 1.1: HNPC:C mutations in the South African cohort as of December 
2002 
Mutation name 
exon 13 C1528T) 
exon 13 (lnsTI521) 
exon 19 C152T) 
exon 19 (C2152T) 
exon 9 (delGITA731) 
exon 6 (G->A 5' OONOR SITE ) 
exon6 (C1~ 
exon 15 AArrn 
exon 6 G965A) 
exon 7 delCf1220) 
exon 8 ·.n!lll-d 1340) 











































These family members live in a wide variety of environments, mainly the 
western parts of South Africa (fable 1.2) (Map 1.1). These environs vary 
from subsistence-living in rural areas, to professional individuals in urban 
areas. 
Table 1.2: Number of individuals and residential areas of those who had a 
genetic test by December 2002 
3 
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Map 1.1: Provincial Map of South Africa(J8) 
SOUTH AFRICA - PROVINCES 
80TSMNA 
""'MI81A 
These individuals, who had been through the predictive testing program. 
we.re thought to be representative enough 10 guide the future management of 
families and individuals in this obviQUS\y growing field of rnedkal science. 
With 21 more families who require to be entered into the predictive testing 
phase of management, this pilot study will guide the future managers 01 
these families with regards to the needs of tht> family members. 
My inspiration for shifting to this relatively new field of nursing carne alter 
reading the first chapter of "The Troubled HeIix"(J9) where patients teU of 
thc:ir soul-searching dilemmas with Hereditary Breast c:.ancer. I discovered 
that there are many parallels between this condition and the hereditary form 
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of colon (:3.ncer(20). There are many arn.'rootes from patients that I manage. 
T ..... o illustrate the problems these individuals have to face: 
• ~ Mary~ is 18 years old. She is the eldest of four children and has had 
to as.. . umc the role of 'Mom' to her younger brothers and sL"ter for the 
last 8 years because ker motner dial of metastatic colon cancer at the 
oge of 30. Mary has a 50 pe~nt risk for inheriting her mother's colon 
cancer. She has been offered a predictive kost that will inform her 
..... hether she has inherited the same g~. Without knowledge of her 
result she will always be al a SO percent risk and ..... ill ncOO biannual / 
annual surveillance colonO!ilCoP)'. After a Ir.lumatic, but normal, 
coionOl'lCopy at the age of 17 she has, at 18 years of age, consented to 
having the family specific predictive genetic test . Her result was 
negative. Mary now knows that she and her children have the same 
ris~ of developing colon cancer as the general population. 
• One of Mary's uncles, ~Aaron", received his predictive genetic test 
results at the age of 34. He attended coIOT\05ICOp\c surveLlIance 
annually. He manifested a pn.'CUf"SOr lesion for the disease and 
underwent an uncomplicated colectomy. He died two months after 
surgery of severe ethanol induced pancreatitis. 
I became increasingly interested in knowing what it was like; i) to decide if 
you wante..! this information or not and ii) knowing you were 'THE ONE'. 
Would Aaron, who died as a result of high alcohol intake, have done so any 
way? Were these just pilIt oflife decisions despite fate? 
These were some of the questions going through my mind when I embarked 
on this research project: 
• Was ' troubled', how they fcit ? 
• How does this complex information affect their lives? 
• How does knowing this information benefit or limit individuals? 
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• Will attitudes detcnnine resPOrlSl..'S to future screening. should it be 
needed? 
• Docs the level of ooucation play II roll' in undcrsronding the complex 
coocepts of geOt'tics? 
This growing c1inicG--gcnctic service (which involves care of individui1ls and 
families with hen.'d itary colon cancer) rt.'quires very close ties with an 
acad"'Illic clinical complex to maintain high levels of surveillance and 
treatment as wdl as continuous counselling for individuals and familk>s. 
Any surveilJanet.' program has both beneficial and d .. >trimental 3Spt.'Cts. For 
this program the benefits are: 
• The pr"'Ycntion of dea th from colon caocCl. 
• Enabling individuals to make positive life decisions. 
• Accurately targeted intervention thereby avoiding unnecessary 
colonoscopics. This reduces both the costs to the community and risk 
and unpleasantness to the majority of individuals. 
Tile possible important detrimental aspects ioclude: 
• The unpleasantness and risks of repeated colonoscopy. 
• The knowledge that a mutation-positive individual is highly likely to 
develop colon or other related cancers. 
• 1bc potential discrimination against family members in tenus of 
cmploymCJ1! and insurance opportunities. 
• The possible negative psychological wnseqUl'oct!S of knowing 
pn.>dictivc test results. 
This research project was aimed al those individuals who had experienced 
realisation of their own risk of developing colon cancer, being offcred 
predictive genetic testing and having the lOoming fate of possibly requiring 
lifetime surveillance. Did I~y perceivc the same benefits and limitations as 
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the providers of the clinko-genetic service? If not. then the service would 
need toadapt its philosophy to meet their needs. 
1.4 The aim of this study 
rhe aim of this study was to evaluate the benefits and limita tions, as 
perceived by family members, of the current management 01 inherit\.'d 
colorectal cancer. 
1.5 The purpose of this project 
Genetic: researchers are rapidly finding new dLo;ea!Je-Causing mutatiOl\.'i. The 
tT.msition from research to cl inical service results in a need to provide many 
more individuals and families with guidance and support [rom health care 
workers who ar"(> tTaiocd to dt'..al with their potential problems(21). In 
assessing how individuals have coped with koowing a little of their own 
d.:'!;tiny, this n.'SCarch Intends to provide data that wiU assist in assessing and 
directing the growing dinico-genetic service to meet the yet unmeasured 
needs of those unique individuals who have to 'outl ive' their fate. 
Respondents have received either a positive or negative prediC"tiye genetic 
result to be el igible lOT the study. These 2 yariables will be usOO to group 
individual responses 111 the statistical analysis of the categorical variables 
grouped into the" obi<'ctiyC5. 
1.6 Objectives 
1. 1"0 est.lblish the sociooemographics of the study population. 
2 To ru;certain the knowlooge and attitudes of indiyiduals who have had 
predictiye genetic testing lor HNPCC, toward genetics, cancer risks, 
and how to pn.'Vent the deyelopment of cancer. 
3. To measure the cfft.octs that the generic test results hayC had on the 
psychological an.1 function.11 health sta tus of subjects. 
Ii. To cvaluate how genetic t\.'Sting impacts on medical d\.'CisialS made 
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by subjects who h:lve n.'CC;vcd predictive genetic t...'St results. 
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2 CHAPTER 2 - LITERATURE REVIEW 
2.1 Introduction 
Colon cancer and the resultant familial risk are briefly explained. The focus 
is un those autosomal dominant conditions that caWlC €:Olun cancer 
particularly I-INPCC. Studies of the role of genetics (predictive genetic 
testing and counselling) and clinical medicine (surveillance and surgery) in 
the management of these famill~ are highlighted. 
2.2 Colon cancer 
2~1 Evolution of colon c.Jncl'r 
Cancers are genetic disorders(22), but not necessarily inherited. The term 
genetic implies that the transformation of a normal cell tu a malignant cell is 
achieved through the step-by-step accumulation of genetic alterations(22). 
Colon cancer occurs after a series of gt.·netic and pathological steps. 
Inactivation of the Arc:. hMSH2 or I,MU-n genes could cause an adenoma, 
and with a further il{UlffiUiation of genetic" abnorm,dities. could resul t in a 
carcinoma (Diagram 21)(23). 
Diagram 2.1: The evolution of colon cancer (24) 
The Evolution of Colon Cancer ,.., -- c&<, __ 
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Eighty £iv" per l,,,"t of ("Iun un!.:",r", .,," <l!; " r~llit uf <:hroulI):;umal 
instability resulting in alterations in chrom05Ol1le number (aneuploidy) of 
chromosomes 5q (APe), lSq, 12 (K-tas), 17p (BAT -26, p53X25). 
Diagram 2.2: Development of coloroclnl callCt'r (Vogelstein J"Ithway)(26) 
• • Nonnal colon cell 
I Deletion 01 good [OilY olAPC 
~ gene on chromOlome ~ 
.. • Smftll polyp 
I ~tfttlon In !IoU 
t ((hromO~ome 12) 
I Deletion oftumor-supprenor 
t genes on cllromosome 18 
with nests 
I Deletlon and/ormutfttlon 
t ofp 5J(cli romosom l! 171 
• COlon cancer 
Fifteen per cent of colon cancers are due to events that do not affecl the 
chromosome COmpk11lCIlI, but accumulate large numbers of DNA repair 
dcit.'C15 in the cell, l'CSulting in genetic instabiHty(25;27). In the proce;s of cell 
division. the original DNA is used as a template 10 replicate a copy, catalyscd 
by an enzyme called DNA polymerase. An error in this process can cause a 
mismatch in the copy. A gene, calk.od a mismatch repair gene, is meant to 
detect and repair the error. Any failure in this editing process will cause an 
iIlCJ'easc in the mulation rate in the n>sultant cells. ~re are four dL'SCribed 
mismatch repair proteins namely liMLH1, liMSH2, IiMSH6 and IiPMS2(22). 
2.2.2 Incidence of colon cancer 
Important population diffcrenre.s eldst. In the United Slntes all ethnic groups 
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are affloctcd, oot African Americans have lhe highest prcvall!OCC and 
mOrlality(28), whll~1 in South Africa, Asial\ Coloured and While fm'lalcs and 
males halle lhe highcst incidence rata 1'hege ratcs are half of those reported 
by the Unite..-! StatL'S, Tasmania. England and Wales. South African Black 
females and males have the lowest rates of colon cancer in relation 10 any 
other countries and population grOlJps(29). The risk of developing COIOn.'CIOlI 
cancer in South Africa is 1 in 91 for males and 1 in 134 for fcmalcs(29). 
Figure 21: International comparisons of oolorcctal C3llO!r incidence(29) 
AoI ........... r.I"~ tOIl 0001 
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Ninety percent of rolorectal caocers occur in individuals over 50(28;30). 
Seventy-five percent of these cancers occur sporadically (without risk factors 
other than age)(28) with a fami ly hlstocy being unusual. 
Survival for colorectal CilnC1!rS is directly relalL>d to the extent of disease at 
pIl'Sentation. The majority of these canC4.'rs develop in a pre-exlsting 
adenoma(22) or pre-malignanl adenomatous polyp(28;30). Thus intervention 
at an early pathological or pre-malignant stage lmprovi.'!l survlvalpl). 
2..2..3 Staging of colon cancer 
1here ate two main staging classifications of oolon cancers i.e. the older 
Dukes or the newer TNM (Tumour, Node, Metas~) classifICations 
(Table2.1) (Figure 24XZ7)· 
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Table 21: Staging of colon canc:er(27) 
St"ging c1"ssifi""tion DeKription 5 year surv;",,1 
Stage 0 Carcinoma in situ 
Stage I (Duke's A/TI) 
Confined to invasion or 
85% to 95% 
the sub mucosa 
T2 ~netrates the 
55% to 85 % 
muscularis propria 
Stage I[ (Duke's 8/ T2. T3 lnvasion is through the 
muscularis propria into 20% t055% 
1'3, T4) 
the subserosa 
T4 Direct invasion of 
1%t03% 
othtor organs 
Stage 1lI (Duke's C/N) Spread to lymph nodes '" 
Stage IV (Duke's 0/ M) Distant metastases 3% 
Figure 23: Staging of roion cancer(32) 
2.2.4 Treatment ot (olon (.meers 
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2.2.4.1 Surgery 
Surgery is the primary fonn of treatment for a colon or rectal canr:er. Part 01 
the decision to olX'ratc dClX'nds on the staging. 
• Stage 0 can be trcated with local removal of the lesion, usually al 
colonosropy. 
• Sl.agcsl, II and III require more extensive surgery depending on the 
locahon of the cancer within the colon or rectum. The ability or 
inability to anastal1lO!le the colon adds to the exlent of the surgery. 
• Colonic surgery in Stage IV (met.aslatic disease) is usually a palliative 
procedure 10 aSSist with quaht), of life. A liver resection could also be 
ronsidcred depcnding on the number of lesions within ~ liver(27). 
2.2.4.2 Che motherOl PY 
Chcmotherapy (fluorourxil. leucovorin and l(>Va~) is usually indicated 
to control systemic diseilSe. Slage 11/ d isease indicates that lymph nodes 
were involved al resection and is thus an indication for treatment. 
Chemotherapy can either be given pre-- and/or post-operalive!y depending 
on the treiltmentlrial or regimen of the institution. 
Stilge IV disease indicates not only a direct spread to local organs but also to 
distant organs. usually INa liver. Chemotherapy is usually a pall iative form 
of treatment atlhis slilge(27). 
2.2.4.3 Radiotheril PY 
Radiotherapy Is usually used for recta] cancers 10 reduce the size of the 
tumour prior 10 surgery, prevent local rllCurrel"lCe post-operatively or as 
pal liation for inoperable reclllllesions(!7). 
Ten to thirty per cenl of all individuals with II colon cancer 11II\·e a 
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for five to ten per cent of all oolon mnccrs(34;36). 
2.3.1 Familial adenomatou5 polyposis (FAP) 
Familial adenomatous polyposis (1 % of colon.'ctal cancer load) is caused by 
gcnnline (i.l>. in ovum or sperm) mutations in the adcnomatous polyposis 
coli (APC) gene that is locatl'll on the long arm (5(21 ) of chroma;ome 5. 
Individuals with this condition develop hundreds of colonic polyps in their 
late tl'CI1S. If not treated, thIS! individuals become symptomatic in their 
twenties, and develop color<'ctal cancer ano.I if untreated, die at a young 
age(37;38). At·risk individuals require regular surveillance of the rectum to 
deted the polyps. 
2.3.2 Heredit;uy Nonpolyposis Colorectal Can(ff (HNPCq 
HNPCC (:t6 to 10,. of colorectal canccr load) is caused by mutations in 
mismatch n.'Pair genes (hMLHl (chromClSOml' 3p), hMSH2 (chromosome 2p), 
hMSH6 (chromosome 2p), hPMSl (chromosome 2q) and IrPM52 
(chromosome 7q»(22;39;40). This condition has no obvious clinical features 
that differentiate it from sporadic coIon.>ctal cancer. It tends to have an early 
age of onset, has a tendency to fonn multiple colorcctal cancers(15) and 
special pathological featurcs(15;.jl) can alert a clinician to its possibility but 
usually it is only when the family pcdign.'C is studied that the autosomal 
d ominance of the condition bet:omcs apparent(4244). 
Common international criteria (fable 22: Amslenlam Criteria) have been set 
10 assist with the cl inical identifICation of HNPCC families (fable 2.2) 
(12;34;41 ;45). 
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predISposItion towards a familial risk. Increased familial risk probably 
results from a combination of genetic and environmental factors(28). 
The gerwt ic factors that formulate inheri ted susceptibility appear to be more 
dominant in those that have a predisposition towards a familial risk. The 
risks for colorectal cancer have been shown to increase thn .. odold by having 
an affected flrSt .. degree relative(33). An affected relative younger than 45 
irercases this risk to fourfold. The number of affected relatives also raises 
the risk for first .. and second-degrt.'C relatives(28;33). 
In inherited cancers, the assessment of individoal risk begins with the 
construction of a family pedigree (Diagram 23). The risk of the development 
of cancer can tncn be determined by analysis of the pedigree, by ascertaining 
family career history (with proven histology) and age of onset of cancer in 
affected individuals(34). 11tis knowledge can then be used in stratL"gising 
surveillance programs(33;35). 
Figure 2.4: A typical autosomal dominant pt.'liigree showing risk assessment 
Key: 0 _ unafft:cted fumBle, Cl - u .... ffuch.'<i male, • - affl'<1l'<l female!. • - affected male 
...... 
• 10CI'Ir0 RIN 
...... 
2.3 Autosomal dominant conditions 
...... • 100" n.II 
"'" ... 
12 5110 ..... 
Numerous genes are probably involved in formu lating a predisposition to 
cancer risk. but mutations in some genes are known to cause cancer(28) and 
defmitely result in two autosomal dominant genetic conditions that account 
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Table 2.2: Amsterdam cri teria 
The modified Amst~rd.un Crih,rilo (or HNl'Cc.: 
Alieast lhra> I1! lallVI!S with a HNPCC-~liItl..:l cancer (colorectal, cnd~1, 
ovary. Wm1a~h. hcp;itobtliary. small bowet lwaio. ~Ier QI" ~ pelvis; and skin) 
~ following crlu-ria should aU be present: 
• One Clo!lo:! ~ first-degree relabve of ~ other tWO 
• At lea.~t two 1JUcces.~,ve g~,ation:l affa:ted 
• At least one case diagnosed before the ageofSO 
• Exclusion of f"milla! adel'OOmlllOtd poIJ'POI'oIS 
• Tumours should be verifiN by ~tholog .... d exanunallOn 
colo n(34;41-43) necessitating repeated (annual Of biennial) roionosroPIC 
SU rveillancc(9;34). 
Figure 25: Coionoscopy(46) 
_ ..
This is an invasive and unpleasant in~rvention requiring expensive 
equipment and a high level of I!Xpertise and extensive colonic preparation. 
llw.-se high-risk individuals are also at-risk. for extra-<:olonic mallgnancies Le. 
endometrium, ovary. 5mall intlOStinC, biliary tract, ureter, rt.'Ilal pelvis, 
stomach and pancreas. Survl'iJlancc o f these organs 5hould 5tart at age 
30(9;3-l;47). 
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2.3.3 Treatment of autosomal dominant (onditions 
When colonk lesions (adenomatous polyp or cancer) are found in either 
(olorectal cancer or familial adenomatous polyposis high-risk individuals, 
the management, as with sporadic colon cancers, requires primarily surgical 
intervention. The procedures will either be a total colectomy with an ileo-
rectal anastamosis (Figure 27) or a restorative proctocolectomy (Figure 28). 
It has been 5ugg<'StL'Ii that prophylactic surgery should be discussed as an 
option of management with a known gene positive colorectal cancer 
individual(15;41 ). 
tkpcnding on pathoJogkaJ staging and site of lesion prc and/ Of post-
operative chcmo-radiation is oHered. 
Figure 2.6: Total colectomy and iJeorectal anastamosis(48) 
u • 
19 
Figure 2.7: Reslorative proclocolt.'Ctorny (49) 
. . ~ -----
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2 4 Gene tic testing 
> 
I 
Should a genetic mutation be found in a Froband's blood, then high-risk, 
COI15Cnting. adult rclahvC$ can be o(f~ed prcd..ctive genetic testing_ DNA 
("an be extractoo from the relatives' blood a:-d 'matched' to that 0( the 
probands' o Each direct relative will have a SOx. (1 in 2) chance of. having 
inherited the sam" mutation (autosomal dominLnce) (Figure 2.5)(U;34). 
In conjunction witl>. genetic testinr... eul) detection strategies, e.g. 
surveillance colonoscopics. arc vital, since eldy lesions found al colon<l'iCopy 
more than halve the risk of coloroXt.l1 cancer, pre.enl colo1'('Ctal cancer deaths 
and decrease overall nlOrlali ty by 65% in IINpC: families(28;36). 
2fJ 
2.4.1 l'fe-predictive genetic testing 
The presence of a colon cancer-causing genetic mutation places an 
individual, or carrier, al an extremely high risk of developing lhe disease (80 
1085%)(2;47;50). Identiftcatilrl of the causative genetic mutation for colon 
cancer increases the accuracy of risk assess~nt(51). A ""Sative genetic 
mutation result returns the individuals' risk to population le-vcl(52) and 
relieves them of unnect'56ary surveillance(53). 
South African medical dl'Ciskm-makt'rs argue that there are significant health 
and eronomic benefits resulting from knowledge of mutation status(3). This 
benefit is to; i) individual: by improving survival through increased focus on 
early detection or prevention stra tegies and; ii) medical economy: by creating 
a foctlS on those who arc (";lrrie\'S of the causative genetic mutation. at-risk 
family members are therefore actively encouraged to accept genetic testing. 
Those that wish to know their predictive genetic test results are entered into 
a predictive genetic testing program (Appendix 1 - protocol). 
The possible psychological risksl d~ may include aruciety(54), 
dt>pression(55), denial and guilt at possibly having passed on the genetic 
muta tion to children(56). They may, on the other hand, experience the 
benefits of safety in the knowledge that they are reacting positively to their 
risk(54). 
2.4.2 Benefits and Umilations 
The decision to accept a predictive genetic test has been stud ied 
internationally. Lennan et 011(55) redesigned and used a 12 item scale, 
initially used for psychosocia l assessments in predictive testing for 
Huntington'S disease(57). The scale measures pcrreption, benefitli and risks 
of genetic testing in litudies that looked fit predictors of genetic test utilisation 
and interest in genetic Ie;ting(55;58). To learn about children's risk(20;55;58-
62) was the mOSI cmrunonly cited reason for requesting a genetk test. To 
increase use of scrrerting tests and 10 take better care of lrIeself(20;5S;59-
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62) as well as Ihe desire to participate in rescarch(60) were also important 
motivalol'll. 
The most CQmmon perceived limitations to genetic tests were concerns abuut 
lIccuracy(20;58) lind the effect on the famil}(61). 
2.4.3 In terest in genetic test ing 
Interest in genetic testing was studied in populations at high-risk for wion 
cancer. Results showal that those from a higher socioeconomic 
backgrounrl(56;63), who were younger and had firsl-dcgwe relatives with 
colon cancer(63) expressed the highest interest and intention to learn their 
genetic results. 
Faclo\'ll predicting test uptake for roloT«ta1 genetic" k'sting have bcI..'fI widely 
investigated. An increasaf perception of risk(54;59;61;63;b1), a greater 
perreived confidence in their ability to rope with unfavourable genetic 
information(59), past experience with testing(~). more can«r 
thoughts(5-I;63) and having at least one colonoscopy were predictors of 
accepting predictive genetic testing. 
FactolS thai were a550cialed with having a hlglHisk perception and OIn 
associated lack of optimism.. were, having a famity history of colon cancer, 
poorer health behaviours and higher levels of anxicty(65;66). Rob el 31(65) 
found thai those males. who we~ older and non-while perceived their risks 
to bo.> lower than their peers which was found 10 be opposite of true risk.. 
Barriers to accepting predictive testing were fou nd by Lerman et 31(47) to be 
1c!JS formal education. lower socioeconomic group, symptoms of depression 
espt.'Ciaily among women and not having heallh insu rance(S8). 
Consistent findings by Croyle el aJ(54) were tha i ind ividuals process and 
evaluate risk information very differently when the information is personally 
relevant. Lerman et al(47) offered genetic testing to II group of clinically and 
molecularly proven family members al high-risk for HNPCC and only 43% 
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eil'Ckd to participatc in the counselling and tt.'Sting program. Rt.'Sults from a 
l't.'Cef1 t study by Keller et al showed that although all patients showt.>d a high 
mlcT1'St in gO:-n('tic testing.. their attitude toward genetic testing was nol a 
valid prt.'tlictor of actually accepting gcnctk l'CSults(62) 
Spirituality was also investigated and il was found that highly spiritual 
womt.'fI wcre IC$S likely to Il.'CCive predictive test T1'SuJts than less spiritual 
women(67). 
2.4.4 Psychological and functional health 
ArOOety. educationallevd and coping style sccmed to be obvious factors to 
research but none was found to be as~ialcd with an intl'rcst in genetic 
testing (54;61). 
Esplen ('I al(60) looked for psychological distress prior to g('flt.>tic !l'Sting.. and 
found female patients with colol't.'Ctal cancer had hlgllL'r lcv('ls of ev('nt stres.<; 
than males. SignifICantly higher (o:-vets of anxi(,'ty and depressiun were found 
in those who WCTC youngo:-r than 50 when thcir colon cancer was diagnosed, 
or YOllngo:-r Ihan 25 when a clO&? relativc was diagnosed. The number of 
family members with colorectal cancers ,Jid no! rorrclato:- with incrcased pre-
test distress but, additi003l losses (not cancer r('lated) Wt.>n.> associated with 
pre-test stress and dcpression(60). Esplcn et 31(60) also found no difft'!n.>oce 
in the psychological fUf'.CttoOing betwl'l'fl those thai antkipan.'ti a nt.'gative or 
positive result. 
Most women anticipated a nl'gativc psychoiogiGilI impact (increased anxiety, 
depression and impaired quality of life) if thcir test was positive for a bft.'ast 
canrer mutation(55). lbl'y also felt that th('y would worry if they had a 
negative result(55)_ Deprcsslon was the strongest predictor of an anticipated 
negative impact of gMctk: tl'Sting(55). 
2.4.5 Predictive genetic testing 
2.4.5.1 P'¥chologiu.l distress 
There are few studies that have investigated psychological distress after 
disclosure of genetic test results for HNPCC. Most have been done before 
the mutation analysis. 
2.4.5.1.1 IJ~ssU1in 
Many studies found depression to be linked with potential problems in the 
predictive genetic testing process. Murakami et al(68) found that a history of 
depression and not disclosure of genetic test results was a significant 
predictor of psychological distress. Lerman et al(47) found that females with 
clinical depression had a fourfold reduction in predictive testing acceptance 
and that depressed individuals may also delay preventative medical care(47) 
thus they suggested that depression could be a barrier to genetic testing. 
They advised that it should be possibly screened for in an individual prior to 
embarking into a predictive genetic testing program(68). 
Ba1mana et al(20) found that depression rates in subjects undergoing breast 
cancer genetic testing, and who were found to be non-carriers, were reduced, 
while in the carriers it remained the same, and increased in those who 
declined testing. This seems to show that those accepting genetic tests are a 
select group with a good ability to cope emotionally with the results. 
2.4.5.1.2 Stress 
According to Atkan-Collan et al(69) the moment of disclosure of mutation 
status was the most stressful time and thus the time for the greatest need for 
support. Making the decision and waiting for the results were also times of 
heightened stress. Esplen et al(60) found that the majority of individuals 
who tested positive experience moderate stress in the short term., but that it 
appeared to resolve over time, while those that did not have a disease-
causing mutation showed an initial reduction in distress. 
Knowledge, experience with the disease and previous experience of 
surveillance prior to the genetic test disclosure, reduced the level of 
stress(70). Dorval et al(71) and Bonadona et al(72) found that those who 
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had cancer, underestimated their distress reactions to disclosure of a 
positive genetic result. There appears to be a group of individuals who 
anticipate and experience adjustment difficulties such as anxiety and 
depression, specifically related to genetic tests(20;60;71). Individuals with 
characteristics of depression and an avoidance style of coping were 
associated with heightened stress(47i70). 
2.4.5.1.3 C;uilt 
Dorval et al(71) found that only modest levels of guilt were reported in 
anticipation of positive or negative results and this remained low after the 
test disclosure. This was supported by Murakami et al(68) who only found 
that 12% of his sample had feelings of guilt one month after disclosure. 
2.4.5.1.4 )\~~ 
Atkan-Collan et al(53) found that a high level of anxiety and worry were 
caused by misunderstanding a predictive genetic result in mutation-positive 
and negative individuals. This misunderstanding was associated with a 
lower pre-test perception of risk in mutation-positive individuals and a 
higher pre-test risk perception amongst the few mutation-negative 
individuals who had misunderstood their result 
Women, adolescents, young adults and mutation-positive individuals 
demonstrated very high levels of anxiety(69i70). 
2.4.5.1.5 Coping s~le 
Busjan et al(73) stated that lIthe psychological processes aimed at 
diminishing stress are called the coping processes or the things people do to 
avoid being harmed by life-strains". 
According to Miller(74) Ilwhen faced with threatening situations, individuals 
who differ in coping styles diverge in their choices of coping strategy: 
Monitors, who characteristically seek information and Blunters, who 
characteristically distract themselves." 
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Petersson(75) found coping style to be unrelated to demographic variables 
as well as measures such as anxiety and depression but Phipps and Zinn(76) 
however found that monitors were more anxious than blunters and that 
there were significant interactions between coping styles and change in 
anxiety and depression scores over time, amongst their subjects who were 
having amniocentesis. 
Steptoe and Sullivan's(77) study found that monitors engaged in more 
vigorous health related information seeking behaviours and were more likely 
to undergo preventative behaviour than blunters. 
2.4.5.2 Impacts on medical decisions 
In a study by Codori et al(64), the subjects were unaffected, high-risk first-
degree relatives of HNPCC families who had been offered predictive genetic 
testing. They found an all-or-nothing attitude. Those who accepted regular 
surveillance because of high risk also accepted genetic testing and vice versa. 
Lerman et al(47) found that persons with lower socioeconomic status or 
alternatively, lack of fonnal education, had low levels of utilisation of 
colorecta1 cancer surveillance. 
Myres et al(78) found older females who had a faecal occult blood test in the 
past were more likely to adhere to surveillance. Men were found to require 
encouragement and instruction in relation to surveillance. Perceptions of the 
severity and curability of the disease, worry about having an abnonnal 
screening test, salience and coherence of the screening test, were positively 
associated with screening. The belief that 'powerful others' could exercise 
control over health and that the perception of an effective physician-patient 
relationship, was found to be positively associated to adherence. 
This view was shared by Johnson et al(79) who stated that ILprevious 
preventative health behaviour, perception of benefit of screening, physician 
recommendation for screening and knowledge of others with colon cancer" 
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were factors that increased screening adherence. 
Hadley et al(36) also found that the most common reason given for an 
individuals decision to screen (or not to screen) was that the doctor did (or 
did not) recommend it. 
Johnson et al(79) also suggest that II absence of symptoms or health problems, 
embarrassment and discomfort of testing, a desire not to know about health 
problems and increased anxiety" were reasons for avoiding surveillance. 
2.4.5.3 Genetic counselling 
Genetic counselling attempts to improve early detection and prevention of 
colon cancer by identifying those at high-risk. Options and 
recommendations are offered to reduce risk, and psychological support 
assists with reducing negativity towards preventative screening(79). Johnson 
et al(79) evaluated the impact of genetic counselling and testing on 
subsequent colorectal screening behaviour, and found that screening 
behaviour correlated with the genetic test result. Recommendations were 
well adhered to by patients who received genetic counselling for positive 
genetic results(79). Hadley et al(36) found that genetic counselling and 
testing influenced endoscopic screening appropriately during the 12 months 
post genetic counselling and testing. 
There appears to be a reluctance to cease surveillance after receiving a low-
risk result(36;52;80). Hadley et al(81) found an element of hypervigilance 
amongst young mutation-positive individuals. 
25 Research instrument 
The Victorian Oinical Genetics Services (Australia) modified a questionnaire 
developed for the investigation of breast cancer (58) for use in HNPCC 
research. 
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The Australian instrument (Appendix 2), (used with permission (Appendix 
3» was modified to suit the South African context (Appendix 4) and then 
translated into Afrikaans and piloted (Appendix 5). Utilising the feedback 
from the pilot study, the instrument was altered to suit the target group 
(Appendix 6). 
The questionnaire consisted of: 
• A sociodemograpbic section 
• A scale used to measure knowledge about inherited colorecta1 cancer. 
This scale was altered by Meiser et al(82) from eleven true-false items 
used by Lerman et al(58) to a revised nine item version of this 
measure. 
• A scale that measures perception, benefits and risks of genetic testing. 
Lerman et al(55) redesigned and used a 12 item scale, initially used for 
psychosocial assessments in predictive testing for Huntington's 
disease(57). The scale has subsequently been used for studies 
concerning inherited breast and colon cancer(20;55;58-61). 
• A set of six points about family members who had cancer. Petersen et 
al(66) used a similar set of questions to depict family history and 
experiences with colon cancer in the family. 
• A scale used to measure coping style called the Miller's Behavioural 
Style Scale (MBSS)(56;74). 
• A measure of stress experienced in the previous year(60). 
• An impact of Events Scale (ThS)(61;83). This scale was devised initially 
to measure the degree of subjective impact experienced as a result of a 
specific event(83), but could also be used to measure this impact over 
a period of time. In this study the stressor was the concern of being at 
risk for colon cancer. 
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• A scale called the Hospital Anxiety and Depression Scale (HADS)(84) 
had been designed specifically for patients with physical illness. 
According to Snaith(84) and Bjelland et al(85) this scale is only valid if 
used for screening purposes and cannot give a definitive diagnosis. It 
has 14 items divided into two subscales, seven for anxiety and seven 
for depression with somatic items excluded. Only the depression 
scale was used in this study. 
• A short version of the Spielberger State-Trait Anxiety Inventory 
(Sf AI)(56;86) which was included as a measure for situational anxiety. 
• A measure that asked about perceptions of risk for developing colon 
cancer(64) which gives a baseline of risk perception to which 
screening and health behaviour can be compared. 
• A medical measurement of risk that utilises family history and 
colonoscopic surveillance which usually yields adenomatous 
polyps(4244;87). 
• An enquiry of actual participation in colonoscopic surveillance, their 
opinions about choices in health related behaviour, beliefs and 
attitudes about the effectiveness of preventative surveillance, opinions 
about colon cancer, and the reasons and motivations for accepting or 
rejecting surveiI1ance(36;79). 
26 Conclusion 
Much has been researched internationally about HNPCC and the predictive 
and actual effects of genetic testing on high-risk individuals. To date there 
is no knowledge of the opinions of South African individuals, some of 
whom had received their results in 1997. The results of this study will be 
compared with this literature and the resultant discussion will offer 




This chapter includes the research design and the steps followed in reaching 
the final sample. The choice and enhancement of the instrument is explained 
with evidence provided for its validity and reliability. Data collation and 
analysis are described with due regard for research and ethical principles. 
3.2 Research Design 
A cross--sectional descriptive survey approach was selected, as it enabled 
flexibility and allowed versatility with regards to venue, scale and mode of 
enquiry(88). 
This non--experimental research is termed ex post facto or correlational 
research. This approach indicates that the research will be conducted after a 
variation (positive or negative genetic result) in the independent variable 
(predictive genetic testing) has occurred(6). Correlational research seeks 
associations between two variables and tries to understand them(7). 
3.3 Sample and Setting 
3.3.1 Sample: 
Up to and including December 31 2002, 173 probands had been recruited to 
enter the HNPCC, University of Cape Town/Groote Schuur Hospital 
research program(l) (Research criteria Appendix 7). HNPCC mutations were 
found in 30 different probands and some extended families of which nine 
had been entered into the predictive genetic testing program (Table 1.1). 
The research population was made up of six out of the nine families (Table 
3.1). The individuals who met the criteria were: 
1. From families with HNPCC caused by the inheritance of a mutation in 
the hMllil gene as a result of a C to T transversion at nucleotide 1528 
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in exon 13 on chromosome 3p(2;3). 
2 Those who had received predictive genetic test results from Professor 
Raj Ramesar (Professor of Human Genetics, University of Cape Town) 
(Appendix 1 - Protocol). 
Table 3.1: Number of families and individuals eligible for inclusion in the 
sample 
Number of Families Number of eligible 
individuals per family 
1 214 individuals 
2 100 individuals 
3 57 individuals 
4 21 individuals 
5 21 individuals 
6 1 individual 
Total 414 individuals 
Subjects were excluded for anyone of the following reasons: 
1. Inability to be contacted; 
2 Refusal to participate; or 
3. Geographical reasons. 
Out of the 414 eligible individuals, 239 were thought to be contactable (fable 
3.2). 
31 
Table 3.2: List of eligible families and individuals after exclusions 
Number of Families Number of eligible 






The 239 individuals live along the West Coast of South Africa. During a 10-
day trip from Cape Town to Port Nolloth, (Map 1.1) (Appendix 10-Itinerary) 
119 subjects were contacted. 
The following flow chart (Flow chart 3.1) was created to explain the attrition 
in the sampling process. 
Levels 1, 2 and 3 in the flow chart are part of the predictive genetic testing 
program offered through the Division of Human Genetics of the University 
of Cape Town and Groote Schuur Hospital. The current study commences 
from level 4 and explains the attrition in the sampling process. 
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31 December 2002. 
173 samples of blood or tissue from probands 
entered to HNPCC genetic research data base 
(Entry criteria - Appendix 1)(1) 
... 
2 30 probands with mutations, thus family members can 
be offered predictive testing (Table 1.1) 
... 
9 families receiving predictive testing management 
(414 individuals who have received predictive genetic testing results for (table 3.1) hMLHl 3 
genetic mutation in exon 13 on chromosome 3p - 6 families) 
• ... 152 individuals 261 individuals alive -----. One family from Upington either died or 
and contactable (6 families) (21 individuals) non-contactable 
4 
6 119 contacted 
120 non-contactable or available for the study 
55 questionnaires not returned 
7 
Figure 3.1: Flow diagram of study sample 
3.3.2 Sample size 
In the current study only 64 individuals were available for data analysis. The 
response rate for this research project was 50% with a hypothesised proportion 
of 40% (difference of 10%) the power of the test among 64 individuals was 36%. 
The ideal sample size with 80% power and 95% confidence interval would have 
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beenn = 194. 
3.4 Instrument 
3.4.1 Selection and Modification 
The Victorian Clinical Genetics Services (Australia) modified a questionnaire 
developed for the investigation of breast cancer(58) for use in HNPCC research. 
The Australian instrument (Appendix 2), (used with permission (Appendix 3» 
was modified. to suit the South African context (Appendix 4) and then translated 
into Afrikaans and piloted (Appendix 5). Utilising the feedback from the pilot 
study, the instrument was altered to suit the target group (Appendix 6). 
The changes made to the original instrument included.: 
• The last paragraph of the instruction sheet was altered to include the fact 
that a data collector would be available to assist with queries about the 
questionnaires and collect them on completion (Appendix 4 English and 
Appendix 5 Afrikaans). 
• Addition of questions. 
• Deletion of questions. 
• Changes to the wording in the English questionnaire, facilitating 
translation into Afrikaans. 
Detailed changes to the final instrument and explanations for the alterations can 
be found in Appendix 8. 
3.4.2 The Final instrument 
3.4.2.1 Objective 1: Sododemographic8 
(Questions 1 to 10) 
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Questions 7 to 10 were added to the original questionnaire. The questions and 
numbering were changed to provide a South African context (Appendices 4, 5 
and 6). 
The following factors were used to measure and record sociodemograpbic 
detai1s: 
3.4.2.1.1 Age and gender 
(Questions 6 and 9) 
The attitude of individuals toward predictive genetic testing could be influenced 
by these two factors(47;60;63). 
3.4.2.1.2 Marital status and children 
(Questions 4 and 10) 
The support structure and stability within a family can have an influence on an 
individual's decision-making. Managers of these families find it vital to know 
how many children are at-risk especially if a parent is positive for a HNPCC 
mutation or affected with colon cancer(20;55;56;59;63). 
3.4.2.1.3 Education 
(Questions 2 and 3) 
An individual's knowledge and education level has been shown to be influential 
in creating a barrier to genetic test acceptance. The in/ability to understand 
genetic concepts, risk, and the basis of knowledge assessment, could contribute 
to that barrier(20;47). 
3.4.2.1.4 Employment and Medical Care 
(Questions 1,8 and 14) 
Financial stability, as well as health and insurance choices, influence benefits and 
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limitations within the predictive testing process(47). 
3.4.2.1.5 ~aith 
(Question 7) 
Beliefs and attitudes can have a basis in spirituality and religion and could 
influence a decision made by an individual or community(67). 
3.4.2.1.6 ()ri~ns 
(Question 5) 
In South Africa, places of origin impact on an individual's education and later 
on, employment status, which in tum would impact on health care provision. 
Rural origins in South Africa often result in migration of younger family 
members to urban environs, with family support remaining in rural areas. 
3.4.2.2 Objective 2: Knowledge and attitude 
(Questions II, 12, 13 and 15) 
An individual's actual and perceived risk would highlight their understanding 
of information provided in pre- and post-test counselling. The perceived 
benefits and limitations of predictive genetic testing would also clarify what has 
been understood(55;58;71). 
3.4.2.2.1 Cancer Risk 
A six-point question (Question 11) about family and family members who have 
had cancer was added. The literature review showed that experience with 
disease was a factor associated with reduced levels of stress(70). Petersen et 
al(66) used a similar set of questions to depict family history and experience with 
colon cancer in the family. 
Question 12 was altered to test th~ research subjects' own experience of receiving 
a predictive genetic test The original questionnaire was used for subjects who 
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had not had predictive genetic tests. 
Question 13 was added to ask if predictive genetic tests had been done. The 
reason for this was that question 12 asked "who referred you to having a test?" 
and question 14 asked "who you go to for clinical help?" For the sake of 
completion it appeared logical to ask if a result had been given. 
3.4.2.2.2 Perceived benefits and limitations of genetic testing 
A modified 12 item scale (Question 15) from a previously validated 
measurement of perceptions of benefits, limitations and risks of genetic testing in 
breast cancer(55;58), had been adapted and piloted in Australia (See Appendix 
3). It was proposed to assess the intention to request genetic testing and 
acceptance of preventative surveillance strategies, should a predictive genetic 
result have been positive for an HNPCC causing mutation. It had also been used 
in other studies to measure benefits and limitations of those undergoing testing 
for HNPCC(55;58;59;61). 
The scale has two sections. The first six statements are concerned with the 
perceived benefits of predictive genetic testing, and the last six about the 
limitations. 
Two scores, a total benefit and a limitation score, were calculated. Subtracting 
the total benefit from the total limitation score generated a resultant risk score. 
The final risk score defined those who felt they had benefited or not from 
predictive genetic testing. 
3.4.2.2.3 Knowledge of colon cancer 
A scale used to measure knowledge about inherited breast cancer and BRCAI 
testing(58), consisted of 11 true-false items, but Meisner et a1(82) used a revised 
nine-item version of this measure. The revised scale (Questions 16 to 24) was 
used to measure subjects' knowledge about colon cancer. 
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One of the nine knowledge scale statements - IIEveryone who has a gene for 
Hereditary Bowel Cancer will get bowel cancer" (Statement 17) - was discussed 
with the content supervisor. All three responses could have been correct for this 
cohort For the purposes of this study, which pertains to families at-risk of 
inheriting this specific mutation (hMLH1 exon 13 C1528T HNPCC mutation), it 
was decided that the correct response was Itrue'. 
Another statement from the knowledge scale (Statement 22) - "Faecal occult 
blood testing will always detect bowel cancer", caused concern. Four other 
sections in the instrument also contained a question referring to faecal occult 
blood testing. 
Faecal occult blood testing had not been part of the predictive testing program 
information package given to this research sample. This concern was discussed 
with the statistician. These questions were not included in the analysis of the 
research objectives but analysed separately as part of a substantiation of 
reliability . 
3.4.2.3 Objective 3: Pnchological and functional health status 
3.4.2.3.1 Coping style 
According to Miller(74) I'when faced with threatening situations, individuals 
who differ in coping styles diverge in their choices of coping strategy". She 
defined two coping styles, namely: 
1. Monitors who characteristically seek information. 
2 Blunters who characteristically distract themselves. 
The validated Miller's Behavioural Style Scale (MB$) (Questions 37 to 40) had 
been included as it enabled a measurement of coping in threatening situations 
and possible responses to these(56;74). 
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This scale asks the subject to imagine four stress-invoking scenarios of an 
uncontrollable nature ie. the dentist, a hostage situation, the threat of job loss 
and a potential aeroplane disaster. Eight statements that offer different ways of 
dealing with the situation follow each scenario. 
Petersson et a1(75;89) suggest that three scores can be derived: 
1. Total monitoring score; 
2. Total blunting score; and 
3. Sum score. 
The sum score is calculated by subtracting the blunting from the monitoring 
total. Individual scores above the sum score refer to monitors and those below 
represent blunters. 
3.4.2.3.2 Stress 
The majority of individuals testing positive, in a predictive genetic testing 
program, experience moderate stress in the short term that appears to resolve 
over ~e, whilst testing negative shows an initial reduction in stress(60). 
The respondents were asked if they had (Question 41a, b, and c): 
a) a stressful1ife event in the last year?; 
b) if 'yes', what was the event? (They had a choice of ten events) and 
c) were presented with a Likert scale asking how stressful the event was for them 
on a scale of 0 (not stressful) to 100 (very stressful). 
The Impact of Events Scale (IES)(61;83) (Questions 55 to 70) was initially devised 
to measure the degree of subjective impact experienced as a result of a specific 
event(83), but could also be used to measure this impact over a period of time. 
In this study the stressor was the concern of being at·risk of colon cancer. 
39 
The scale consists of two major responses intrusion and avoidance. Initially the 
scale consisted of twenty items. Horowitz(83) revised and published a scale 
consisting of 15 items (seven intrusion and eight avoidance items). These two 
subscales were developed and worded to apply to any event A specific life 
event examined could then be added to the top of the form. 
Scoring applied to the raw data was, 0 = not at all, 1 = rarely, 3 = sometimes 5 = 
often. The scale provides sub scores: 
• Avoidance with a potential range of 0 to 40 
• Intrusion with a potential range of 0 to 35 
• Total score (sum of the two subscales) with a range of 0 to 75 
A score of 40 or more is suggested as a significant stress response(90). 
3.4.2.3.3 I)~SsU1.n 
Subjects undergoing breast cancer genetic testing showed that depression rates 
varied depending on genetic results(20). In individuals who were mutation-
negative it was reduced, in mutation-positive individuals it remained the same, 
and increased in those who declined testing(55). 
The Hospital Anxiety and Depression Scale (HADS)(84) (Questions 42 to 48) had 
been designed specifically for patients with physical illness. The scale is reported 
to be vaHd if used for screening purposes and it cannot give a definitive 
diagnosis(84;85). It has 14 items divided into two subscales, seven for anxiety 
and seven for depression with somatic items excluded. Only the depression scale 
was used in this study. 
Each item has a four point response ranging from 0 to 3, where 0 is no problem 
and 3 is a high level problem. The individual's total score range is 0 to 21, with 
scores of 0 to 7 regarded as normal, 8 to 10 suggestive of depression and 11 and 
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higher as a probable presence of depression. 
3.4.2.3.4 Anxiety 
Most first-degree relatives of women with breast cancer anticipated a negative 
psychological impact (increased anxiety, depression and impaired quality of life) 
if their test was positive(55). They also felt that they would still worry if they 
had a negative result(55). 
The Spielberger State-Trait Anxiety Inventory (SIAI-State Short version) 
(Questions 49 to 54) is included as a measure for situational anxiety(56;86). 
Marteau and Beld<er(86) developed this shortened version of the Spielberger 
State-Trait Anxiety Inventory (SIAl). The full length SIAl consisted of two 
questionnaires of 20 items each. The SIAI-State Short version has six items 
which according to Marteau(86) provides acceptable levels of reliability and 
validity and maintains the inventory as sensitive to different degrees of anxiety. 
Statements 50, 51 and 54 had optional scores of 1, 2, 3 or 4 and statements 49, 52 
and 53 had these scores weighted in reverse. MitclUe et al(91) also used the 
shortened version(86) but pro-rated the score to be equivalent to the full form of 
the scale giving a score range of 20 to SO. The scores were multiplied by 3.33 to 
achieve this. ~ pro-rated scale had a cut off score of 42 with scores above 
indicating clinical levels of anxiety. 
3.4.2.4 Objective 4: Impacts on medical decisions 
3.4.2.4.1 Awareness of risk and medicol decisions mode 
The medical measurement of risk utilises family history and the colonoscopic 
surveillance yield of adenomatous polyps(42-44;87). Colonoscopic surveillance 
was found to reduce the incidence of bowel cancer in people at-risk for HNPCC 
by performing a polypectomy at intervals of one to three years(50;92). 
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Two measures (Question 25) that asked about risk-perceptions for developing 
colon cancer (64) gave baseline knowledge of the subjects' risk perception to 
which screening and health behaviour could be compared. 
In a study on attitudes towards a colon cancer gene test, it was found that risk 
perception was linked to the number of affected relatives, cancer worry and a 
younger age(66). An increase in risk perception was found to be a predictor of 
accepting a predictive genetic test(54;59;63). 
3.4.2.4.2 Effects of genetic results on beliefs about effectiveness of surveillance metlwds 
Genetic counselling attempts to improve early detection and prevention of colon 
cancer, by identifying those at high-risk. Surveillance recommendations were 
found to be well adhered to by patients who received genetic counselling for 
positive genetic results(36;79). 
The subjects' actual participation in colonoscopic surveillance and their opinions 
about choices in health-related behaviour were ascertained by questions 26, 27 
and 28. This data was compared to their genetic mutation status. 
The individual's beliefs and attitudes about the effectiveness of preventative 
surveillance were measured by questions 29 to 36. Their opinions about colon 
cancer, beliefs about the effectiveness of surveillance methods, and the reasons 
and motivations for accepting/rejecting surveillance, were accumulated. 
Surveillance forms part of the preventative health mode1(78) that combines sets 
of factors/variables which could influence an individual's decision to take 
preventative health action. The following four factors make up a preventative 
health model: 
1. Background factors - sociodemographic information. 
2 Representation factors - perceptions with respect to the threat and 
procedures available to cope with the potential threat. 
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3. Social influence factors - relationships of individuals with health care 
professionals and social norms regarding prevention. 
4. Program factors - individual, group, or mass communications. 
In isolating, the representation factors of Myers et al(78), the perceived 
susceptibility to the threat of disease, severity (Question 29), curability (Question 
30) and worry (Questions 30, 31 and 36) about the consequences, which shape an 
individuals' psychological view of the threat, were measured. 
Myers et al(78), from their preventative representation factors, suggest that 
"individuals engaging in preventative health behaviour, must judge it to be 
technically effective (Question 34), practically convenient (Question 33), and 
personally beneficial and actively encouraged by significant others" (Question 
35). They call these perceptions salience and coherence. 
3.4.3 Translation 
The English questionnaire was translated into Afrikaans. The clinic registered 
nurse in Okiep (town and clinic where much of the Northern Cape HNPCC 
management and co-ordination occurs) was consulted to make sure that the 
choice of words was accurate (compared to the English versions) as well as 
making sure that the vocabulary would be understood. 
Once the translated questionnaire was piloted, it was critically scrutinised for 
appropriateness of responses to questions by the pilot subjects that could have 
been due to the translation. The pilot subjects made constructive translation 
suggestions and these were adopted. 
3.4.4 Pilot study 
The English and the terms used in the questionnaire were adapted to suit the 
South African context (especially the sociodemographic section) and then 
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translated into Afrikaans·(Appendices 5 and 6). Five Afrikaans questionnaires 
were used as a pilot study to guide further changes to the measuring tool. The 
main aim was to create a tool that the subjects would easily understand, retain 
the original meaning and ensure a reliable measurement 
Five individuals from a HNPCC family with a different mutation (hMU12 with a 
cr deletion at 1220 on the gene! exon 7) who resided in Cape Town were asked 
to complete the translated questionnaire. These individuals were of similar 
ethnic characteristics and economic and educational status to the sample for the 
main study. They bad also received predictive genetic test results during a 
similar time period. 
Five questionnaires were issued (between 17 February 2003 and 7 March 20(3) 
and four were returned. 
The data fields were transferred to an excel spreadsheet with each question 
placed in its own column and each questionnaire in its own row. The translated 
questionnaire was re-evaluated, with guidance from the pilot respondents 
comments and responses to the questions. 
The statistician assisted with answers to questions about how the data should be 
captured (Appendix 9). In performing this exercise it became clear that changes 
to the questionnaire were required These changes were implemented 
(Appendix 6 - Final Afrikaans questionnaire) 
3.4.5 Validity 
3.4.5.1 Face validity 
The instrument was chosen for this research because of itS face validity, as its 
variables appeared to fulfil the needs of this construct 
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3.4.5.2 Content VaIidity 
Content representativeness(93) was found in the international literature 
reflecting the measurements of knowledge and attitudes toward predictive 
genetic testing. 
3.4.5.3 Construct Validity 
The measurements of individuals' knowledge and attitudes toward predictive 
genetic testing were divided into four objectives (sociodemographics; knowledge 
and attitudes; effects of genetic testing on psychological and functional health 
status; and effects of genetic testing on medical decisions). These objectives in 
turn were met by various validated scales and inventories(7;93). 
3.4.6 Reliability 
The instrument for the current study was received with permission &om the 
Victorian Oinical Genetics Services (Australia) (Appendix 3). Their instrument 
contained 11 well..cfocumented and previously validated scales and inventories. 
For the purposes of this study the complete questionnaire was modified to suit 
the South African situation and piloted once for the purposes of maintaining the 
original meaning of the questions in the translation. 
Polit and Beck(7) state that reliability coefficients, that measure internal 
consistency, are adequate at .70, but desirable at .80 or higher. 
Results published by researchers who developed and utilised the scales and 
measures used in the instrument, were considered to be vital information for 
proof of stability and internal consistency of the instrument This is shown in the 
following examples: 
1. Lerman et al(58) found that the twelve item scale for measuring the 
benefits and limitations of predictive genetic testing to have a high 
internal consistency of a= .83 and .81 respectively 
45 
2. Miller(74), in her article on vaHdating the monitoring and blunting as 
coping styles, did a test-retest to assess the stability of the subscales. She 
found the monitoring subscale to be stable with a reliability co-efficient of 
r =.72 and the blunting subscale r =.75. 
3. Martea.u and BeJder(86) developed a short form of anxiety inventory. 
They proved the short version to be reliable and vaHd, with an internal 
consistency of a = .82 for the six item scale. 
4. Horowitz et al(83) revised the impact of events scale and found the 
stability of r = .86 and internal consistency of a == .78 for the intrusion scale 
and a = .82 for the avoidance scale. 
5. Bjelland et a1(85) looked at the vaHdity of the Hospital Anxiety and 
Depression scale (HADS) and found the mean internal consistency to be a 
=.82 
The above results show that the instrument had measures that were reliable. To 
prove its reliability in the current research, the results were assessed by 
comparing them to those found in the international literature. 
The factor used to prove that scores could be produced repeatedly and 
consistently within the instrument were the questions about faecal occult blood 
(FOB) testing. These were posed in two dif.ferent sections (impacts on medical 
decisions and knowledge and attitude) of the instrument, involving five 
questions (Questions 22, 26d, 26e, 34 and 35). 
The results could substantiate the reliability of the instrument by proving that 
the majority of the South African subjects should consistently not have been sure 
of FOB testing. 
3.4.7 Data Collation 
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3.4.7.1 Data Colledion 
A research assistant was appointed and the eligible sample list created. These 
individuals were telephonically recruited where possible by the researcher, local 
clinic nurses, and family members who were asked to assist with recruitment of 
blood relatives who were not readily contactable. 
It became quite clear early in data coll~on, that it took at least one hour to 
complete a questionnaire. The majority of subjects took the questionnaire home 
and completed it without the proposed supervision. The questionnaires were 
returned a month later when the colonoscopy surveillance team visited the 
Northern Cape. In the Western Cape the completed questionnaires were either 
delivered to the research assistant or arrangements were made to collect them. 
The questionnaire was supplied in a pre-packaged personally addressed 
envelope delivered to the relevant person It was delivered after written 
informed consent was obtained from the subjects. The following explanation 
was given to the subjects: 
1. The questionnaire should be completed in private. 
2. Once the labelled envelope was opened, the envelope should be 
discarded. 
3. To check that one questionnaire and one unlabelled envelope were 
present in the labelled envelope. 
4. Once completed, the questionnaire should be placed and sealed in the 
unmarked envelope. 
5. Maintain the integrity of this envelope and return it to the researcher. 
3.4.7.2 Bias 
• It was attempted to keep the situational contaminant of the researcher's 
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presence to a minimum. In order to achieve this, the researcher attempted 
not to stay in the proximity where the research assistant was engaged 
with a research subject 
• At all times completion of the questionnaire was voluntary and no 
pressure was exerted on the subjects to participate. 
• A table was created comparing the profiles of the respondents and the 
non-respondents (Table 3.3). 
• Finally, in order to identify a bias by positive-tested respondents, a 
comparison was made of the responses of the research individuals whose 
genetic test results had been either positive or negative for the hMLH1 
(exon 13 C1528T) HNPCC mutation(94). 
3.5 Ethics 
35.1 Rieb/Benefils 
The subjects who voluntarily assisted with this study had been involved with the 
genetic research service since the mid 1980's. The essence of this research project 
was to obtain an honest answer about how the clinico-genetic service and 
surveillance program had impacted on the lives of the subjects. 
This research project would reflect personal and collective attitudes and opinions 
of the research sample. Future and current service providers could be informed 
with knowledge that could predict psychological trauma to an individual at high 
risk. Their predictive testing and surveillance management could be altered 
accordingly. Changes to the current management protocol (Appendix 1 -
Protocol) could be guided by the recommendations of this small descriptive 
study, which serves as a pUot to further research 
35.2 Voluntary participation and anonymity 
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The researcher and research assistant created an awareness of confidentiality by 
initially creating trust with ensuring that time was spent explaining the purpose 
and voluntary-ness of the study. 
Maintaining total anonymity was not possible as the cohort was well known to 
the researcher. Every respondent was therefore given assurance (verbally and in 
writing on the information sheet) that his or her individual identity would 
remain anonymous and protected. 
3.5.3 Informed consent 
An English consent form and information sheet were created and translated into 
Afrikaans. These were incorporated into the English and Afrikaans 
questionnaire packages (Appendices 4, 5, and 6). 
All participants were 18 years and older, thus legally competent to participate in 
the research and sign their own consent Written informed consent was obtained 
from all subjects. It was made clear that they could withdraw at any time and 
that choice of participation would not affect future medical treatment 
3.5.4 Autonomy and privacy 
Autonomy is difficult to maintain when decisions involve families. In the 
interests of time management, respondents were permitted to take the sealed 
questionnaires home and return them within one month. The justification was 
that the principle of autonomy, as well as the maintenance of confidentiality and 
privacy would be improved. Social pressure and stigma could be minimised in 
this way. 
3.5.5 Confidentiality 
The information sheet and consent form did not require identifying information 
and identification codes were allocated. To prevent researcher bias, the data 
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collector maintained a strict numbering system for the completed questionnaires. 
Reassurance was provided that information supplied in the questionnaires 
would be kept separate from identifying information. Access to identifying 
information would be restricted to the researcher only. 
The double envelope system was another attempt at providing confidentiality. 
A predictive genetic result is very confidential information. Family members and 
clinic staff from small towns know each other well and are usually very 
supportive of each other. It was made clear that even though the envelope had a 
name on it, the participation of individuaIs was not dependant on predictive 
genetic test results. In essence this meant that although the member was 
participating in the research, it did not imply that they were mutation-positive. 
Once a questionnaire was completed, the subject was instructed to seal it in the 
return address envelope. This was strictly adhered to by all the subjects. The 
envelopes were opened later by the researcher and filed according to allocation 
codes for data collation and analysis. All these questionnaires were safely 
stored. 
To maintain ethical integrity, the data initially used to identify and contact the 
individuaIs was collated and analysed separately from the ucr Human Genetics 
database, thus preventing any links to the current service and individuals in 
their care. The data was kept in the strictest confidence. All the final results do 
not identify any of the subjects. 
The study proposal was submitted and approved by the Research Ethics, 
Committee of the University of Cape Town (Reference number 334/2001 -
Appendix 11). 
3.6 Analysis 
Predictive genetic test results are confidential. These results formed the basis of 
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this study and were integral in selection criteria. Including this vital information 
was essential as it would shed light on whether the result itself was possibly 
responsible for. an individuals' response. Maintaining confidentiality was thus 
vital. The results were transferred to a spreadsheet and aligned with the 
appropriate allocation code, thus no individual details were integrated into the 
data. 
3.6.1 Statistics 
The statistician advised that all unanswered questions be included in all 
frequencies. Descriptive and analytical statistics were used to explore the data 
from the study population. All data was assumed to be nonparametric because 
of the non-normal distribution of scores. Frequencies, percentages, measures of 
central tendency and dispersion were produced (median and upper and lower 
quartiles (q1 q3». 
3.6.2 Summary of analysis 
- STATA(95) was used to create descriptive statistics from the raw research 
data captured on a spreadsheet (Microsoft Excel (Microsoft office XP 
20(3». 
- The descriptive data was presented in Microsoft Word. 
- This descriptive data was grouped into the described scales or inventories 
and placed back onto a spreadsheet (Microsoft Excel (Microsoft office XP 
20(3». 
- Microsoft Excel was then used to rearrange the descriptive nominal data 
to produce collective results and graphical descriptions. 
- 2x2 pivot tables were created in Microsoft Excel (Microsoft office XP 20(3) 
with the grouped nominal data. 
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- The data from the 2x2 tables was analysed by SfATA(95) in search of 
statistically significant associations between descriptive variables within 
the four objectives. Chi2 or Fisher exact (when any of the four frequencies 
was below 5% in the 2x2 table) non-parametric statistical tests were used. 
A result of p = 0.05 and below(5) was considered to be significant 
- StaiSoft Statistica 6(96) computer program was used when comparing two 
independent samples. The Mann Whitney U non-paramebic test was 
used. 
3.6.3 Data analysis 
The analysis was arranged according to the research objectives: 
Objective 1: To establish the sododemographics of the study population 
(Questions 1 to 10) 
Age (Question 6), number of cbildren (Question 11) and number of relatives with 
cancer were nominal variables and the rest of the data was categorical. 
The categorical data needed to be converted into a nominal form thus enabling 
statistical analysis and associations to be made e.g. categorical results of positive 
or negative predictive genetic tests were then converted to nominal data with 
positive = 1 and negative == o. 
Questions 1 to 9 excluding question 6 were single questions (employmen~ 
education, marital status, origins, gender, faith and medical aid) and each had its 
own nominal conversion list. 
Question 6, age, was a nominal variable. 
Question 10 was a set of questions about children, number and ages. A simple 
nominal list was created for Yes and No. The other information was used in the 
descriptive statistics. 
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Ogective 2: To ascertain the knowledge and attitudes of individuals, who have 
had predictive genetic testing for HNPCC, toward genetics, cancer risks, and 
how to prevent development of cancer (Questions 11, 12, 13, 15 and 16 to 24). 
Question 11 consisted of eight questions (related to cancer exposure) with 
nominal variables. These were combined to show how many respondents had 
affected first-degree relatives. 
Questions 12, 13 and 14 were single questions (own experience of genetic testing) 
with a choice of responses. These responses were used descriptively and then 
regrouped to create nominal data. 
Question 15 was a 12-item scale. Data was grouped into responses i.e. benefits 
and limitations. The respondents answered not at all, somewhat and very much 
or not applicable (in some cases) to the 12 statements. The frequencies were 
tabulated and very much and somewhat were converted to percentages and 
added together to give an overall percentage for both the benefit and limitation 
questions. These results were used descriptively 
The original responses in the raw data for the two responses was converted to 
nominal data with not at all and not applicable = 0 and somewhat and very 
much = 1. Two scores (one benefit and one limitation) per respondent were 
generated. The limitation score was subtracted from the benefit score with a 
resultant individual risk score. 
Questions 16 to 24 were a nine-item knowledge scale. Results were grouped into 
correct and incorrect answers. This data was used descriptively per question. A 
resultant score out of eight (excluding the question about faecal occult blood 
testing) per respondent was used to compare with related factors. 
Okjective 3: To measure the effects that the genetic test results have had on the 
psychological and functional health status of subjects (coping style (Questions 37 
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to 40), stress (Question 41a, b, and c) (Questions 55 to 70), depression (Questions 
42 to 48), anxiety (Questions 49 to 54). 
Questions 37 to 40 made up a validated MBSS scale. The data was grouped 
according to the responses (coping style) and lists of scores were established that 
were described. A sum score list was created and used. as a nominal Jist 
Question 41 had three components, which were used. descriptively 
Questions 42 to 48 make up a seven-item scale (HADS). The raw data consisted 
of possible scores of 0, 1, 2 and 3 per question. The scoring in questions 44, 45 
and 46 was reversed to score 3, 2, 1 and O. The sum of each individual score 
could range from 0 to 21 with below eight considered normal, :t!: eight suggestive 
of depression or :t!: 11 indicating the probable presence of depression. Descriptive 
data was derived as well as a nominal list created, after placing results above or 
below a level stated in the literature. 
Questions 49 to 54 were a six-item scale (SfAI). By adding the numbers allocated 
(1, 2, 3 or 4) per question, a score was obtained per respondent A nominal list 
was created of the scores above or below a level stated in the literature. 
Questions 55 to 70 were a 1S-point scale (IFS). The responses were divided into 
intrusion and avoidance subsca1es and descriptive scores were derived. A total 
nominal list score was created, after placing results above or below a level stated 
in the literature. 
Oijective 4: To evaluate how genetic testing impacts on medical decisions made 
by subjects who have received predictive genetic test results (Questions 25 26, Zl, 
28, and 29 to 36). 
Question 25 was two similar questions (opinion about colon cancer risk) 
answered in different ways. Both were used. descriptively and statistically 
compared to genetic results. 
54 
Question 26 consisted of five questions (surveillance opinions). These were used 
descriptively and statistically compared to genetic results. 
Questions 27, 28a and 28b, and 29 to 36 were questions (colon cancer and 
surveillance) with a choice of responses. These were used descriptively and 
statistically compared to genetic results. 
Graphs were constructed utilising this data (Results Chapter 4). 
3.7 Conclusion 
This chapter described in detail the research design, sample size and selection as 
well as the data collection process. The method of data analysis was outlined in 
this chapter. The results are discussed further in OIapter 4. Recommendations 
were made for changes to the current clinico-genetic service as well as possible 
further research opportunities in Chapter 5. 
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4 CHAPTER 4 - RESut TS 
4.1 Introduction 
The analysis of the datil is arrangoo into four sections each representing an 
objective i.e.: 
I. Sociodcmographics 
2 Knowledge and attitudes 
3. The effects thai the genetic test results have had on psychological and 
functional health status 
4. How genetic tl'Sting impacts on medical dedsions 
4.2 Analysis 
Profile of the re5ean:h sample 
,.." 
,.." 
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Figure 4. 1: QU<'Stionflaire response from the lOur families in the final re!j(!arch 
sample 
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Questionnaires were ise;ul'<i tQ 119 individuals from four diffen>nt families with 
I-INPCC. It took appraximatdy twl) months (29 July 2OO'J to 6 Octoh!r 2003) to 
coIll!C:l the ljucstionnain:_'S. nH~ response rale was 64(54%) respondent!l and 
55(45%) nOrlMn'Spondent!l (Figure 4.1). 
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Figure 4.2: The genetic mutation slatus of individuals who m;ade up the final 
research sample from the four fami lies 10 whom questionn.lires were issued 
The genetic mutation sta tus 01 the 6-1/ 119 respondents revealed that 3 1(48~ ) 
were mutation-positive and l3(52~) were mutation-nl'gative (Figure 4.2). 
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Figure 4.3; The g('nt!tic mutation st.-ltus of individual~ from the four families thai 
did not rerum questionnairl'$ (oon-rl'Spondcnts) 
The n(m-rcspond~ts were from three different families with 19(35" ) who were 
mutation-positive and 36(6S~) who were mutation-negative (Figure 4.3). These 
genetic results were givcll between 1997 and 2002. 
,. 
Graph 4.4 Area distribution of respondents and non 
respondentsn=119 p·OOO'/OIi2 
Egure 4.4: The residential areas of respondent and non.respondents 
The area distribution of the non-respondents (Figure 4.4) showed that the 
majority came from the Northern Cape 35(64 ~) with 32(58%) from rural areas. 
The majority, 42(66%), of respondents came from urban areas and 31 of them 
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Figure 4.5: A comparison 01 the Dse-ranscsof :\.'Spondenls and non-respondents 
Although the age of respondents was similar 10 non-respondents (median 38 \' 
36 years (upper and lower quartiles q l-q' 31-49 v 28-47). there was a trend 
towards a greater proportion of responde,,!. . Jl the fourth decade of lifu, and 
non-respondents in the third decaj .. of Ufe (Figure 4.5). 
4..2.1 Sociodemographics of the stud)' popuh' tion 
4.21.1 Gendn 
Gender (n - (4). 
The respondent group consisted Df 40(63":1.) females and 24(37%) males (figures 
4.1 and 4.9) 
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Figure 4.6: The !'Ige range of the respondenl:!l 
The median age was 38, ql-q3 31-49 (Figure 4.6). 
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Figure 4.7: The age range and gender of the respondents 
, , , 
1be age and gender distribution of the research subjects showed an even 
distribu tion of II"IilJes and fema.les 3CJ"OSS the age ~-pectrum (20 to 59) (Figure 4.7). 
46(72%) of the 64 respondcots were in the30 10 59 year range. 
61 
. ·OtoO_~U 







• • ...- , . , 
Figure 4.8: The age rilnge and genetic mutiltion results of respondents 
There were 14(45%) of the 31 mutation·positi\le respondents who were in the 
fourth decade of lill', while ten of the 33(30%) mut:ltion-ncgatl\le respondents 
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Figure 4.9: Ag(>, gender anJ g{'nt'tic mutation result5 
Th06C that had positive genetic results wcre 15(62~) of the 24 males and 16 
(40%) of the 40 female,. 
ThOSt! that had negative genctic T('SullS were 8(331.) of the 24 males and 22(55%) 
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Figure 4. 10: Places of birth of the respondents 
The majority of the respondents 36(56%) were born in tl1l' WC$~rn Cape and 
26(40%) wert" born in the Northern Cape. One individual was born in Namibia 
and the other did not document the plare of birth. 
Two thirds of the rl$pondcnts were bom in Kommagas 15(23%), Wup~'ftal 
12(19%) and Worcester 13(20%). Kommagas (Northern Cape) and Wuppertal 




Figure 4. 11 : Rural and urmo plares of birth of respondents 
IlaJf of the respondents M.'re born In rural areas and the remaindt'r in urban 
are.u (two unknown) (fdblc 4.1) (Figure 4.11). 
Table 4.1: Comparison of rural and urban pian'S of birth 
Northern Numwr of 







Western Number of Weslern I Number of 
Cape Rural Respondent. Dpe Urb;tn Respondents 
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Strand 1 
WOKeSb:r 13 
Totals 12 Totill. " 
4.2.1.3 Faith 
The ma;ority of the respondents 62(~) 1l'poI'"ted that they had a $trong filith . 
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I-lgure: 4. 12: School education or rl'Spondcnts 
-, 
School Mutation ends at Grade 12 (Standard 10 or matric) and 2~33") achieved 
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Figure 4.13: Post school education of resrondents 





Figure 4.14: Marital status of the resrondents 
J 
Half of the resrondents had partners 34(54" ): 2(3%) were divorced, 3(5%) had a 
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Figure 4.15: Employment sla tus of the respondents 
Iialf of the respondents had no personal income 33(52%). 7(10"') o f these were 
housewives, 2(3%) were full-time students and 23(36%) were unemployed. 001' 
third had full-time employment 21(33"'). Seven were employed part time (II "), 
2(3"') were unli t for work and 1 was retired (Figure 4.1-1). 
4.2.1.7 Gender, employment. lIW'it,i1 .btus lind educ.ation 
Some fonn of income was available to 31(48"') subjects, 23(14"') of these 
individuals were females and 8(26"') were males. MQre than half (n) of the 40 
females workoo, however only 8 of the 24 males worked. Of those thilt were 
employed, 24 of 39 had no post-school education and 6 of 11 had post-school 
education. Of the working females, 10 had no p ... rtne~ and 12 had partners. 
One wOl"king woman did nol state whether she had a partner or not Two 
working males had 00 partners. while 6 had partners. 
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4.21.8 Medical Aid 
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Figure 4.16: Mt>(\ ical aid/ in.~urance and incomt' status of rt'Spondents 
TIle majority, 46(72%), of the n.>SpOndents did not have any fonn of medical aid 
and just over half (25) also had no income. O f the 18(28%) respondents who had 
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Figure 4.17: Number of children per respondent 
Thl' majority of respondl'nt!;, 48(73%), had child1l'n, while 16(25"') did nol. Male 
children ilC(ountro for 52"'(61/1 17), while females made up 48%(57/117). Most 
58(90%) respondents had 0 to 3 dlildn'T\ per family (Figure 4.17) and 24(38%) 
weT\' two P.1Tt'nt famiJit'5 with children (Figurr 4.18) while 21(33%) were single 
parent families. 
Figure 4.18: Rt.'!Ilpondl.'tlts family s tatus 
n - 117 _.-





FigUrt' 4. 19: Age distribution of respondents' children 
"-·Iore than half, 58%(68 of the 117), of the , hildren were ~low the <lse of 20 
(Figure 4.19). 
• 
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Iligure 4.20: Re:opomlents choke of primary health care 
The local government funded clink was used by 36{56%) ~dents while 24 
used iI privare general practitioner for their primary health care !K'eds (Figun' 
4.20). 
4.2.2 Knowledge and attitudes 
4.2.2.1 C.neer Risk. 
AU 6-1 research sut;ects had rl"C'eived predictive genetic rest resul15. 62 of these 
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Flgurt' 4.21: Thl' age al which respondents reali5('d they were at-risk for HNPCC 
Respondents reaUscd th,-,t they were al· ri!>k fur HNPCC ~twl,<,n the agt'S of 12 
and 70, (Median - 29 y~, 'l1-q3 21 - 40). A th ird, 2O(31'X.) of !he subjfds rt'a liscd 
this risk between the ages of 20 and 29 but 25(~) wen' over 30 whl'fl they first 
bl.>came aware of this risk (F igure 4.21). 
All rcspondl'nts had met the entry criteria but 10 of 63(16") respondents 
maintaill<.'ti they had nol had a predicllYe genetic blood It'Sl and a further fou r 
were not sure. Six of the 14 (who responded that they had not h.,d a predictive 
genetic ~ult) are mutation.-Jl'O!"itive. 
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Figure 4.22: The person who had advi<;ed the respondent to have II, p~dicli\'e 
genetic test 
Of those who Solid they had not had or were unsure if they had had a predictive 
genetic test, 13 answered this question (Figure 4.22). Four of the 49 who agreed 
that they had results did oot an.~wcr. One individual did oot answer ei~r 
question and had a negative genetic mutation (Graph 4.22). 
4~2.2 Exposure 10 CannoT. 
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Figure 4.23: The respondents' eJo:posure to cancer 
Of the 12(19%) respondents who had iI cancer themselves, 10 had colon cancer 
and two (who had negative HNPCC genetic tests) had breast ca~r. 
Of the respond<'Tlts wi th close r<'latives wi th cancer, ZJ of 60(45" ) respondents 
who answered this question had a brothi':'r and 10 of 58(11") had a sisb:' r who 





Figure 4.24; Number of respondents wi th fitst-degll.~ rela tives wi th cancer 
One 01 the 64 respondents did not answer the questions roocerning rc1ativClil 
with ~r. 52(83") reported at least on(! fi rst-degrl't! re ]Dtive who had a c.lneer. 
I I reported that they had no first-degree rdatives who had developed canCl'r 
(Figure 4.24). 




ro __ _ -._.-., '--.. <-_ ... . ". 
- .,.. 10'!00 20'10 :10'>. _ _ _ """ _ .."., .00'II 
"'01 __ .... 
~ .. 
Figure 4.25: The percentages of responses to ~ six questions on the perccived 
benefits of predictive genetic IL"§ting 
The I"('Sponuenl:!l perreived risk reduction and knowledge of their own risk o( 
cancer as the most important benefits of genetic testing (Figurl" 4.25). 
In half the respondents. gmetic testing inAuenct'd decisioll!i 10 have children (18 
respondents had a negative geactic mut.ltioo result and 12 had a positive ro!SUlt). 
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figure 4.26: 'The percentages of rt'sponses to the six qul'Stions on the perceived 
limitations of predictive genetic testing 
More than half the respondents were concerned about the dfect of predictive 
testing on themselves ( 14 respondents Mel a positivc genetic mutation r~'Sult and 
23 had negative results) and their family (IS respondents had a positive gl'n (':tic 
mut3tion reo;ull and 18 had negative results) (Pigure 4.26). 
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Figure: 4.27: The risk scores of the lespondents 
"1111.' median risk score was 3, ql-q:l I - 4. 
, • • 
Fiv(' (8%) respondents p!!rccived that predictive genetic testing was harmful 
(Figure 4.27). Thrl'C of these individuals had a negative predictive gcm>tic test 
result (Figure 4.28). 
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Figure 4.28: Utilising the risk score as the resultant perceived benefit and 
limitation to compare with respondents' genetic mutation results 
Ilqual numben; of respondents with positive geIK'tic mutation I\'sults, 27(42%) 
and negative results, 26(40%), felt they had benefited. from receiving their 
pn>dictivc gent>Lic result (Figure4.28). 
4.2.2.5 Knowledge of bowel canccr 
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Figure 4.29: Percentages of COl'l'l'Ct responses to eight questions ascertaining 
respondents' knowledge of HNPCC 
Most respondents, 59(94%), believed that colonoscopy would detect a colon 
cancer (Figure 4.29). 
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Figure 4.30: 1be distribution of respond ents' scores. out of eight. 10 the HNPCC 
knowledSl!'-<Jucstions 
"ille median SCOIl' was 4, q l-q3 2 · 5. Sixteen (25%) ~pc'ndl'fll:i soored 5/ 8, and 
10 scored higher (6 and 7/ 8). Thirty eight (59~) fl"Spoool'nls 9:OI'ed between 0 
and 4/ 8 (Figure 4.30). 
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Figure 4.31: The dislribution of fI.':5pondents' S('I)tl!S. out of eight. to the HNPCC 
knowledge questions compared to their genetic mutation rl!Sults 
Of the 33 respondents who had negative genetic tt.'sults 9(27") scon..'<f 2 out of 8 
and a further 19(59%) scor~-d 4 to 7 out of 8. 20(65%) of the 31 respondents with 
mutation-positive results scoroo 4 to 7, while 13(38") scored 0 to 3 out of 8 
(Figute 4.31). 
4.2.3 Psychological and £unctiolli'll health s tatus 
4.2.3.1 Coping Style 
Coping style scale n " 60. 
The median monitors score - 6.5, qJ-q3 3 - 9. 
The median blunters score - 2, q 1-q3 1 -..1. 
Median sum score was 4.5, q 1-q3 2 -7. Individuals !!Coring O!! 4.5 were considered 
tn be monitors and <4.5 blunlers. 
Four individuals did nol compl\!tc this section. 30(50%) were monitors and 
bluntcrs rcspecth·ely. 
e o " -. -. 
Coping Sty" 
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Figure -1.32: The re;pondents' aUocall'd roping styles cum pared to their genetic 
mutation results 
Of the four ind ividuals who did not answer the roping style questions three had 
po5itive gelletic results, Tl'Sulting in 28(47':') mutation-positive and 33{55%) 
mutation-negative respondents to the roping style questions 
Of the 30 monitors 1l(36%) had positive genetic results and 19(63%) were 
negative, while 16(5.3%) of the 30 blunters had po5itive genetic:' results and 14 
(46%) had negative results (Figure 4.32). 
4.2.3.2 StreS!! 
While 32(50%) respondents reported not having had a s tressful Life event in the 
last year, 22(34%) dil imed they had and 10(16%) did not answer the qUl':Stion. 
Al though 22(35%) respondents claimed they had a stressful Life event. 30(47%) 
individuals listed i1 t least one s tressful event in the next question. Of the~, 24 
illdividuals listed a single s tressful event, fi ve listed "'10 l'vents and one person 
lis ted four evCllts. One respondent claimed they had had a stressful life event 
but did not document what tha t event was. 
Al though five of seven respondents claimed they did nol havt" a stressful Lift" 
event in the last year, one individual claimed onc evcnt and two, two events. 
Two respondents did nol answer the life strcs.s question but allocated th ree 
('vents between them. 
A lotal of 31 respondents St.'em to have had a litrcs.sfuJ Jife event in the ycar prior 
to this sludy. 38 e\'enls were logged for 31 individuals who reported stressfu l 
events (Table 4.5). 
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Table 4.5: Li.~ted stressful events in the last yea r 
Sl~ful """nl in Ih" lasl y"ar Number of evenlS 
Pa...,nts d iagnosed with canct'r , 
Parents died of ca!'l<:Cr 2 
Siblings diagnosed with cancer 6 
Sibl ings dil.:d of GlnC'er 2 
Death of a family member or friend from a caU:ieothcr Ihan canrer 11 
Own dillgnosb of benign bo;r..'eI disea:ie 3 
Work related ~ 8 
0""', 4 
TOlal " 
Of the 38 $l:rcssful events, 15(39%) events were relilled to deaths (four were 
cancer related) and 12 were reJalL>d to Cilnrers. 
F'II . 33 Dt~l" 01 '''''' In.,. 
Figure 4.33: The degree of stress caused by the reported stre$f'ul e ... enl 
The degree of stress creilled by the s~rs was measured using the Likert scale. 
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'Zl respondents rompleloo !his question. lbc range was 0 to 100% with the 
mt...:Iian at SO'l and q l-q2 20- 80 (Figure4.33). 
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Figure 4.34: Stressful events and gCf1('tic mul<ltion results 
A tolal of 31(48%) reo;poudcnts reporllod having stress, Or a str~~ful evenl in the 
lasl year. 33(52") recordl'li no Stn$S and in addition did not document a 
stressful event in the last year (Figure 4 .34). 
4.2.3.3 Impact of Events 
Items WL>re scored by frequency of their occurrence (n - 64). 
The avoidance subseale median - 9.5, ql-q2 3 -IS. 
The intrusion subscale median - 4. q 1-q3 0 - 9.5. 
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Figure 4.35: The impact of events scale consists of three SC01l'5 (avoidance, 
intrusion and tolal) 
Of the 58 rt:SpOIldents, 6(10%) had it t()tal SOOn' of ~ 40, indicating it significant 
stn'S/l response (FIgure 4.35). Four (If the six were mutation-negative and tv.'o 
were positive. 
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Figure 4.36: The depression.o;rore range of the respondents 
I 
Of the 6 1 respondellts 3(5%) had a depression score of 11 and above (probable 
presence of depression) while 13(21 %) had scores above 8 (suggcstive of 
depression) (Figure4.36). 
No. OIlndiYidu ... 
" -M 
0107 BI010 111021 "" .. -
Dop,.,,'on.cM ."", •• 
. R>o .... e->O''' , ..... 
o Nog_ ~I<: , .. <Ito 
Figure 4.37: Respondents' depression !iCOres oompared to their genetic mutation 
results 
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Of the 64 respondcnts 10(16%) who showed probable signs of depression were 
mutation. n<'gative (Graph 4.39), 11 were female and five were male. 
The three sub;ects with dinical dcprcssion were mutation-positive (two were 
female and one was male). 
4.2 3.5 Anxictv Scale 
Five individuals either responded to only one or none of the scales' statcmellts, 







Figwe 4.38: Anxiety scale results oompar<.'(i to genefu: mutation results 
Of the 59 rcspond<.'Ilts, 22(37%) had a pro-rated anxiety score above 42 of whom 
L I subjects were mutation-positive and 1 L subjccts were mutation-negative 
(Flgure4.38). 
4.2.3.6 Compar isons with coping style 
• 14 blunters and 14 monitors experienced strcs/ifuJ events. 
• Four blunters and two monitors hat! an impact of oolon cancer event 
stress response. 
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• Four blunter!! ami J J munitun had potential depression.. 
• II blunter!! and 11 munilt)rs had anxiety. 
4.2.4 How genetic tl$ling impacts on medical decisions 
4.2.4.1 Awau.'ness of ri sk and medical decisions made 
Of the 64 respondents, 18(28%) had surgery. two were genetic mutation·negative 











fjgure 4.40: The genetic mutation rCl)u lts of thoSo:! who had colonic surgery 
Of the 64 respondents, 16(25%) had <x)wmk surgery and were muta tion-positive 
(Figure 4,40). 
- -"-" • , • • • • . ,~ .-. , , , • , 
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Figu~ 4.4 1: Respondenb' g ... netic mutation results and opinions of their riSk for 
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colon cancer compared to people their own aSe 
Of the 6(9%) respondents who did not answer this '1ucs1ion, five were mutation-
positive and four had colonic surgery for rolCNl ~ncer_ 
Of the 64 responu C'nls, 19(30%) felt their risks weI"(! the same and 12(191.), a little 
or much lower than people their own age. Of these respondents, ten were 
mutation-posith-c and rour had colonic surgl!'f)' 
Of the 64 respondents, 27(42%) fclt their risks -Nere a little or much higher than 
people their own age and 11 of these inJividuals w(!rC' genC'tic mutation-
negative, 16 were mutation-positive with ho:alf having had rokmic surgery 
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Figure 4.42: Opinions o f risk for do!veloping colon caocer amI genetic mulation 
results 
Of the 64 respondents, 7( 11 %) did not givC' their opinion, three of these non-
respondents were mutation-p05itive and one hLd rolonic surgery. 
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n - Sl, Median SO~. q l-q3 20~ - 90~ . 
Using a Ukcrt scale, 23(36%) of the 64 respondents felt their chilJK1"S of 
dL'Ycloping colon Gil.flCer WeTe less thilIl SO~ and four of these respondents were 
genetic mutarion-poslu\'C and thrw had colooic surgery. 
Of the 6-1 respondenlS, 3-1(53%) fel t they had a SO" and greak'r chan«' of 
developing colon cancer and ten of them were mutation-negative (rlgure 4,42). 
4.2.4.2 Health rela ted decis iol'ls 
.·om __ u ".,. ___ ..,., I 
Figure 4.43: Opini01l.'l on preventative colectomy comparco.J to rl"!ipondents' 
genetic mutation tl'Sults 
Of the 64 respondents, 28{44") reported thllt thL'Y would choose 10 have a 
preventative colectomy if they were genetic mutation-positive (Figure 4.43). 
4.2.4.3 Surveill.m(e decisions 
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Figure 4.44: Respondents' surveillance cllQict'S if tht·y had bIx-n mutation-
positive compared to their genetic mutation resu lts 
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Hgure 4.45: Respondents' surveillance choices if they had been mutation .. 
negative oomparo,.>d 10 their genetic muroli\)Il r<.'Sults 
Of the (H r<.'Spondents, 25(39%) would have more surveillance, lind 16 of these 
respondents were rnuliltion-negative. 
Of the (H respondents, 17(27'l(,) would not change surveillance and II of the~ 
respondents were murotion·po'Sitive. 
Nine mUliltion-positivl' and 16 mutation-negative respondl'nts would choose 
more freq uent SU(Vl'ilIance (Graph 4.47). 
4.2.4.4 Effects of genetic n.'!Iulls on beliefs abouteffectivenellS of sUD'eillance 
methods 
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Figure ·1.46: Rt.'Spondents· opinions of the severity (chance of survival) of 00100 
cancer and thdr genetic muliltion results 
Of the 64 respondents, 42(661.) (elt that people wi th oolon can«>r had a good 
chance of survival. More than hat( of \hesoI' respondents were mutation-positive 
9. 
and 12 of them had colonic: surgeI)'. Of the M respondents, 2:0(31 %) felt thai the 
chances of survival Wl're slim and 14 of IhL'lTl were mutation-negative (Figure 
4.46). 
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Figure 4.47: Respondents opinions of the curability of colon can«'r if found 
early and their genetic mUliltion results 
Of the M respondents, 51:1(90%) fell thai rolon cancer oould be cured (Figure 
4.47). 
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Figure 4.48: Responses by Il!SpondenlS to the 'worry' ilSIlOdatoo with 
colorKJ!!il'Opic surveillance deroctmg a (JOlon cancer and their genetic mutation 
re!iults 
Of the 64 respondents, 42(66%) were concerned thai 5urveillance might delect a 
colon cancer and 24 of these 5ubjects were mutation-negative (19 female and five 
males). Of the 64 respondents, 18(28") were nol concerned that surveillance 
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Figure 4.49: Opinions on the effectiveness (If colol'lOSoOOpy at detecting colon 
cancer and genetic: mUt.ltiOn results 
Of the 64 respondents, 54(84.%) fel t that oolonosoopy was effective al detecting 
colon canrer while S('\'en respondents were unsure of the efficacy of colonOSCQpy 
(six of the5e subjects weT(' mutation.negative) (Figure 4. 49) . 
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Figure 4.50: Opinions of Ihe 'salience' (firn.! il easy 10 do) of having a 
rolonoscopy and genetic mutation rt.'Sults 
Of the 64 respondents 40(63%) fell thai rolont)SCOpy was not a difficult 
procedUJ"1.' for thl.'Dl to enduJl.'. Of the 64 respondents, 14(22%) did not know and 
12 of these SUbjL'CIs were mutJliun-nega tivc (Figure 4.50) • 
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Figure 4.51: Opinions of the respondents 'worry' about being at-risk for 
eJ(tTaroloni<: cancers and genetic mutation results 
01 the M re~-pondel1ts, 5IttlU~) were conccmL>d about extrncoJOnJC cancers 
(Figure 4.51). 
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Figure 4.52: Recollection of having had a colon~py and gcnclk mutatiOl1 
results 
Of the 64 respondents, 43(67%) had previously had a colonosc:opy and 15 of 
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Figure 4.53: Recollection of having had a colonoscopy in the last two years and 
genetic mutation rC5u]t 
Of the 64 n..>spondents. 33152,,) said they had a colonoscopy in the last two years 
96 
and 26 of these subfL'Cl5. were gCJlCtic mutation-positive and seven were negative. 
Of the 64 respondents, 12(19%) had not had a colonosropy in the IOIst h..-o yeOl rs 
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Figure 45 4: Rt'Colicction of having an adenomatous poly p removed OIt 
co[onosropy and genetic mutation results 
O f the M respondents. 13(20%) hold an adenoma/ous polyp removed at 
OO[OfUl§COpY, 12 of whom weI'C mutation-positive and nine of these subjocts went 
on to have colonic surgery (Figure 4.54). 
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Figure 4.55: Respondents coping styles compared to the number of children they 
h,d 
The re;pondents with a blunting coping style hold families of 0 10 3 children, 
white moni tors had a range of 0 to 10 children (Figure 4.55) 
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Figure 4.56: Coping style and rt.'C(lllection of having had a colonoscopy 
Of the 60 re;pondents, 41(68%) had oolonoscopics and more than half (25) of 
these subjects had a blunting coping style. 
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Of til(! 60 respondents. 19(32%) had not had a colol105OOPY and 14 of these 
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Figure 4.57: Association between colon cancer knowledge scores and opinions of 
5urvival chances with colon cancer 
Of the 64 respondents, 38(59%) had higher mlnn COlOrer knowledge scores (4 to 
7) and 31 of them felt that there was a good chance of survival with bowel 
cancer. 
Of tile 64 respondents, 23(36%) had lower knowledge scores (0 to 3) and II of 
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Figure 4.58: Association between oolonO!iOOpy salience and those who 
experience benefits or limitations with thi'! predictive genetic testing process 
Of ~ 63 respondents. 52(83%) felt they hold benefitl'd from predictive genetic 
testing of whom 35 agn .. '\."j that a ooloooscopy would be a prOCt."jurc they .... ould 
endure (Figure 4.58). Of the 63 rl.'Spondents, 5(8%) had fell harm (limitations) 
from prl>dictive genetic testing but felt they could enduI'C a oolollOSCtlpy. 
p <OOOO._....." 
., , .. • 
103 
J1igurc 4.59: Association with having had a colOOO5COp)' and affectl'd first-
degree I'l'latives 
Of the 62 respondents, 52(84%) had a first-degree relative affectM with colon 
can!;Cr, 42 of them had a colonoscopy. Of the 62 respondents. 10(16%) 
respondents did not hove an affected first-degree relative and eight of them had 
nol had a colonosropy (Figure 4.59). 
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Figure 4.60: Association with opinions of early detection and cUTabili ty of oolon 
canC{"r and wloo cancer knowlellge scores 
Of the 6J respondents. 39(63%) had high colon cancer knowlt.>dge scores (4 to 7) 
and 37 of these subjects felt that colon cancer could be cured If found early. Of 
the 63 respondents, 24(38'10) had low knowledge !iCOres (0 to 3) and 23 of these 
s ulJ;ects also agreed about the curability of colon cancer (Figure 4.(0). 
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Figure 4.61: Association betwt'Cn opinions of 'severity' and 'curability' of rolon 
m"= 
Of 62 respondents, 58(94%) felt cancer could be cured if found early and 42(68%) 
fel t that pc!Ople with rolon cancer would survive (Figure 4.&1). 
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Figure 4.62: Associaticn of surveillaJ"lCe opinions if mutation·negative and 
severity of colon carx::er 
Of the 59 respondents, 40(68%) felt thai people who have oolon CclIlcer had a 
good chance of survival and 27 of them lelt they would either not change or have 
more surveillance if their mutation res.::!t was negative. Of the 59 respondents, 
19(32%) fult colon cancer gave little hope and 16 of them also wanted 10 continue 
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Figure 4.63: Association of opinions of salience and S(.'Vcrity of (olon cancer 
Of the 62 respondents, 42(68%) felt that people with colon cancer had a good 
chance ol survival and 40(65%) considered a colonoscopy easy to do (Figure 
4.63). 
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Figure 4.64: Association with having h.ld colonic" surgery and relatives affl.'CtOO 
with colon Cilncer 
Those that had colonic surgery all had relatives with a colon cancer. 11 
respondents who had not had colonic surgery also did not have rdatives with 
colon cancer (Figure 4.(4). 
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Figure 4.65: Associati{m between rolonk surgery (or not) and opinkms toward 
prcventatillc colectomy 
The data ba~ information of individuals who had colonic surgery oorTespondoo 
to those R-spond('nts who reported having had colonic surgery. No-one who 
had colonic surgery said no 10 II pr'Nenbtive colectomy (Figure 4.65~ /I.]ost. 
25(4.1%), of those subjects who had not had colonic sutgcry said they would 
consider it and seven had 11 positive genetic mutatiorl and 18 a n.:ogative mutation 
resull 
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Figure 4.66: A~iiltion with respondents with poto:!ntial depression and anltK>ty 
Of the 61 respondents, 15(24" ) had a pOh.'fltiill depression and 10 subjects al<;() 
had anxiety. or the 61 respondents, 46(75%) had no depression.. and.Jol of these 
subjects also had no anxiety (Figure 4.66) 
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tl gurc 4.61: Association with the opinion of salimct' of having a rolonCl'lCOJ')' 
and anxiety 
Of the 64 respondents, 40(63%), agreed thai they muld have a mkmosoopy and 
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23 of these subjl.'Cts had no anxi<'ty while, 1 0(16~) respondents fclt a coklnosoopy 
would be d ifficu lt to do and six of these subjloctsalso had no anxiety. 
Of the 6-1 rt.'Spondents. 14 (22") were not sure and 13 of these subjects also had 
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Figure 4.68; Association with the rt.'Spondents worry about surveillance d !!ll'rting 
a colon o,:ancer and depression 
Of ~ 61 respondents, L5(26~) had a potential depro!SSion and 13 of these 
subjlocts agreed that they were ron.r:emed that surveillance may detl'd 11 ooJon 
cancer, while 43(7tl~) respondents were not depresst...t and 27 of them were 
worrjed about finding a colon cancer at surveillance (Figure 4.(8). 
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Figure 4.69: Association of stress scores (1£5) and worry of colont)SC()PY 
SUlVcillance detecting a bowel cancer 
O( the 59 respondents, 41(69%) agreffi thai they were worried about a colon 
cann'!" being found at survciUance colonosoopy and 35 of th<'SC subf\.'Cts reported 
no event stress, while six rC~"p(lndcnts who had experienced colon cancer as an 
event stress, werc worried (Figure 4.69). 
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Figure 4.70: Opinion of personill risk fo r colon cancer and experience of s tressful 
life eventli 
Of the 58 respondentli, 12(21%) fell they had lower colon canCt.'l" risk Ih"n their 
peers ilnd eighl of these sub;ects experienced s tressful eventli while 46(79%) 
subjcctli felt they had the same o r higher risk than their peers and 26 of them 
experienced no stressful eventli (Figure 4.70) . 
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Figure 4.71: Association wi th school and posl-school education 
Of the 53 re.~pondentli, 35(66%) had no mabie certificate and 29 of thesc subjects 
had no posl-school qualifICa tions, while 18(31 %) had a matric Ct.'l"tificate and ten 













Figure4.72: Assoriiloon of post-school education and number of dlildrcn. 
Of the 55 respondenlS, 39(71~) had no post-school education and 37 of these 
subjects had 0 In 3 children, while 16(29%) had a post-school education and 14 a f 
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Figure 4.73: Gender and opinion on worry that cancer surveiUance would detect 
a colon cancer 
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Of the 61 respondents, 42(~) agrl~ tOOt thll' were worried about a 
roloflO5(.'()py finding a coIOIl cancer, 3 1 of th('!;(' sub;ects were female while 19 
(31 ~ ) subjects were not worried, 12 of them w .. 'I'e males (Figure 4.73). 
4.2.6 Substanti"tion of reli"bility 
In order to prove that S(.'Ofes could ~ produ(Cd repeatedly and cons>stcndy 
within the instrument, qUestiOflS about faecal ocrull blood testing.. which were 
asked in two diHereot ot;cctive se<:tions (impacts on medical decisions and 
knOWledge and attitude) of the instrument, involving five questions (Questions 
22. 26d, 26<', 34 and 35). wen' i:solated. 
The statistician was oon~'Ulted as faecal OCC\Jlt blood information had not bcer1 
part of the background knowledge of this research sample. He felt associatioN' 
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Figure 4.74: Responses to five questio~ on filf,'cal OCC\l lt blood testing 
• • 
Of the M respondents, 37(58~) were unsure if faecal occult blood was a reliable 
way to dc~t colon CiIJ1Cer, 20(3 1 %) thought it was and 5(9%) thought it was nol. 
Of the 64 respondents, 44(69%) had never Iwd a fil l'Cil l occult blood tcst and 3 1 
(48" ) did not know if 11 fa ecal occult blood test was an effective way to dctoct 
cancer, or (34 (53%») if it was an easy thing to do (Figure 4.74). 
4.3 Conclusion 
The analysed d.lta within Ihe four objectives leads Into a d iscussion of the 
"' '''''li ''8 .... "" v"luc of the rC!l<lh.!-, The <:n-Jibility of !hex r~ulb CAn Abo be 
assessed by comparing them to published research, The signiHcance of some of 
11 6 
these associations has resulted in the recommendations described in Chapter 5. 
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5 CHAPTER 5 - DISCUSSION 
5.1 Introduction 
The aim of this study was to evaluate the benefits and limitations, as perceived 
by family members, of the current management of inherited colorecta1 cancer in 
South Africa. A unique cohort of individuals from four different families, who 
all share a single hMIH1 mutation as a result of a C to T transversion at 
nucleotide 1528 in exon 13 on chromosome 3p, was chosen. All subjects received 
their predictive genetic test results and information sessions from the same 
person, using the predictive genetic testing protocol (documented in Appendix 
1) over a six-year period from 1997 to 2002. 
5.2 Research associations 
5.2.1 Response 
The research sample had all been through a predictive genetic testing program 
with information sessions about colon cancer including pre- and post-test 
counselling. Those who are mutation-positive were enrolled in a surveillance 
program while those who are mutation-negative become part of the normal 
population risk for colon cancer and are released from follow-up. Nearly half of 
the targeted sample chose not to return a completed questionnaire. Those who 
did not return the questionnaire were significantly more likely to live in a rural 
environment in the Northern Cape. They were of similar age, gender and 
mutation status compared to those who had returned the questionnaires. The 
other possible reason for their non-response was: 
1. The altered data collection strategy required that questionnaires be 
collected a month later (on the annual colonoscopy surveillance trip). The 
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arrangements were of an ad hoc nature thus creating this possible 
methodology flaw. 
2. Most non-respondents were mutation-negative and did not need a 
surveillance colonoscopy, thus it could have been potentially difficult for 
them to return the questionnaires to the research assistant 
3. They may have had difficulty completing the questionnaire from an 
educational level 
4. They may have just forgotten to complete the questionnaire or felt that 
they did not want to participate. 
The final sample size was 119 individuals with a response rate of 54 %, resulting 
in a power of 36%. The response rate in this study was similar to other studies 
with similar design who had response rates of 24% to 77 %(54;63;65;66;97). The 
response rate in studies where telephonic or personal interviews were 
performed reported higher response rates of 63% to 96 %(47;55;56;58;69;81). 
5.2.2 Sociodemographics 
The majority of respondents had limited economic resources. Few had achieved 
higher education. Most studies about predictive genetic testing examined older 
individuals with higher education and economic resources (47;58;64;78;98;99). 
5.2.3 Knowledge and attitudes 
5.2.3.1 Knowledge 
The majority of this cohort had experienced cancer in a first-degree relative. The 
average knowledge score amongst them was 42%. The knowledge score 
recorded by Lerman et al(58) was higher at 55% and Meiser et al(82) at 57% in 
studies of cohorts with higher education. The data presented here showed no 
association between knowledge score, education level or exposure to cancer. 
119 
Meiser et al(82) did find an association with education but not with cancer 
exposure. 
The information retained by the respondents showed that they had a good 
knowledge of colonoscopic surveillance but moderate to low levels of recall 
about colon cancer and its inheritance. A significant association was found 
between knowledge scores and the understanding of the severity of colon cancer 
(p < O'(X>9). 
5.2.3.2 Benefits and Limitations 
Most respondents thought that predictive genetic testing was beneficial or did 
no harm. Five individuals felt that predictive genetic testing was harmful 
because of the effect they felt it had on their family. Four of them also distrusted 
modern medicine and three found it difficult to handle emotionally, as they 
believed that cancer was inevitable. 
The benefits with the highest ratings were that of being certain about, and 
understanding how to reduce risk. Helping research, p1anning for the future 
and learning about their children's risk were also rated highly and just under 
half of the respondents used the testing process to make decisions about having 
children. In simi1ar studies, learning about children's risk(55;58;61), p1anningfor 
the future(55;61) and participating in research(60) were stated as the most 
inlportant beneficial reasons for wanting genetic tests. 
Concerns about coping emotionally with predictive genetic testing information 
were the most important perceived limitations amongst the majority of 
respondents. This was not found in a study by BaImana et al(20). Other 
important concerns cited in the current study were that predictive genetic testing 
may have an effect on families, also found by Meiser et al (61), and that they 
believed cancer was inevitable. The honesty and sensitivity of this response 
should send a strong message to future managers of these families that they 
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require the necessary support Other studies however have shown that the 
accuracy of the test was the most highly rated Jimitation(2Oi58) and that concern 
about losing insurance seemed to be unimportant (20;55;58). The South African 
cohort seemed to have trust and confidence in the test results and in modem 
medicine. 
5.2.4 Psychological and functional health status 
5.2.4.1 Stress 
Stressful events, related to deaths and cancers, in those respondents with 
positive genetic mutations, were more common in the year prior to the study 
than in those with negative results. 
In this study, the minority of subjects expressed stress about being at-risk for 
colon cancer. Of the six individuals who were stressed by their risk of colon 
cancer, four had a negative genetic mutation result 
5.2.4.2 Coping style 
Although there was no difference in the coping styles related to mutation status, 
blunters had more colonoscopies performed compared to monitors (p< 0.025). 
An increased frequency of colonoscopy attendance was expected of the monitors 
based on the findings of Steptoe and Sullivan(77), who found that monitors were 
more likely to undergo pap smears than blunters. It was expected that monitors 
would also have higher knowledge scores, as found by Steptoe and Sullivan(77), 
but this cohort had similar numbers of monitors and blunters with high 
knowledge scores. Blunters in this cohort had an increased frequency of 
colonoscopy attendance and this may be a reflection of the slightly higher 
number of mutation-positive individuals who were blunters. There is a greater 
proportion of mutation positive individuals in the blunter group (16 vs 13 
blunters, and 11 vs 19 monitors mutation positive vs negative (Fig. 4.32». This 
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difference was not statistically different (p=O.3). However, each mutation 
positive individual is likely to have many colonoscopies, while a mutation 
negative may never have any. This multiplier effect is probably the cause of the 
statistically significant result of more colonoscopies in the blunter group, rather 
than it being a re8ection of the coping style. 
In addition, blunters were found to have had smaller families (p < 0.012). This 
may be significant when considering the discussion of inheritance of colon 
cancer. 
Coping styles in this cohort were not related to demographics, anxiety and 
depression. This finding is similar to others(61;75) but differs from Phipps and 
Zinn(76) who found that monitors were more anxious than blunters and that 
there were significant interactions between coping styles, anxiety and depression 
scores. 
5.2.4.3 Anxiety 
Just over a third (37%) (German general population with anxiety = 7% and non-
patients with a health complaint = 33 %(100» of the respondents appeared to 
experience anxiety, and equal numbers of these subjects had positive and 
negative genetic mutation results. Esplen et al(60) found 22% of their sample 
(who are at intermediate and high-risk for familial colon cancer) had anxiety. 
Again, a significant association was found between the salience (it would be easy 
to have) of having a colonoscopy and those respondents with low anxiety levels. 
5.2.4.4 Depression 
Scores suggestive of potential depression were found in 13(21%) of respondents 
and 10 of them were mutation-negative while all three (5%), that had scores 
showing the probable presence of depression, were mutation-positive (German 
general population with depression = 5% and non-patients with a health 
complaint = 13%(100». Fsplen et al(60) found 15% of her sample to be 
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depressed. A significant association was folmd with anxiety (p < 0.011) which 
was also shown by Esplen et al(60). 
Most respondents, not only those who had depressive symptoms (p < 0.017) or 
event stress (p < 0.020), were concerned about a colon cancer being found during 
colonoscopy. 
In their search for predictive factors for psychological distress, Murakami et 
al(68) found that a history of major or minor depression was a significant 
predictor, but genetic test results were not According to Lerman et al(55) 
depression was the strongest predictor of an anticipated negative impact of 
genetic testing. Bleiker et al(99) reiterate that the best predictor of distress was an 
existing pre-test emotional state. 
There was no difference in the levels of depression in mutation-positive and 
negative subjects in this cohort. Lerman et al(101) found that depression rates in 
subjects undergoing breast cancer genetic testing (pre- and post-testing), were 
reduced in non-carriers (mutation-negative) while it remained the same in the 
carriers (mutation-positive). Overall the mutation-positive subjects had a higher 
depression rate than the mutation-negative subjects. 
No more than a third of the South African cohort had a form of psychological 
distress. The distress was not due to genetic results (supported by Bleiker et 
al(99», coping-style or sociodemographic factors. 
5.2.5 Genetic testing and medical decisions 
5.2.5.1 Risk 
Individuals with positive mutation results thought that they were at higher risk 
than those who were mutation-negative (p < 0.(47). However, it was 
disappointing to find that a third of individuals who had been counselled and 
had information sessions over many years, still had not grasped their 
appropriate risk for the development of colon cancer. Ten individuals, who had 
a positive genetic mutation result, thought that they were at a lower risk of 
developing colon cancer than the general population. Pour of these subjects had 
already had surgery for a colonic neoplasm. Eleven individuals, who had 
negative genetic mutation results, thought that their risk of developing colon 
cancer was higher than the general population. These findings were confirmed 
by a Likert scale assessment of the chance of developing colon cancer. It was 
disappointing that lloyd et al(102) found 66% of women who had attended 
genetic counselling, could not recall their lifetime risk for breast cancer 
accurately. Atkan-Col1an et al(53) found that one month after receiving their 
results, individuals with a negative genetic mutation result understood their 
post-test risk more often than those with a positive genetic mutation result. They 
found this difference in understanding to be even greater after a year. 
A significant association was found between awareness of risk and experiencing 
stressful life events (p < 0.042). Those who felt they were at higher risk and 
experienced stressful life events had a positive genetic mutation result and those 
who were at the same or lower risk and had not experienced stressful life events 
had negative results. 
5.2.5.2 Colectomy 
Preventative colectomy for HNPCC positive genetic mutation individuals with 
normal colons has not been routinely offered because the potential complications 
of surgery are far higher than those of colonoscopy. Nearly half of this cohort felt 
that it was a reasonable option. It appears that this option for management 
should be more openly discussed with high-risk individuals. The individuals 
who had not had colonic surgery felt strongly that preventative colectomy was 
an option (p < 0.0001). 
5.2.5.3 SarveUlance 
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Possible reasons for these answers may be fear of cancer. Imagining what it 
could be like to have the opposite genetic mutation result may have been too 
difficult or they may have felt that they were not doing enough when it came to 
surveillance. It may have been a reflection of hypervigilance which Hadley et 
al(81) showed amongst young mutation-positive individuals or, that there was a 
reluctance to cease surveillance even after a low-risk result(36;52;80). They may 
have thought it was what they were expected to say or that they did not 
understand the question. 
This may explain the South African cohorts' enthusiasm to increase their 
surveillance even amongst mutation-negative individuals who had a 
colonoscopy in the last two years. 
5.2.5.4 Severity and Cure 
This cohort felt strongly that colon cancer could be cured and that survival was 
possible (p < 0.0001). There was a significant association found between cure, 
survival and colon cancer knowledge scores (p < 0.0(9). 
5.2.5.5 Worry 
The following statements: - III am worried that surveillance may find bowel 
cancer" and "being at-risk for cancers other than colon cancer... II stirred the 
perceived worry in the cohort It is understandable that mutation-positive 
individuals would carry the burden of this worry but it seems that mutation-
negative individuals do as well. Eighteen subjects had found a way to dispel 
this burden and half of them had a positive genetic mutation result The six 
subjects who reported having event stress were all incorporated in the group 
who were concernetl about a colonoscopy finding a cancer (p < 0.020). Females 
were more worried about this than males (p < 0.0(9). Those with a potential 
depression (p < 0.007) were also concerned that cancer would be detected on 
colonoscopy. 
125 
It is of interest that mutation-negative respondents were more worried about the 
chance of a colonoscopy finding a colon cancer (p < 0.(47) than mutation-
positive individuals. 
The strong thread of awareness of colonoscopy surveillance was continued with 
strong agreement about the effectiveness of the colonoscopy procedure in 
finding a colon cancer as well as the salience (easy to do) of the procedure itself. 
A significant association was found between this sentiment and those who had 
benefited from predictive genetic testing (p < 0.(47). They also felt that 
individuals with colon cancer would survive (p < 0.026). Even those respondents 
with anxiety felt they could endure this procedure (p < 0.019). 
The majority of respondents had a colonoscopy (even some mutation-negatives). 
A significant association was noted between those that had a colonoscopy and 
those that had affected first-degree relatives (p < 0.0001) (Figure 4.59) as well as 
being mutation-positive (p < 0.0001) (Figure 4.52). Those that had a colonoscopy 
in the last two years (p< 0.0(4) (Figure 4.53) and had an adenomatous polyp 
removed (p < 0.039) (Figure 4.54) were also mostly mutation-positive 
respondents. 
Lerman et al(47) found that persons with lower socioeconomic status or 
alternatively, lack of formal education had low levels of utilisation of colorectaI 
cancer surveillance. This was not the case in this South African cohort This has 
been a challenge for health care professionals to convey complex risk and 
surveillance information in an easily accessible manner to people of different 
socioeconomic and cultural backgrounds. It also highlights the vulnerability of 
these populations and according to Hadley(36) and Johnson et al(79) the most 
common reason given for an individuals' decision to screen (or not to screen) 
was that the doctor did (or did not) recommend it 
Johnson et al(79) also found that factors which increase adherence to surveillance 
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were that the physician had recommended the procedure, knowledge of others 
with colon cancer, previous preventative health behaviour and a perception ofa 
benefit of surveillance. 
This cohort had an overwhelming confidence in the colonoscopy surveillance 
program with 49/64 (77%) respondents being sure of the effectiveness of 
colonoscopy to detect a colon cancer. With regards to the salience of 
colonoscopy, 40/64 (63%) respondents stated it would be easy for them to do. 
Continuity of care may be the reason for the positive attitude toward 
surveillance and treatment, as the colonoscopy surveillance team is well known 
to the subjects. H a polyp or lesion was found, the same team is involved in their 
surgical management and follow-up. 
5.3 Reliability 
The following two examples show the reliability of the instrument: 
1. Faecal occult blood testing had not been part of the information package 
given to this cohort as part of the predictive testing programme. It was 
felt that the high frequency of the 'don't know' responses, reflecting that 
the majority of respondents had never had the test, would be a sign of the 
honesty with which this questionnaire was answered. The results 
substantiate the reliability of the instrument by proving that the majority 
of these research subjects constantly were not sure of faecal occult blood 
testing. 
2 The confidence shown by the cohort of the role of colonoscopy in the 
detection of colon cancer, was consistent throughout the questionnaire 
(e.g. test of colon cancer knowledge, surveillance decisions, effectiveness 
of surveillance methods, 'salience' of the colonoscopy procedure and 
participation in surveillance). This evidence suggests that the instrument 
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was reliable. 
3. Two questions asked for an opinion on the risk of developing colon 
cancer. The responses of the subjects to the two questions were very 
similar. A significant association was found between risk and genetic 
mutation results. This was a reflection of true risk thus showing honesty 
in the subjects' responses. 
4. The validated Miller's Behavioural Style Scale was used by Petersson (75) 
in her thesis about group rehabilitation of cancer patients. In her search 
for monitor and blunting coping styles she suggested utilising a sum 
score, created by subtracting the total blunting score from the total 
monitoring score. She claimed her sum median to be four. This median 
was also achieved with this sample. 
5.4 Limitations 
5.4.1 Sample size 
This is a small study with a power of 36%. To achieve an 80% power with a 95% 
confidence interval would require 194 respondents. Assuming a 50% response 
rate, the sample size would need to be 388 individuals. This is not possible when 
using subjects with a single mutation. 
5.4.2 Methodology 
• No research has been done in South Africa on 'predictors' for accepting or 
rejecting predictive genetic testing for HNPCC. International studies have 
been done in this field, and in retrospect, this may have been a limitation 
of the methodology, the research subjects were asked to express opinions 
of what they may do or think if their genetic mutation result were 
different 
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• A different method of data collection may have resulted. in a higher 
response rate and sample size. i.e. telephonic or personal interview. 
• The altered data collection strategy required that questionnaires be 
collected a month later (on the annual colonoscopy surveillance trip). The 
arrangements were of an ad hoc nature thus creating this possible 
methodology flaw. 
• Multiple logistic regression analysis could have been used to examine the 
relationship between the dependant variable (genetic results) and 
independent variables. Bivariate analysis was used to analyse the 
associations between categorical variables. Multiple logistic regression 
could not be used due to the low statistical power and sample size as well 
too few significant associations. 
5.4.3 Bias 
5.4.3.1 Instrument 
The length of the instrument, and time it took to fill it in, may have created a bias 
towards not completing some of the latter questions. Many of the research 
subjects solved the problem on their own by requesting to take the questionnaire 
home and completing it in their own time and comfort zone. This eliminated the 
problem of reactivity to the location and a strange environment 
Those that took the questionnaire home had a month to complete it This 
administration variation might have created a bias. It may also have reduced the 
participation rate by not enabling queries to be readily answered by the research 
assistant 
5.4.3.2 Non-res.pondents 
The non-respondents were mostly from the rural areas of the Northern Cape 
and were mostly mutation-negative. Even though the colonoscopy 
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surveillance team visited the area a month later, it may still have been difficult to 
return the completed questionnaire. 
5.4.3.3 Re$J!onse set bias 
One (Question 28) of the questions shows what appears to be a response set bias. 
The responses to two questions seem to connect the researcher to the 
colonoscopy surveillance team and the responses are uncharacteristically 
inflated. 
5.5 Summary 
The sociodemographics showed middle to lower socioeconomic group of single 
and two parent families with mostly dependant children. They were also low 
scholastic achievers who predominantly reside where they were born. 
Frequent exposure to cancer, knowledge of genetic risk, and a predictive genetic 
test were recalled by most of this group. Their retained knowledge of the 
consequences of HNPCC inheritance and subsequent effects was moderate to 
low except with regards to the question about colonoscopic surveillance. This 
showed a high level of insight into how to prevent colon cancer. The majority of 
this group also had a positive attitude toward predictive genetic testing. 
At the time of the study most of the cohort was not experiencing stress about 
being at-risk for colon cancer, but there were those who had experienced 
stressful events. Most of the subjects with positive genetic mutation results had 
experienced a stressful event in the last year and these were mainly caused by 
death or cancer. At the time of the study most of the respondents were coping 
psychologically and did not have anxiety or depression. 
The subjects were confident that the medical team would find, cure and enable 
survival after colon cancer was diagnosed. Even though the accuracy of the 
surveillance worried them, they seemed positive about undergoing the 
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procedure and were eager to decrease its intervals. 
These health decisions are made based on an understanding of risk, and those 
individuals, who had misunderstood their risk, even after a predictive genetic 
test result had been disclosed, could have misdirected their health decisions. 
5.6 Recommendations 
This research shows that even though the same information is given to 
individuals, the retention and understanding varies considerably. The essence of 
the message conveyed in a predictive genetic information and result session is 
that of reduced (mutation-negative) or increased (mutation-positive) risk. Vital 
future health decisions are made with this information In finding that there 
were individuals with both negative and positive genetic mutation results who 
had; i) misunderstood their risk, ii) low colon cancer knowledge scores, iii) 
experienced harm from predictive genetic testing iv) found that the impact of 
being at-risk for colon cancer had caused stress and; v) experienced depression 
and anxiety, it was important to recommend that not only individuals with 
positive genetic mutation results, but also those with negative results, require 
ongoing counselling. 
The admission of concerns regarding not coping emotionally with genetic results 
strengthens this recommendation The significant association with the worry 
about colonic and extracolonic cancers being detected, especially by mutation-
negative individuals, also stresses the need for ongoing counselling. 
Those mutation-positive individuals who had not already had surgery 
supported the concept of a preventative colectomy. Mutation-negative 
respondents also felt that it was an option. More research would need to be done 
to explore this clinical treatment option for HNPCc. 
In the literature, a history of depression was found to be a barrier to genetic 
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testing and could delay preventative medical care(20;47;68). It is a 
recommendation that depression should possibly be screened for in an 
individual prior to embarking on a predictive genetic testing program. This 
information would be a guide for the counsellor. 
Assessing depression status could also be a guide in assisting those individuals 
who know their high-risk genetic mutation results but do not utilise preventative 
health care. 
Differences in coping styles of individuals were reported to effect assimilation of 
information as well as the engagement in preventative health behaviours(77). 
Assessment of an individuals' coping style, prior to entering a predictive genetic 
testing program, may be a useful guide for the counsellor. The method, style 
and volume of the information delivered to those with different coping styles, 
may require variation. More research is required to establish these variations. 
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5.7 Conclusion 
This research has taken a broad but pointed look at individuals from four 
families, all of whom who have had predictive genetic results for a unique 
HNPCC mutation. What they have tmderstood and experienced about this 
process, how they are coping and what decisions they have made, or will have to 
make, has been documented and analysed. 
The respondents were forthcoming about their perceptions of current 
management With the increasing role that genetics is playing in clinical 
medicine, there is an equally important role for nurses to fulfil in creating the 
support structures that these families need. This can only be achieved by 
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7 APPENDICES 
7.1 Appendix 1: Protocol for surveillance of high-risk HNPCC 
patients 
• Initial colonoscopy is performed at age 16. 
• Pre-predictive test counseling is offered at age 18. 
• Those who wish to know their predictive genetic result have bloods taken after 
signing consent. 
• Prior to releasing the test result they are counseled again. 
• Results are released by the Professor of Human Genetics (Frof. Raj Ramesar). 
• Those who choose not to have mutation analysis are offered surveillance 
colonoscopy on alternate years till age 30 and then annuall!" to age SO. 
• Those who test positive are offered colonoscopy on alternate years till age 30 and a 
total colectomy and ileorectal anastamosis will be the surgery of choice if a 
significant lesion is found. 
• All women must have annual gynecological checkups. 
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7.2 Appendix 2: Origin,,:l Australian Questionnaire 
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Reqlatr8lion I1UI'IIbef MF(noendo) 
I I I I I 
I I I I I I I 
Genetic Testing Questionnaire 1 
We would like to ask you to eompIete tie following queatior'Nire. All tie In1onnatIon will be 1nNIted as 
ItrlctIy confIdentteI and your IdentIly wi! never be AlWlllIed In any 1\IpOIta. The completed 
quastIonnalres will be kept &epIII1deIy from tnt hlfollilatloli that could identify you and will be kept 
MCUI1tIy under lock and key. ,..".,.. no need for you to wrItIt your name on th. questionnaire. 
,..".,. are no rtght or wrong anl'Nll'I, and M ask you simply to lick thole answers that II10IIl apptf to 
you. SOme of the questIona m111 not bet reItMtnt (0)'011. However, It II Import8ntfortheatudythet lat 
all poaIbIe, )'011 anaMW" the questions. 
Pai1Ic:Ipa\Ion In th'-1tUdy Is an\IreIy voluntary; you are not obliged to pe!ticIp8III and ,you do participate 
you can withdraw at tnt 1Ime. Whatever your decisIon,lt will not aII'ed your medical treatment or your 
reIsIIOnshlp with medical staI'f. 
Before completlllg tie quesllonnalre, may M request that you reed and • the encIotIed ComIent 
Form. 
When you have cornplatad the quastiOnnaIre. please retum the questionnaire In the encklHd reply 
paid envelope and post it within tie next &even days, if posaible. 
Would you lice to receive a free IUITII118IY report of the IIndings? 
a Yes 
a No 
'11IanII JOU wry much for your help In thII study. 
The III'It I8CIIon of the quea\Ionnalre asks some general analysing tie daW. It will not be ulMld for identifiCallon. 
backgIound quasIIons which will be helpful to us In 
2 
1. What • your Cl.ll'l8nt employment Itatua? 
2. 
3. 
(Plea .. lick tie bole that belt cIescribas your main 
~) Full-lime employed 
IJ2 P..r-tlme employed 
0 3 U~ 
c:r' SeIf~ 
I:f Homemaker 
I:f Full-time student 
0 7 Part-time student 
Of Permanently unable to work 
0' Retired 0 '0 Other _____ _ 
What is the h/ghelrl quaIiIIcation you have 
obtained since Iea\ling 1ChOOI? 
0 ' No post«hool 
~ Trade I appIlI'IIIceshIp 
101- CertitIcate from college I TAFE :!: Diploma ~ Year 12) 
101 Bachelors degree 
c;t' Pos1graduate diploma I degree 0
' 
Other __________ _ 
Do you speak a language oller than English at 
home? 
0 ' No, only EngliIh IJ2 Yes, IIIIIIan 
ca Yes,Greek 
c:r' Yes, ChInese 
I:f Yes, ArabIc a Other ____________ _ 
4. What. your country of birth? 
0 ' Aultralla IJ2 United KingdOm 
ca Greece 
c:r' VIetnam 
I:f Lebanon a Other ____________ _ 
5. What is your preI8IIt marital status? 
r- 0' Never married 
IJ2 WIdowed 
0 3 DIvorced 
c:r' Sepatated but not divorced 
a' MarrIed or de faCtO 
B. What Is your age? 
Age:_-yell'I 
7. Do you have children? 
10, Many people haveCOl'llIdered reasons for having 
or not having an HNPCC gene test. We would 
like to know hoW much each c:I tie fOllowing 
1st Child: Age: 
Boy? ~ 
GII1? 0 2 
2nd Child: Age: 
Boy? ~ 
GIlt? 0 2 
3td Child: Age: 
Boy? ar-
Gh1? IJ2 
4th Child: Age: 
Boy? ~ 
Gilt? IJ2 
If you have mont than four children. could you please 
supply fuIther InformaIlon on tie last page of th. 
questionnaire. 
Now M would lice to ask you some specific questions 
abOUt genetic 1MtIng for HNPCC, a condition which 
predIspoee8 to bOwel cancer. The answers you give are 
oompIeteIy contIdentitJl and wi! not be shown to the 
genetic counaeIor or doc:IDr In tie genetic clinic. It is 
poasIbIe that lie clinic staI'f may ask you some of tie .. 
questions again during your conauItation. 
B. Whoea Idea was It to come to have a genetic tell 
forHNPCC? 
9. 
0 ' My own idea IJ2 Other family member 
c' General practiIIoIMlI' 
c:r' SpecialIst 
c' Family bOwel clinic c' Other ____________ _ 
HNPCC gene IIIsts (bIoocI1IIsts which ...... 
your !I(eIIhood of developing bowel canc:er) may 
be dllcl.lned with you by the genetic counsellor 
or clinic doc:IDr. Ate you Intiarested in having an 
HNPCC gene test? 
0 ' Yes.defIn_ IJ2 Yes. probably 
c' ~ not. Please go to Question 15. :!: 0efInIt!IIy not. Please go to question 15. 
w· Don'tknow 
faCtOrs Inlluenced your decision about wheller or 










A f8c:t0r which Influenced my decision Hout 
whether or not to hllft a gene _t Is ... 
... to leam about my children'8 risk 
0' Not at aU 
0 2 Somewhat 
I. 
0 3 Very much 
... that I believe that cancer Is inevitable 
0' Not at all 
0 2 Somewhat 
0 3 V&rymuch 
0 3 Very much J. 
O· Not applicable 
... that I woUld ftnd It dllftcult to handle the 
knowledge emotionally 
... to help me understand what steps to take to 
reduce my risk or developing cancer 
0' Notata. 
0 2 Somewhat 
0 3 Very.much 
... to plan for the future 
0' Notata. 
0 2 Somewhat 
0 3 verymuch 
. .. to help research 
0' Notata. 
02 Somewhat 
0 3 Verymuch 
... to be car1aIn about my risk 
0' Notata. 
0 2 Somewhat 
0 3 Verymuch 
. .. to make decisIonS about having children 
0' Notata. 
02 Somewhat 
0 3 Verymuch 
O· Not applicable 
... that I am wonted about losing insuranca 
0' Not at a. 
0 2 Somewhat 
0 3 Verymuch 
A factor which Influenced my decision about 
whether or not to have a gene t..t Is ... 
... that I am concamed about the effect or gene 
tasting on the family 
0' Not at a. 
0 2 Somewhat 
0' Not at all 
0 2 Somewhat 
0 3 Verymuch 
k. . .. that the test result might be inaccurate 
0' Not at all 
0 2 Somewhat 
0 3 Verymuch 
... that I dlatru8t modern medicine 
0' NotataH 
0 2 Somewhat 
0 3 Verymuch 
The foIlGwing questions are to _ hew much you akudy 
know about genes for HNPCC, a condition which 
predispoees to bowel cancer. Please indicate whether 
you think each item Is True or False or if you Don't Know. 
11. Bowel cancer Is always inherited. 
0' True 
0 2 False 
0 3 Don'tknow 
12. EV8fYOI18 who has a gene for HNPCC will get 
bowel cancer. 
0' True 
0 2 False 
0 3 Don'tknow 
13. A person who doeS not have an altered HNPCC 
gene can still develop bowel cancer. 
0' True 
02 False 
0 3 Don'tknow 
14. There i8 more than one gene that can cause 
bowel cancer. 
PIe .. con.nue 011 next_ 
4 
0' True b. 
0 2 False 
0 3 Don'tknow 
15. The gene for HNPCC cancer can al80 increase 
the risk for other cancelS. 
Please rata·your chancea or getting bOwel cancer 
on a scale from 0 to 100, where 0 = a 0% or no 
chance and 100 = a 100% chance, meaning that 
you will deftnltlllly get It. Please make a mar\( on 
one or the vertical lines to indicate your chances, 
given your current 8ituation, that i8 prior to gene 
ta8ting. In your opinion, what number from 0 to 







0 2 False 
0 3 Don'tknow 
CoIonoscopy (the Inside or the bowel is viewed 
with a special tube) is very likely to detect bowel 
cancer if it is present 
0' True 
0 2 False 
0 3 Don'tknow 
Faecal occult IJk)od testing (a test which teals for 
blood in stool) wUl always detect bowel cancar. 
0' True 
0 2 False 
~ Don'tknow 
In a family where a gene for HNPCC has been 
found, tboae w/ttIoutthe gene have the same risk 
for getting bowel cancer a8 the general 
population . 
0' True 
0 2 Fall8 
0 3 Don'tknow 
If a person looks like, or has the peraonality or, a 
relative who has or has had bowel cancer. they 
are Hkely to have Inherited the gene from that 
person. 
0' True 
0 2 False 
0 3 Don'tknOW 
o 100 
This section asks about your expel iet IC8 or having cancer 
screening testa. Please tick the box that comes cIoseat 
to your 8ituation. 
21. 
a. Have you ever had a coIonoscopy (the inskIe or 
the bowel 18 viewed with a special tube)? 
0' No. Please go to Question 22a. 
02 Yes 
0 3 Don't know. Please go to Queatlon 228. 
b. If you have answered yes, have you had a 
coionOIcopy In the pest two years? 
0' No 
0 2 Yes 
0 3 Don'tknow 
c. Have you ever had an adenomatous polyp 
remoYed during a coIonoacopy (a polyp Is a smaR, 
usually benign growth)? 
0' No 
0 2 Yes 
0 3 Don'tknow 
22.a. Have you ever had a faecal occult blood testing (a 
20. The following statements ask youroplni0n8 about test which tests for presance or blood in 81oo1)? 
being at risk for bowel cancer. In your opinion, 
compared to other people or your own age, what 22b. If you have answered yes, have you had a faecal 
are your chanoas or getting bowel cancer? occult blood test in the past two years? 
0' Much Jower 
0 2 A little lower 0' No 
0 3 About the same 0 2 Yes 
O· A little hlther 
0 5 MUChh her 
PIN. continue 011 next oeC18 







I 'AOU1d call for the flight atIendant and ask exactly 
What the problem wea. 
I 'AOU1d order a drink or IranquHHser from the 
stew8r\:Sel.$. 
I 'AOUId listen carefully to the engines for the 
ullUllual noises and would watch the CfeIt to see 48. 
their behaviour W8I out of the ordinary. 
I 'AOU1d talk to the passenger bealde me about 
what might be wrong. 
I 'AOU1d settle down and read a book 01' magazine 
or write • letter. 
0Ifica use only: 
ScoreM 49. 
ScoreB 
46.a. Ha ... you experlencad aerIoUs, atresaful life 
e ... ntls a...r the past year? 
1J1 NO. Please go to QuestIOn 47. 
1J2 Yes 
b) What were the life events? Please circle the SO. 
number to the left of the life eventIs. 
(1) Parant's diagnosis with bcMIel cancer 
(2) Parent's death from bowel cancer 
This questionnaire '- de8lgned to help us know how you 
feel. Please read each Item below, and lick the box 
WhIch comes closest to how you haVe been feeling in the 51. 
PAST WEEK There are no light 01' wrong al1tWtd. 
Don't take too long a...r your repIieI; your Immediate 
reac:tIon to each Jan will probably be more 8CCUI'IIII8 than 
a long 1tIought out response. 




SIblIng's diagnoIis with bowel cancer 
SiblIng's death from bowel cancer 
Death of relative or Mend from causes 
Other than bowel canoer 
My own diagnosl8 of benign bowel 
disease 
MovIng household 
IJ Definitely as much 
IJ Not qUita 80 much 
IJ Only a little 
IJ Hardly at aH 
I can laugh and see the funny IIde of things. 
IJ As much as I always could 
IJ Not qUita 80 much now 
IJ DefInItely not 80 much now 
IJ Not at all 
I feel cheelful. 
IJ Not at aU 
IJ Not often 
IJ SometImes 
IJ Moet of the time 
I feel as If I am slOWed down 
IJ SometImes 
IJ Not at ali 
IJ Very often 
IJ Neartv all the lime 
I h .... Jost Intelelt in IT'ft appearance. 
IJ DefInItely 
IJ I don't take as much care asl should 
IJ I may not take qUile as much care 






Separation ordlvorte from IT'ft partner 
Work-relat8d stress 
53. I can enjoy a good book 01' radio or TV p!OgI8m 
Other (please specify) 
c.)How stressful were these e'leflt(.) on you 0..., the 
past year? Please make a mark on one of the 
vertical lines to Indlcata how stressful. 
IJ 0fIen 
IJ SomeIImes 
IJ Not often 
IJ Very seldom 
A number of statements which people ha ... used to describe themletvea are gl'ven below. Read each statement and 
then lick a box to indicate how you feel RIGHI NOW AT THIS MOMENT. 
54. I feel catm .......................... . 













58. lam upset ......................... IJ IJ IJ IJ 
57. I feel relaxed ....................... IJ IJ IJ IJ 
58. I feel conlant ........................ IJ IJ IJ IJ 
59. I am WOfried ......................... IJ IJ IJ IJ 
Below Is a list of comments made by people about being at risk for bowel cancer. Please tick a box to indicate how 
frequently these comments were true for you during the last sewtn deys. 
Not •• n Rarely SolMllmetl 0I'tan 
80. I thought about it when I didn't mean to IJ IJ IJ IJ 
81. I avoided IetIIng myself get upset when I 
thought about or was reminded of It IJ IJ IJ IJ 
82. I tried to remove It from IT'ft memory IJ IJ IJ IJ 
83. I had trouble faDing aaIeep or .taytng 
aaIeep because of pictures 01' thoughts 
about it that came into IT'ft mind 
IJ IJ IJ IJ 
84. I had waves of strong feelings about It IJ IJ IJ IJ 
PIe_ con/Inue 0/1 next_ 
9 
Not_ ... RaNIy SometImn on.n 
85. I had dreams about It CJ CJ CJ CJ 
ee. I ~ Nay from remlnder& of It CJ CJ CJ CJ 
87. I felt I. If It wasn't 1811 CJ CJ CJ CJ 
ee. I tried not to tall: about It CJ CJ CJ CJ 
O. Pictures popped up Into my mind CJ CJ CJ CJ 
70. Other things kept making me IIlnk about It CJ CJ CJ CJ 
71. I waa aware tItd 11111 Md I lot of feelings CJ CJ CJ CJ 
about It. but I didn't deal with them 
72. I tried not to tllnk about It CJ CJ CJ CJ 
73. Arrt AIIIlInder bfought back feelings CJ CJ CJ CJ 
about It 
74. ~ feelings were 10ft of numb CJ CJ IJ IJ 
0IIIce UI8 only: 
SubtoIaII __ 
SubtotIIA 
75. Are IheIe any other iMue& tItd we have not addIeuId in Ilia questionnaire? 
May we raqUlllt that you poet lila questionnaint and !he encIoIed Conlent Fonn at your eaI1Iest convenience. using !he 
prepaid retum envelope addreuad to !he Murdoch Inllllule. 
YOU HAVE MADE Inl 
THANKS AGAIN. 






Mon, 02 Apr 2001 16:42:50 +1000 
"Bettina Meiser n<:B.Meiser@unsw.EDU.AU> 
<:ursula@curie.uct.ac.za> "Algar U Ursula Sr" 
Dear Ursula, 
Thank you very much for contacting me with regard to previous studies 
on knowledge, attitudes and beliefs of families towards genetic 
testing for HNPCC. 
For the past three years I have been involved in a study assessing the 
impact of genetic testing for HNPCC. Baseline data collection for this 
study will be completed in December this year, and 12-month follow up 
in December 2002. The study is being administered at the Victorian 
Clinical Genetics Services, Melbourne, and data is being collected 
through six familial cancer clinics, in Sydney, Perth, Brisbane and 
Melbourne. 
As part of this study, we also assessed knowledge and attitudes 
towards genetic testing for HNPCC. To assess perceived importance of 
benefits and limitations of genetic testing for HNPCC, we modified a 
previously used scale on attitudes towards BRCA1 testing. The 
publication details are: 
Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with 
hereditary breast-ovarian cancer. JAMA 1996j275(24) :1885-1892. 
To assess knowledge about HNPCC genetics, we modified the scale 
assessing breast cancer genetics knowledge used in the above study. 
Over the past few years several studies of attitudes, knowledge of 
genetic testing for HNPCC have been published. I undertook a 
literature search recently and found the following articles: 
Codori AM, Petersen GM, Miglioretti DL, et al. Attitudes towards colon 
cancer gene testing: Factors predicting test uptake. Cancer Epidemiol 
Biomarkers Prev 1999;8:345-353. 
Croyle R, Lerman C. Interest in genetic testing for colon cancer 
susceptibility: Cognitive and emotional correlates. Prev Med 
1993;22(2) :284-292. 
Glanz K, Grive J, Marchand LL, Gotay C. underreporting of a family 
history of colon cancer: Correlates and implications. Cancer Epidemiol 
Biomarkers Prev 1999;8:635-639. 
Lerman C, Marshall J, Audrain J, Gomez-Caminero A. Genetic testing for 
colon cancer susceptibility: Anticipated reactions of patients and 
challenges to providers. Int J Cancer 1996;69:58-61. 
Lerman C, Hughes C, Trock BJ, et al. Genetic testing in families with 
hereditary nonpolyposis colon cancer. JAMA 1999;281(17) :1618-1622. 
Petersen GM, Larkin E, Codori AM, et al. Attitudes toward colon cancer 
gene testing: Survey of relatives of colon cancer patients. Cancer 
Epidemiology, Biomerkers and prevention 1999;8:337-344. 
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Smith KR, Croyle RT. Attitudes toward genetic testing for colon cancer 
risk. 
Am J Pub Health 1995;85(10) :1435-1438. 
Vernon SW, Perz CA, Gritz ER, et al. Correlates of psychological 
distress in colorectal cancer patients undergoing genetic testing for 
hereditary colon cancer. 
Health Psychol 1997;16(1) :73-86. 
You might consider matching some of your outcome measures with one of 
the scales published in these articles. 
I hope this information is helpful to you. Please do not hesitate to 
contact me again, should you require further information. 
Best wishes, 
Bettina Meiser 
Bettina Meiser, PhD 
Head of Psychosocial Research, Department of Medical Oncology, 
Prince of Wales Hospital, Randwick, NSW 2031, Sydney 
Thursday & Friday: Tel 0061-2-9382-2638, Fax 0061-2-9382-2588 
NHMRC Post-Doctoral Fellow, Department of Psychological Medicine 







Mon, 09 Apr 2001 17:19:41 +1000 
"Algar, U, Ursula, Sr" <ursula@curie.uct.ac.za> 
Bettina Meiser <B.Meiser@unsw.EDU.AU> 
Re: Help again 
I checked with the other members of our team about shring the measures 
we 
used. Everyone felt happy with this provided you acknowledge our 
group in 
any publications that may emerge from your research work. 
Please find attached (i) a short research plan, (ii) the baseline 
questionnaire for women (with questionaires about ovarian and 
endometrial 
cancer), (iii) the baseline questionnaire for men (without questions 
about 
ovarian and endometrial cancer), (iv) the one-year follow up 
questionnaire 
for women, and (v) that for men. 
I hope this is helpful information. Please let me know if you have 
difficulty opening the files, and I will save them in a different 
format. 






Re: Re connecting Date: Sun, 23 Feb 2003 16:42:03 +1100 
From: Bettina Meiser <b.meiser@unsw.edu.au> 
To: ursula@curie.uct.ac.za 
Dear Ursula, 
Good to hear from you. 
It's a shame you weren't able to work on your HNPCC study over the 
past, year, but I am sure as you say, that you will be able to 
continue again. 
As for our study, it turns out that we won't be able to complete 
12 month follow up data collection until May 2003. Therefore, there 
are no results to report as yet. I anticipate that we will be 
sUbmitting a manuscript in about July/August next year. 
Good luck with your study! 
Best wishes, 
Bettina 
Bettina Meiser, PhD 
Head of Psychosocial Research, Department of Medical Oncology, 
Prince of Wales Hospital, Randwick, NSW2031, Sydney 
Tel 0061-2-9382-2638, Fax 0061-2-9382-2588 
http://www.psycho-oncology.net/Webpage20021.html 
You could make a reference to our group (there is no 
official name as 
yet for this group) by saying that the group is undertaking 
an Australian 
multicentre study on the psychological impact of genetic 
testing and that 
the Chief Investigators are: Dr Jane Halliday, Dr Bettina 
Meiser, Dr Clara 
Gaff, and Associate Professor James St John. You could 
make reference to 
our e-mail correspondence, confirming that we are happy to 
share our 
questionnaire with you. 
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7.4 Appendix 4 : South African English version of the 
Questionnaire 
Registration number 
I I I I I 
Date issued 
I I I I I I I 
Genetic Testing Questionnaire 
Thank you for your interest in our research project. 
We would like to ask you to complete the following questionnaire. All the 
information will be treated as strictly confidential and your identity will never 
be revealed in any reports. The completed questionnaires will be kept separate 
from any information that could identify you and will be kept securely under 
lock and key. There is no need for you to write your name on this 
questionnaire. 
There are no right or wrong answers, and we ask you simply to tick those 
answers that most apply to you. Some of the questions may not be relevant to 
you. However, it is important for the study that, if at all possible, you answer 
all the questions. 
Participation in this study is entirely voluntary; you are not obliged to 
participate and if you do participate you can withdraw at any time. Whatever 
your decision, it will not affect your medical treatment or your relationship 
with medical staff. 
Before completing the questionnaire, we request that you read and sign the 
enclosed Consent Form. is available to answer any 
questions you may have about the questionnaire. Once you have completed the 
questionnaire, please return it to ______ _ 
Thank you very much for your help in this study. 
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I Consent Form 
I, " .... """" .. "" .. "" .... " .... """ .. " .... " .. """"" .... """"" .. "" .. "" ...... " .. """ .. " .. """,, ...... ,,,, .... ,,.,,",, .. ,, ...... ,," If" •• , hereby 
consent to participate in this survey. 
I declare that all information given is an honest reflection of my thoughts 
and feelings at the time of the survey. 
I am aware that all the information I have given will remain confidential. 
I understand that my participation in the survey is voluntary and of my own 




The first section of the questionnaire asks some general background 
questions, which will be helpful to us in analysing the data. It will not be 
used for identification purposes. 
1. What is your current employment status? 
(Please tick the box that best describes your main job) 
IJ1 Full-time employed 
IJ2 Part-time employed 
0 3 Unemployed 
0 4 Self-employed 
05 Housewife 
IJ6 Full-time student 
0 7 Part-time student 
0 8 Permanently unable to work 
0 9 Retired 
010 Other 
2. What standard did you reach at school? 
0 1 Standard 10 (Matric) 
0 2 Standard 9 
0 3 Standard 8 
0 4 Standard 7 
05 Standard 6 
0 6 Standard 5 
0 7 Other 
3. What is the highest qualification you have obtained since leaving 
school? 
0 1 No post-school 
0 2 Trade / apprenticeship 
0 3 Certificate from college 
IJ4 Diploma (beyond Std 10) 
IJ 5 Bachelors degree 
0 6 Postgraduate diploma / degree 
IJ7 Other _______ _ 
4. What is your present marital status? 
0 1 Never married 
0 2 Widowed 
IJ3 Divorced 
IJ4 Separated but not divorced 
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0 5 Married or married in common law 
5. What is the town of your birth? 
6. What is your date of birth? 
7. Do you have a strong faith? 
0 1 Yes 
0 2 No 
8. Do you have a medical aid? 
0 1 Yes 
0 2 No 
9. Are you male or female? 
0 1 Male 
0 2 Female 
10. Do you have children of your own (blood relatives)? 
0 1 No. 
0 2 Yes 
lOa) 1st Child: Age: 
Boy? 0 1 
Girl? 0 2 
lOb) 2nd Child: Age: --
Boy? 
Girl? 0 2 
10c) 3rd Child: Age: 
Boy? 0 1 
Girl? 0 2 
10d) 4th Child: Age: 
Boy? 0 1 
Girl? 0 2 
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If you have more than four children, could you please supply further 
information on the last page of this questionnaire. 
11. Some questions about your family. 
11a) How many brothers do you have? 
11b) How many sisters do you have? 
11c) How many of your brothers have had cancer? 
lld) How many of your sisters have had cancer? 
11e) How many of your brothers are still alive? 
11£) How many of your sisters are still alive? 
11g) Did one of your parents have cancer? 
01 Yes 
0 2 No 
11h) How old were you when you realised you were at risk for bowel 
cancer? 
12. Whose idea was it to come to have a genetic test for hereditary bowel 
cancer? 
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0 1 My own idea 
0 2 Other family member 
0 3 General practitioner 
0 4 Specialist 
0 5 Family bowel clinic 
0 6 Other -------------------
13. Have you had a genetic blood test result for hereditary bowel cancer? 
0 1 Yes 
0 2 No 
0 3 Not sure 
14. Who do you visit if you feel sick? 
0 1 General practitioner 
0 2 The clinic sister/ doctor 
0 3 Noone 
0 4 Other -------------------
15. Many people have considered reasons for having or not having a 
Hereditary Bowel Cancer gene test. We would like to know how much each 
of the following factors influenced your decision about having a gene test. 
A factor which influenced my decision to have a gene test is ••. 
15a. ... to learn about my children's risk 




15b. . .. to help me understand what steps to take to reduce my risk of 
developing cancer 
0 1 Not at all 
0 2 Somewhat 
0 3 Very much 
15c. ... to plan for the future 
0 1 Not at all 
0 2 Somewhat 
0 3 Very much 
15d. ... to help research 
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15e. 
Not at all 
Somewhat 
Very much 
... to be certain about my risk 
Not at all 
Somewhat 
Very much 
15f. . .. to make decisions about having children 
0 1 Not at all 
0 2 Somewhat 
0 3 Very much 
0 4 Not applicable 
A factor which influenced my decision to have a gene test is .•. 
15g. . .. th~t I was worried about losing insurance 
0 1 Not at all 
0 2 Somewhat 
0 3 Very much 
0 4 Not applicable 
ISh. . .. that I was concerned about the effect of gene testing would have on the 
family 
0 1 Not at all 
0 2 Somewhat 
0 3 Very much 
151. ... that I believed that cancer was inevitable 
0 1 Not at all 
0 2 Somewhat 
0 3 Very much 
15j. ... that I would have found it difficult to handle the knowledge 
emotionally 
0 1 Not at all 
0 2 Somewhat 
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0 3 Very much 
15k. ... that the test result might be been inaccurate 
0 1 Not at all 
0 2 Somewhat 
0 3 Very much 
15L. ... that I distrusted modern medicine 
Not at all 
0 2 Somewhat 
0 3 Very much 
The following questions are to see how much you already know about genes for 
Hereditary Bowel Cancer (a condition which predisposes to bowel cancer). 
Please indicate whether you think each item is True or False or if you Don't 
Know. 
16. Bowel cancer is always inherited. 
0 1 True 
0 2 False 
0 3 Don't know 
17. Everyone who has a gene for Hereditary Bowel Cancer will get bowel 
cancer. 
01 True 
0 2 False 
0 3 Don't know 
18. A person who does not have an altered Hereditary Bowel Cancer gene 
can still develop bowel cancer. 
0 1 True 
0 2 False 
0 3 Don't know 
19. There is more than one gene that can cause bowel cancer. 
0 1 True 
0 2 False 
0 3 Don't know 
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20. The gene for Hereditary Bowel Cancer can also increase the risk for other 
cancers. 
0 1 True 
False 
0 3 Don't know 
21. Colonoscopy (the inside of the bowel is viewed with a special tube) is 
very likely to detect bowel cancer if it is present. 
0 1 True 
0 2 False 
0 3 Don't know 
22. Faecal occult blood testing (a test which tests for blood in stool) will 
always detect bowel cancer. 
IJ1 True 
IJ2 False 
0 3 Don't know 
23. In a family where a gene for Hereditary Bowel Cancer has been found, 
those without the gene have the same risk for getting bowel cancer as the 
general population. 
0 1 True 
0 2 False 
0 3 Don't know 
24. If a person looks like, or has the personality of, a relative who has or has 
had bowel cancer, they are likely to have inherited the gene from that 
person. 
True 
0 2 False 
0 3 Don't know 
25a. The following statements ask your opinion about being at risk for bowel 
cancer. In 
your opinion, compared to other people of your own age, what are your 
chances of 
getting bowel cancer? 
IJ1 Much lower 
IJ 2 A little lower 
IJ3 About the same 
IJ4 A little higher 
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0 5 Much higher 
25b Please rate your chances of getting bowel cancer on a scale from 0 to 100, 
where 0 = a 0% or no chance and 100 = a 100% chance, meaning that you 
will definitely get it. Please make a mark on one of the vertical lines to 
indicate your chances, given your current situation. In your opinion, what 
number from 0 to 100 reflects your chances of getting bowel cancer? 
0% 10 20 30 40 50 60 70 80 90 100% 
This section asks about your experience of having cancer-screening tests. Please 
tick the box that comes closest to your situation. 
26a. Have you ever had a colonoscopy (the inside of the bowel is viewed with 
a special tube)? 
0 1 No. Please go to Question 26d. 
0 2 Yes 
0 3 Don't know. Please go to Question 26d. 
26b. If you have answered yes, have you had a colonoscopy in the past two 
years? 
0 1 No 
0 2 Yes 
0 3 Don't know 
26c. If you have answered yes, have you ever had an adenomatous polyp 
removed during a colonoscopy (a polyp is a small, usually benign 
growth)? 
0 1 No 
0 2 Yes 
0 3 Don't know 
26d. Have you ever had a faecal occult blood test (a test which tests for 
presence of blood in stool)? 
0 1 No. Please go to Question 27. 
0 2 Yes 
0 3 Don't know. Please go to Question 27. 
26e. If you have answered yes, have you had a faecal occult blood test in the 
past two years? 
0 1 No 
0 2 Yes 
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27. It would be helpful to know what options. you would consider if your 
gene test result indicated that you carry the gene for hereditary bowel 
cancer. 
Below is a list of options, some of which may not be relevant to you. These 
options do not represent proven methods for preventing cancer but may 
be discussed with you by the genetic counsellor or clinic doctor who will 
explain what they involve. Please tick the box which represents your 
preferred option. . 
If my blood test showed that I carry the gene for hereditary bowel 
cancer, I would consider ... 
... a preventative colectomy (an operation to remove the bowel) 
0 1 No 
0 2 Yes 
0 3 Don't know 
0 4 Done / in progress 
28. It would be helpful to know how the gene test result would affect your 
plans for having screening for bowel cancer. If your blood test showed 
that you do carry the gene for hereditary bowel cancer, would you 
change your plans for bowel cancer screening? Please tick the box which 
is closest to your views. 




... not change my screening 
... have screening more often 
... have less screening 
... stop screening 
If your blood test showed that you do NOT carry the gene for hereditary 
bowel cancer, would you change your plans for bowel cancer screening? 
If my blood test showed that I do NOT carry the gene for hereditary 
bowel cancer I would ... 




... not change my screening 
... have more screening 
... have less screening 
... stop screening 
This section asks about your opinions about bowel cancer and having bowel 
cancer screening tests. We would like to know how much you agree with 
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each of the following statements. Please answer all questions even if you have 
never had bowel cancer screening. Please tick the statement which comes 
closest to your opinion. 
29. 1 think people diagnosed with bowel cancer have little chance of 
surviving the disease. 
0 1 Strongly disagree 
0 2 Mildly disagree 
03 Mildly agree 
0 4 Strongl y agree 
30. When found early, bowel cancer can be cured. 
01 Strongly disagree 
0 2 Mildly disagree 
0 3 Mildly agree 
0 4 Strongly agree 
31. I am worried that bowel cancer screening will show that I have bowel 
cancer. 
0 1 Strongly disagree 
0 2 Mildly disagree 
0 3 Mildly agree 
0 4 Strongly agree 
32. Colonoscopy (the inside of the bowel is viewed with a special tube) is an 
effective way to find bowel cancer early. 
0 1 Strongl y disagree 
0 2 Mildly disagree 
0 3 Mildly agree 
0 4 Strongly agree 
0 5 Don't know 
33. Having a colonoscopy would be an easy thing for me to do. 
0 1 Strongly disagree 
0 2 Mildly disagree 
0 3 Mildly agree 
0 4 Strongly agree • 
0 5 Don't know 
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34. Faecal occult blood testing (a test which tests for blood in stool) is an 
effective way to find bowel cancer early. 
0 1 Strongly disagree 
0 2 Mildly disagree 
0 3 Mildly agree 
0 4 Strongly agree 
05 Don't know 
35. Faecal occult blood testing would be an easy thing for me to do. 
Strongly disagree 
0 2 Mildly disagree 
IJ3 Mildly agree 
IJ4 Strongly agree 
IJ5 Don'tknow 
36. In some families the gene for hereditary bowel cancer also increases the 
risk for cancer in other parts of the body. We would be interested to 
know how concerned you are about being at risk for cancers other than 
bowel cancer. 
Being at risk for cancers other than bowel cancer ... 
I 
0 1 .•• strongly concerns me 
0 2 ••• somewhat concerns me 
0 3 ... does not concern me 
Please explain (optional) 
Different people cope with stress in different ways. In the following, four 
imaginary scenarios are described and we would like to know how you think 
you would react in each of these situations. Please read each question carefully 
and tick alongside all the statements that would describe what you would do. 
37. Vividly imagine that you are afraid of the dentist and have to get some 
dental work done. Which of the following would you do? Please tick aU 
of the statements that might apply to you. 
37a) 0 • I would ask the dentist exactly what he was going to do. 
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37b)0 I would take an anti-anxiety drug or have a drink before going. 
37c) 0 I would try to think about pleasant memories. 
37d) 0 I would want the dentist tell me when I would feel pain 
37e) 0 I would try to sleep 
37£)0 I would watch all the dentist's movements and listen for the sound 
of his drilL 
37g) 0 I would watch the flow of water from my mouth to see if it 
contained blood. 
37h)0 I would want to do mental puzzles in my mind. 
38. Vividly imagine that you are being held hostage by a group of armed 
terrorists in a public building. Which of the following would you do? Please 
tick all the statements that might apply to you. 
38a)O I would sit by myself and have as many daydreams and fantasies 
as I could. 
38b)O I would stay alert and try to keep myself from falling asleep. 
38c)O I would exchange life stories with the other hostages. 
38d)O If there was a radio present, I would stay near it and listen to the 
news items about what the police were doing 
38e)0 I would try to sleep as much as possible. 
38£)0 I would think about how nice it's going to be when I get home. 
38g)O I would make sure I knew where every possible exit was. 
39. Vividly imagine that, due to a large drop in sales, it is rumoured that 
several people in your department at work will be dismissed. Your 
supervisor has handed in an evaluation of your work for the past year. 
Please tick all the statements that might apply to you. 
39a)0 I would talk to my fellow workers to see whether they knew 
anything about what the supervisor's evaluation of me said. 
39b) 0 I would review the list of duties for my present job and try to 





I would try to remember any arguments or disagreements I might 
have had with the supervisor that would have lowered his 
opinion of me. 
I would push all thought of being dismissed out of my mind. 
I would tell my spouse that I'd rather not discuss my chances of 
being dismissed. 
39f)0 I would try to think which employees in my department 
the supervisor might have thought had done the worst job. 
39g) 0 I would continue doing my work as if nothing special was 
happening. 
40. Vividly image that you are on an aeroplane, thirty minutes from your 
destination, when the plane unexpectedly goes into a deep dive and then 
suddenly levels off. After a short time, the pilot announces that nothing 
is wrong, although the rest of the ride may be rough. You, however, are 
not convinced that all is well. Please tick all statements that might apply 
to you. 
40a) 0 I would carefully read the information provided about safety 
procedures in the plane and make sure I know where the 
emergency exists were. 
4Ob)O I would make small talk with the passenger beside me. 
4Oc)0 I would watch the end of the movie, even if I had seen it before. 
40d) 0 I would call for the flight attendant and ask exactly what the 
problem was. 
40e) 0 I would order a drink or tranquilliser from the stewardess. 
4Of)0 I would listen carefully to the engines for the unusual noises and 
would watch the crew to see their behaviour was out of the 
ordinary. 
4Og)O I would talk to the passenger beside me about what might be 
wrong. 
40h) 0 I would settle down and read a book or magazine or write a letter. 
41a. Have you experienced serious, stressful life event/ s over the past year? 
01 No. Please go to Question 42. 
0 2 Yes 
41b. What were the life events? Please circle the number to the left of the life 
event/so 
(1) Parent's diagnosis with bowel cancer 
(2) Parent's death from bowel cancer 
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(3) Sibling's diagnosis with bowel cancer 
(4) Sibling's death from bowel cancer 
(5) Death of relative or friend from causes other than bowel cancer 
(6) My own diagnosis of benign bowel disease 
(7) Moving household 
(8) Separation or divorce from my partner 
(9) Work-related stress 
(10) Other (please specify) 
41c. How stressful were these event(s) on you over the past year? Please 
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Very 
This questionnaire is designed to help us know how you feel. Please read each 
item below, and tick the box which comes closest to how you have been feeling 
in the PAST WEEK. There are no right or wrong answers. Don't take too long 
over your replies; your immediate reaction to each item will probably be more 
accurate than a long thought out response. 
42. I still enjoy the things I used to enjoy. 
o Definitely as much 
o Not quite so much 
o Only a little 
o Hardly at all 
43. I can laugh and see the funny side of things. 
o As much as I always could 
o Not quite so much now 
o Definitely not so much now 
o Not at all 





Not at all 
Not often 
Sometimes 
Most of the time 
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45. I feel as if I am slowed down 
o Nearly all the time 
o Very often 
o Sometimes 
o Not at all 
46. I have lost interest in my appearance. 
o Definitely 
o I don't take as much care as I should 
o I may not take quite as much care 
o I take just as much care as ever 
47. I look forward with enjoyment to things. 
o As much as I ever did 
o Rather less than I used to 
o Definitely less than I used to 
o Hardly at all 
48. I can enjoy a good book or radio or TV program 
o Often 
o Sometimes 
o Not often 
IJ Very seldom 
A number of statements which people have used to describe themselves are 
given below. Read each statement and then tick a box to indicate how you feel 
RIGHT NOW AT THIS MOMENT. 
Not at all Somewhat Moderately Very much 
49. I feel calm 0 1 0 3 0 4 
50. I feel tense 0 1 0 3 0 4 
51. I am upset IJ1 0 3 0 4 
52. I feel relaxed 0 1 IJ3 0 4 
53. I feel content 0 1 IJ3 0 4 
54. lam worried 0 1 0 3 0 4 
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Below is a list of cotnments made by people about being at risk for bowel 
cancer. Please tick a box to indicate how frequently these comments were true 
for you during the last seven dilys. 
Not at all Rarely Sometimes Often 
55. I thought about it when I didn't mean to []1 []2 Il3 14 
56. I avoided letting myself get upset when I 
thought about or was reminded of it r]1 []2 [J3 [14 
57. I tried to remove it from my memory ~J2 [1 3 lJ4 
58. I had trouble falling asleep or staying 
asleep because of pictures or thoughts 1]1 0 2 0 3 [)4 
about it that came into my mind 
59. I had waves of strong feelings about it 0 1 ~2 []3 f]4 
Not at all Rarely Sometimes Often 
60. I had dreams about it ,-,I L:2 LJ3 [i ,--
61. I stayed away from reminders of it [Jl 0 2 LJ3 iJ4 
62. I felt as if it wasn't real 0 1 2 U3 [~4 
63. I tried not to talk about it 0 1 [J2 ll3 [J4 
64. Pictures popped up into my mind LJl IJ2 []3 ]4 
65. Other things kept making me think about it ,Jl [;2 Ll3 
[]4 
66. I was aware that I still had a lot of feelings []l 0 2 0 3 
[J4 
about it, but I didn't deal with them 
67. I tried not to think about it [Jl [J2 0 3 []4 
68. Any reminder brought back feelings -12 [13 !J4 
about it 
69. My feelings were sort of numb rl1 0 2 []3 [14 
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70. Are there any other issues that we have not addressed in this 
questionnaire? 
lOcont. 
10f) 5th Child: Age: 
Boy? 0 1 
Girl? 0 2 
109) 6th Child: Age: 
Boy? 0 1 
Girl? 0 2 
10h) 7th Child: Age: 
Boy? 0 1 
Girl? 0 2 
101) 8th Child: Age: 
Boy? 0 1 
Girl? 0 2 
lOj) 9th Child: Age: 
Boy? 0 1 
Girl? 0 2 
10k) 10th Child: Age: 
Boy? 0 1 
Girl? 0 2 
YOU HAVE MADE IT!! 
THANKS AGAIN. 
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7.5 Appendix 5: Afrikaans translation of questionnaire prior to 
piloting 
Rertrasienommer 
I I [ I 
Datum Uirereik 
[ [[ [[ [ 
Genetiese Toetsingvraelys 
Dankie vir u belangstelling in ons navorsingsprojek. 
Ons wi! u graag vra om die volgende vraelys te voltooi. Al die inligting sal 
streng vertroulik hanteer word en u identiteit sal nooit in enige verslag 
openbaar word nie. Al die voltooide vraelyste sal apart gehou word van enige 
inligting wat u sou kon identifiseer en sal weggesluit word. U hoef nie u naam 
op hierdie vraelys te skryf nie. 
Daar is geen regte of verkeerde antwoorde nie - ons vra dat u slegs die 
antwoord merk wat die meeste van toepassing is op u. Van die vrae mag dalk 
nie op u van toepassing wees nie, maar dit is belangrik vir die opname dat u so 
ver as moontlik al die vrae beantwoord. 
U deelname aan hierdie projek is vrywillig; u is nie verplig om deel te neem nie 
en as u weI deelneem, kan u op enige stadium onttrek. U mediese behandeling 
en verhouding met die mediese personeel sal geensins deur u besluit 
geaffekteer word nie. 
Voordat u die vraelys voltooi, sal u asseblief eers die aangehegte 
toestemmingsvorm lees en teken. is beskikbaar om 
enige vrae wat u aangaande die vraelys mag h@, te beantwoord. Sodra u die 
vraelys voUedig voltooi het, sal u dit asseblief terugbesorg aan 




Ek, ................................................................................... , gee hiermee 
my toestemming om deel te neem aan hierdie opname. 
Ek verklaar dat al die inligting wat ek verskaf het, 'n eerlike weergawe van my 
gedagtes en gevoelens ten tyde van die opname is. 
Ek is bewus van die feit dat al die inligting wat ek verskaf het, streng vertroulik 
sal bly. 
Ek begryp dat ek heeitemal vrywillig aan hierdie opname deeineem en dat my 





Die eerste gedeelte van hierdie vraelys is algemene vrae oor u agtergrond wat 
vir ons sal help wanneer ons die inligting verwerk. Dit sal nie gebruik word vir 
enige identifkasie doeleindes nie. 
1. Wat is u werkstatus op die huidige oomblik? 
(Merk asseblief die boksie wat die mees toepaslik is.) 
Voltydse werk 
Deeltydse werk 
0 3 Werkloos 
0 4 Eie besigheid 
0 5 Huisvrou 
0 6 Voltydse student 
0 7 Deeltydse student 
0 8 Permanent ongeskik om te werk 
0 9 Afgetree 
010 Ander ______ _ 
Wat is die hoogste vlak wat u op skool behaal het? 
0 1 Standerd 10 (Matriek) 
0 2 Standerd 9 
0 3 Standerd 8 
0 4 Standerd 7 
0 5 Standerd 6 
0 6 Standerd 5 
0 7 Ander _______ _ 
Wat is die hoogste kwalifikasie wat u sedert skool behaal het? 
0 1 Geen naskoolse kwalifikasies 
0 2 Ambagswerk 
0 3 Sertifikaat van 'n kollege 
0 4 Diploma (na Std. 10) 
0 5 Baccalaureusgraad 
0 6 Nagraadse diploma of graad 
0 7 Ander __________ _ 
Wat is u huidige huwelikstatus? 
0 1 Nooit getroud 
0 2 Weduweejwewenaar 
0 3 Geskei 
0 4 Uitmekaar, maar nie geskei nie 
0 5 Getroud (insluitend gemeenregtelike huwelik) 
In watter stadj dorp is u gebore? 
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Wat is u geboortedatum? 
Het u In sterk geloof? 
0 1 Ja 
0 2 Nee 
Behoort u aan In mediese fonds? 
0 1 Ja 
0 2 Nee 
Wat is u geslag? 
0 1 Manlik 
0 2 Vroulik 
Het u enige kinders? 
0 1 Ja 
02 Nee 
lste kind: Ouderdom: 
Seun? 0 1 
Dogter? 0 2 
2de kind: Ouderdom: 
Seun? 0 1 
Dogter? 0 2 
3dekind: Ouderdom: 
Seun? 0 1 
Dogter? 0 2 
4dekind: Ouderdom: 
Seun? 0 1 
Dogter? 0 2 
Indien u meer as vier kinders het, sal u asseblief verdere inligting op die laaste 
bladsy van die vraelys verskaf. 
Vrae oor u gesin 




Hoeveel susters het u? 
Hoeveel van u broers1 en susters2 het al kanker gehad? 
0 1 ____ _ 
Hoeveel van u broers1 en susters2 lewe nog? 
0 1 ____ _ 
Het een van u ouers kanker gehad? 
0 1 Ja 
0 2 Nee 
Hoe oud was u toe u besef het u is In risikogeval? 
Wie het u aangeraai om vir In genetiese toets vir oorerflike kolonkanker te 
gaan? 
0 1 My eie idee 
0 2 In Lid van my gesin 
03 Algemene praktisyn 
0 4 Spesialis 
Familie dermkliniek sister? 
06 Ander _________ ___ 
Het u al/n genetiese bloedtoets resultaat vir oorerflike kolonkanker gehad? 
0 1 Ja 
0 2 Nee 
0 3 WeetNie 
Wie gaan u sien wanneer u siek voel? 
0 1 Algemene praktisyn 
02 Klinieksuster / dokter 
0 3 Niemand 
0 4 Ander ___________ ___ 
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Mense het verskeie redes hoekom hulle die Oorerflike Kolonkanker genetiese 
toets wil ondergaan of nie. Ons wil graag weet hoeveel elk van die volgende 
faktore u besluit om vir In genetiese toets te gaan, beinvloed het. 
In Faktor wat my besluit om vir In genetiese toets te gaan, beinvloed het, is ... 
a. om te weet wat my kinders se risiko is 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
0 4 Nie van toepassing 
b. . .. om te kan vasstel hoe ek my risiko vir die ontwikkeling van kanker, 
kan verminder 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
c. . .. om vir die toekoms te beplan 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
d. . .. om navorsing te bevorder 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
e. . .. om seker te wees van my eie risiko 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
f. . .. om In besluit te kan neem oor gesinsbeplanning (om kinders te he of 
nie) 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
0 4 Nie van toepassing 
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III 
In Faktor wat my besluit om vir In genetiese toets te gaan, beinvloed het, is ••• 


















Nie van toepassing 














k. ... die toetsresultaat mag miskien foutief wees 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
1. ... ek het In wantroue in moderne medisyne 
0 1 Gladnie 
0 2 Effens 
0 3 Baie 
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Die volgende vrae is net om uit te vind hoeveel u al weet van gene wat 
Oorerflike Kolonkanker veroorsaak ('n toestand wat dermkanker voorafgaan). 
Dui asseblief aan watter antwoord volgens u Waar of Vals is, of Weet Nie. 
15. Dermkanker is altyd oorerflik 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
16. Almal wat 'n geen vir Oorerflike Kolonkanker het, sal dermkanker kry 
0 1 Waar 
0 2 Vals 
Weetnie 
17. Iemand wat nie 'n veranderde Oorerflike Kolonkankergeen het nie, kan 
nog steeds dermkanker kry 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
18. Daar is meer as een geen wat dermkanker kan veroorsaak 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
19. Die geen vir Oorerflike Kolonkanker kan ook die risiko vir ander kankers 
verhoog 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
20. In Kolonoskopie (die binnekant van die derm word met 'n spesiale buis 
besigtig) is heel moontlik in staat om dermkanker op te spoor indien dit 
teenwoordig is 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
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21. In Okkultebloed-stoelgangtoets ('n toets wat onsigbare bloed in die 
stoelgang aandui) sal altyd dermkanker opspoor 
0 1 Waar 
0 2 Vals 
0 3 Weet nie 
22. In In familie waar In geen vir Oorerflike Kolonkanker gevind is, sal die' 
sonder die geen dieselfde risiko h~ om dermkanker te kry as die algemene 
bevolking 
0 1 Waar 
0 2 Vals 
0 3 Weet nie 
23. Indien iemand Iyk soos, of dieselde persoonlikheid het as, In familielid 
wat dermkanker het of gehad het, het hy / sy heel moontlik die geen van 
daardie persoon g~rf 
0 1 Waar 
0 2 Vals 
Weet nie 
24a. Die volgende stellings wi! u mening omtrent u vatbaarheid vir 
dermkanker bepaal. Volgens u mening, in vergelyking met ander mense van u 
eie ouderdom, wat is u kanse om dermkanker te ontwikkel? 
Baie kleiner 
0 2 Effens kleiner 
0 3 Min of meer dieselfde 
0 4 In Bietjie groter 
0 5 Baie groter 
24b Dui asseblief u kans om dermkanker te kry aan op In skaal van 0 tot 100, 
waar 0 = In 0% of geen kans en 100 = In 100% kans, bedoelende dat jy dit 
beslis sal kry. Merk asseblief die horisontale lyn om jou kans op dermkanker 
aan te dui. Vol gens jou opinie, watter nommer van 0 tot 100 weerspie~l jou 
kanse om dermkanker te kry? 
0 __________________________ 100 
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Hierdie afdeling handel oor die ondervinding wat u al met kankersiftingstoetse 
gehad het. Merk asseblief die boksie wat vo~gens u omstandighede die naaste 
aanreg is. 
25a. Het u al ooit In kolonoskopie gehad (die binnekant van die derm word 
met In spesiale buis ondersoek)? 
0 1 Nee. Gaan asseblief voort met Vraag 26a 
02 Ja 
0 3 Weet nie. Gaan asseblief voort met Vraag 26 
25b. Indien u ja geantwoord het, het u in die laaste twee jaar een gehad? 
0 1 Nee 
0 2 Ja 
0 3 Weetnie 
25c. Was In poliep al ooit tydens een van u kolonoskopiee vewyder ('n poliep 
is In klein, gewoonlik nie-kwaardaardige vergroeisel) 
0 1 Nee 
0 2 Ja 
0 3 Weetnie 
26a. Het u al ooit In okkuItebioed - stoeigangtoets gehad (In toets vir 
onsigbare bioed in die stoeigang)? 
0 1 Nee. Gaan asseblief voort met Vraag 27 
0 2 Ja 
0 3 Weet nie. Gaan asseblief voort met Vraag 27 
26b. Indien Ja, het u bogenoemde toets in die afgelope twee jaar gehad. 
0 1 Nee 
0 2 Ja 
27. Dit sal van huip wees om te weet watter opsies u sou oorweeg indien u 
geentoets aandui dat u die geen vir Oorerflike Koionkanker besit. Hieronder is 
In lys van opsies - van hulIe mag glad nie op u van toepassing wees nie. Hierdie 
opsies verteenwoordig nie bevestigde metodes vir die voorkoming van kanker 
nie, maar kan met u deur die genetiese berader of kliniekdokter bespreek word, 
oor wat dit behels . Merk asseblief die boksie wat u keuse aandui. 
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Indien my bloedtoets aantoon dat ek die geen vir Oorerflike Kolonkanker 
besit, sal ek die volgende oorweeg ... 
... /n voorkomende kolektomie ('n operasie om die dikderm te verwyder) 
0 1 Nee 
0 2 Ja 
0 3 Weet nie 
0 4 Klaar gedoenj sal gedoen word 
28. Dit sal van hulp wees om te weet hoe u geentoets - resultaat u planne vir 
toekomstige skandering vir dermkanker sou beinvloed. Indien u bloedtoets 
toon dat u weI die geen vir Oorerflike Dermkanker gedra het , sou u u planne 
om dermkankerskandeering te ondergaan veran<~.er? Merk asseblief die boks 
wat die naaste is aan u siening. 
Ek sou nie my skanderingsessies verander nie 
Ek sou meer gereelde skanderingsessies ondergaan 
Ek sou my skanderingsessies verminder 
Ek sou my skanderingsessies stop 
Indien u bloedtoets toon dat u NIE die geen vir Oorerflike Dermkanker dra nie, 
sou u u planne om dermkankerskandering te ondergaan, verander? 
Ek sou nie my skanderingsessies verander nie 
Ek sou meer gereelde skanderingsessies ondergaan 
Ek sou my skanderingsessies verminder 
Ek sou my skanderingsessies stop 
Hierdie gedeelte handel oor u siening omtrent dermkanker en dermkanker -
skanderings. Ons wil graag weet tot watter mate u saamstem met elk van die 
volgende stellings. Antwoord asseblief al die vrae selfs al het u nog nooit 
dermkankerskandering ondergaan nie. Merk asseblief die stelling wat die 
naaste is aan u seining is. 
29. Ek dink mense wat met dermkanker gediagnoseer word, het min kans 
om die siekte te oorleef 
0 1 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
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30. Dermkanker kan genees word indien vroetydig opgespoor 
0 1 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
31. Ek is bekommerd dat dermkankerskandering sal aantoon dat ek 
dermkanker het 
01 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
32. Kolonoskopie (die binnekant van die derm word met In spesiaale buis 
besigtig) is In effektiewe manier om dermkanker vroegtydig op te spoor 
Verskil sterk 
02 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
0 5 Weetnie 
33. Dit sal vir my maklik wees om In kolonoskopie te ondergaan 
0 1 Verskil sterk 
0 2 Verskil effens 
03 Effens saamstem 
0 4 Sterk saamstem 
0 5 Weetnie 
34. In Okkultebloed-stoelgangtoets ('n toets wat onsigbare bloed in die 
stoelgang aandui) is In effektiewe manier om dermkanker vroegtydig op te 
spoor 
0 1 Verskil sterk 
0 2 Verskil effens 
03 Effens saamstem 
04 Sterk saamstem 
05 Weetnie 
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35. Dit sal vir my maklik wees om vir 'n okkultebloed - stoegangtoets te 
gaan 
0 1 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
IJ4 Sterk saamstem 
0 5 Weet nie 
36. In sommige families verhoog die besit van die geen vir Oorerflike 
Dennkanker ook die risiko om kanker in ander dele van die liggaam te kry. Ons 
wil graag weet hoe besorg u is omtrent u vatbaarheid vir ander kankers as 
dermaknker. 
Om vatbaar te wees vir kanker buiten dermkanker ..... 
... bekommer my erg 
... bekommer my effens 
... bekommer my glad nie 
Verduidelik asseblief (opsioneel) 
Verkillende mense hanteer stres op verskillende maniere. Hieronder volg vier 
opgemaakte situasies en ons wi! graag weet hoe u dink u in elk van die 
vOI§.ende situasies sal reageer. Lees asseblief elke vraag aandagtig deur en merk 
al dIe stellings wat beskryf wat u sou doen. 
37. U is bang vir die tandarts en dat daar aan u tande gewerk moet word. 
Watter van die volgende sal u doen? Merk asseblief AL die stellings wat op u 
van toepassing mag weeSe 
o Ek sou die tandarts vra wat hy presies gaan doen 
o Ek sou 'n kalmeermiddel neem of 'n drankie drink voor ek gaan 
o Ek sou probeer dink aan aangename herinneringe 
o Ek sou wil h~ dat die tandarts vir my moet s~ wanneer ek pyn gaan voel 
o Ek sou probeer slaap 
o Ek sou al die tandarts se bewegings dophou en luister na die geluid van 
die boor 
o Ek sou die waterstroom vanuit my mond dophou om te sien of daar 
bloed in is 
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o Ek sou breinspeIeljies in my gedagtes wi! speel 
38. U word as gyselaar gehou deur In groep gewapende terroriste in 
In publieke gebou. Watter van die volgende sal u doen? Merk asseblief AL die 
stellings wat op u van toepassing mag wees. ' 
o Ek sou alleen gaan sit en soveel dagdroom en fantaseer as wat ek kan 
o Ek sou op my hoede wees en probeer verhoed om nie aan die slaap te 
raak nie 
o Ek sou my Iewensverhaal met die ander gyselaars deel 
o Indien daar In radio was, sou ek naby probeer bly om na die nuus te 
Iuister oor wat die polisie gaan doen 
o Ek sou probeer om soveel as moontlik te slaap 
o Ek sou daaraan dink hoe Iekker dit gaan wees om by die huis te kom 
o Ek sou seker maak dat ek weet waar elke moontlike uitgang is 
39. As gevoIg van In groot daling in verkope, is daar 'n gerug dat verskeie 
mense in u werksdepartement afgedank gaan word. U hoof het In evaluasie van 
u werk van die afgelope jaar ingehandig. Merk asseblief AL die stellings wat op 
u van toepassing mag wees. 
o Ek sou met my medekollegas praat om uit te vind of hulle enige iets van 
my evaluasie af weet 
o Ek sou my Iys van pligte vir my huidige beroep nagaan en probeer 
uitwerk of ek aan almal voldoen het 
o Ek sou enige argumente of verskille wat ek met my hoof gehad het, wat 
moontlik sy opinie van my mag benadeel het, probeer onthou 
o Ek sou enige gedagtes van afdanking uit my kop verban 
o Ek sou aan my lewensmaat ~ dat ek my kanse van afdanking liewer nie 
wi! bespreek nie tI 
o Ek sou probeer dink wie van die werknemers in my departement deur 
die hoof gesien word as die' wat die swakste werk verrig 
o Ek sou aangaan met my werk asof niks besonders gebeur het nie 
40. U is op In vliegtuig, dertig minute vanaf u bestemming wanneer die 
vliegtuig onverwags duik en dan weer stabiliseer. n Kort rukkie daarna kondig 
die 1000s aan dat niks verkeerd is nie, alhoewel die res van die rit onstuimig 
mag wees. U is egter nie oortuigdaarvan dat alles in orde is nie. Merk asseblief 
AL die stellings wat op u van toepassing mag wees. 
o Ek sou die inligting omtrent veiligheidsprosedures wat in die vliegtuig 
verskaf word, deeglik deurgaan en seker maak dat ek weet waar al die 
nooduitgange is 
o Ek sou oor onbenullighede met my medepassasier gesels 
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o Ek sou die fliek tot aan die einde kyk, selfs al het ek dit voorheen gesien 
o Ek sou die lugwaardin roep en vra wat presies die probleem was 
o Ek sou 'n drankie of kalmeermiddel bestel 
o Ek sou aandagtig na die enjin luister vir enige ongewone geluide en sou 
die bemanning dophou vir enige ongewone gedrag 
o Ek sou met my medepassasier gesels oor wat moontlik verkeerd kon 
wees 
o Ek sou rustig raak en 'n boek of tydskif lees of 'n brief skryf 
41a. . Het u enige ernstige, stresvolle lewensgebeure die laaste jaar 
ondervind? 
0 1 Nee. Gaan asseblief voort met Vraag 42. 
0 2 Ja 
41b. Watwas hierdie lewensgebeure? Omsirkel asseblief die nommer wat op 
u van toe passing is. 
(1) Ouer met kanker gediagnoseer 
(2) Ouer oorlede aan dermkanker 
(3) Broer of suster met dermkanker gediagnoseer 
(4) Broer of suster aan dermkanker oorlede 
(5) Dood van 'n familielid of vriend aan oorsake buiten dermkanker 
(6) Ekself is gediagnoseer met 'n nie-kwaadaardige dermkwaal 
(7) Verhuising 
(8) Egskeiding of skeiding van my lewensmaat 
(9) Werksverwante stres 
(10) Ander (spesifiseer asseblief) 
41c. Hoe stresvol was hierdie gebeure vir u? Merk asseblief die horisontale 
lyn om aan te dui hoeveel stres u gehad het. 
Nie stresvol Baie stresvol 
Hierdie vraelys is ontwerp om ons te help bepaal hoe u voel. Lees asseblief elke 
item hieronder en merk die een wat die naaste is aan hoe u die afgelope week 
gevoel het. Daar is geen regte of verkeerde antwoorde rue. Moerue te lank oor u 
antwoord dink rue; u onmiddelike reaksie op elke item sal heel moontlik meer 
akkuraat wees as 'n goed deurdagte antwoord. 
42. Ek geruet nog steeds die dinge wat ek voorheen geniet het. 
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o Beslis sovee1 
o Nie heeltemal soveel nie 
o Net 'n bietjie 
o Omtrent geensins 
43. Ek kan lag en die snaakse kant van dinge insien. 
o Net soveel as voorheen 
o Nie meer heeltemal soveel nie 
o Beslis nie meer so veel nie 
o Glad nie 
44. Ek voel opgewek. 
o Glad nie 
o Nie dikwels nie 
o Partykeer 
o Meeste van die tyd 
45. Ek voel asof ek traag geword het. 




46. Ek het belangstelling in my voorkoms verloor. 
o Defnitief 
o Ek versorg my nie soveel as wat ek moet nie. 
o Ek mag my dalk nie genoeg versorg nie. 
o Ek versorg my net soveel soos aityd. 
47. Ek sien met ogewondenheid uit na dinge. 
o Soveel soos voorheen 
o Redelik minder as voorheen 
o Defnitief minder as voorheen 
o Amperniks 
48. Ek kan 'n goeie hoek, radio-of TV-program geniet. 
o Dikwels 
o Partykeer 
o Nie gereeid nie 
o Baie seIde 
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In Verskeidenheid van stellings waarmee mense hulleself beskryf, word 
hieronder gegee .. Lees elke stelling en merk dan In boks om aan te dui hoe u 
PRESIES OP HIERDIE OOMBLIK voel. 
Gladnie Effens Redelik Baie 
49. Ekvoelkalm 0 0 0 0 
50. Ek voel gespanne 0 0 0 0 
51. Ek is onsteld 0 0 0 0 
52. Ek voel ontspanne 0 0 0 0 
53. Ek voel tevrede 0 0 0 0 
54. Ek is bekommerd 0 0 0 0 
Hieronder is In Iys van uitsprake wat deur mense gelewer is omtrent hulle 
vatbaarheid vir dermkanker. Merk asseblief In boks om te toon hoe gereeld 
hierdie uitsprake op u van toepassing was gedurende die laaste sewe dae. 
Glad nie Seide Partykeer 
55. 
Dikwels 
Ek het daaraan gedink sonder dat ek wou 
n 
56. Ek het myseH daarvan weerhou om [J 
ontsteld te raak wanneer ek daaraan 
gedink het of daaraan herinner is 
57. Ek het dit uit my gedagtes probeer ban [J 
58. Ek het moeilik aan die slaap geraak of aan 
die Slaap gebly a.g.v. beelde en 0 
gedagtes daaroor wat in my kop gekom het 
59. 
60. 
Ek het met tye sterk gevoelens daaroor gehad 
o 
Gladnie 
Ek het daaroor gedroom 
61. Ek het probeer om nie daaraan herinner 
te word nie. [l 
il I J 
n o o 
o o [I 
IJ o 
SeIde Partykeer Dikwels 
[] o 
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62. Ek het gevoel asof dit nie In werklikheid 
wasnie D D D D 
63. Ek het probeer om nie daaroor te praat nieD D D D 
64. Beelde het in my gedagtes bly verskyn D D 0 0 
65. Ander dinge het gemaak dat ek gedurig 
daaraan dink D D D 
66. Ek was bewus daarvan dat ek nog baie 
opgekropte gevoelens daaroor het, maar ek het 
nie aandag daaraan gegee nie D 0 D 
67. Ek bet probeer om nie daaraan te dink nieD D 
68. Enige herinnering daaraan het gevoelens 
daaromtrent teruggebring D D D D 
69. My gevoelens was soort van afgestomp D D D D 
70. Is daar enige ander sake wat ons nie in hierdie vraelys aangespreek het 
nie? 











Seun? 0 1 
Dogter? 0 2 
8dekind: Ouderdom: 
Seun? 0 1 
Dogter? 0 2 
9de kind: Ouderdom: 
Seun? 0 1 
Dogter? 0 2 
10dekind: Ouderdom: 
Seun? 0 1 
Dogter? 0 2 
_KNAP GEDAANU 
WEEREENS BAlE DANKIE. 
190 
7.6 Appendix 6: Final Afrikaans questionnaire after piloting 
Registrasienommer 
I I I I I 
Genetiese Toetsingvraelys 
Dankie vir u belangstelling in ons navorsingsprojek. 
Ons wil u graag vra om die volgende vraelys te voltooi. Al die inligting sal 
streng vertroulik hanteer word en u identiteit sal nooit in enige verslag 
openbaar word nie. AI die voltooide vraelyste sal apart gehou word van enige 
inligting wat u sou kon identifiseer en sal weggesluit word. U hoef nie u naam 
op hierdie vraelys te skryf nie. 
Daar is geen regte of verkeerde antwoorde nie - ons vra dat u slegs die 
antwoord merk wat die meeste van toepassing is op u. Van die vrae mag dalk 
nie op u van toepassing wees nie, maar dit is belangrik vir die opname dat u so 
ver as moontlik al die vrae beantwoord. 
U deelname aan hierdie projek is vrywillig; u is nie verplig om deel te neem nie 
en as u weI deelneem, kan u op enige stadium onttrek. U mediese behandeling 
en verhouding met die mediese personeel sal geensins deur u besluit 
geaffekteer word nie. 
Voordat u die vraelys voltooi, sal u asseblief eers die aangehegte 
toestemmingsvorm lees en teken. is beskikbaar om 
enige vrae wat u aangaande die vraelys mag h~, te beantwoord. Sodra u die 
vraelys volledig voltooi het, sal u dit asseblief ter6gbesorg aan 
Baie dankie vir u deelname aan hierdie projek. 
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I Toestemmingsvorm 
Ek, ................................................................................... / gee hiermee my 
toestemming om deel te neem aan hierdie opname. 
Ek verklaar dat al die inligting wat ek verskaf het, 'n eerlike weergawe van my 
gedagtes en gevoelens ten tyde van die opname is. 
Ek is bewus van die feit dat al die inligting wat ek verskaf het, streng vertroulik sal 
bly. 
Ek begryp dat ek heeltemal vrywillig aan hierdie opname deelneem en dat my 





Die eerste gedeelte van hierdie vraelys is algemene vrae oor u agtergrond wat 
vir ons sal help wanneer ons die inligting verwerk. Dit sal nie gebruik word vir 
enige identifkasie doeleindes nie. 
(Merk asseblief die blokkie wat die mees toepaslik is.) 
Wat is u werkstatus op die huidige oomblik? 
0 1 Voltydse werk 
0 2 Deeltydse werk 
0 3 Werkloos 
0 4 Eie besigheid 
0 5 Huisvrou 
0 6 Voltydse student 
0 7 Deeltydse student 
0 8 Permanent ongeskik om te werk 
0 9 Afgetree 
0 10 Ander 
Wat is die hoogste vlak wat u op skool behaal het? 
0 1 Standerd 10 (Matriek) 
0 2 Standerd 9 
0 3 Standerd 8 
0 4 Standerd 7 
0 5 Standerd 6 
0 6 Standerd 5 
0 7 Ander _______ _ 
Wat is die hoogste kwalifikasie wat u sedert skool behaal het? 
0 1 Geen naskoolse kwalifikasies 
0 2 Ambagswerk 
0 3 Sertifikaat van In kollege 
0 4 Diploma (na Std. 10) 
0 5 Baccalaureusgraad 
0 6 Nagraadse diploma of graad 








Wat is u huidige huwelikstatus? 
0 1 N ooit getroud 
0 2 WeduweeJwewenaar 
0 3 Geskei 
0 4 Uitmekaar, maar nie geskei nie 
0 5 Getroud (insluitend gemeenregtelike huwelik) 
In watter stadJ dorp is u gebore? 
Wat is u geboortedatum? 
Het u In sterk geloof? 
0 1 Ja 
0 2 Nee 
Behoort u aan In mediese fonds? 
0 1 Ja 
0 2 Nee 
Wat is u geslag? 
0 1 Manlik 
0 2 Vroulik 
Het u enige kinders van u eie (bloedverwande)? 
Ja 
0 2 Nee 
194 
lOa.) lste kind: Ouderdom: 
Seun? 01 
Dogter? 02 
lOb.) 2de kind: Ouderdom: 
Seun? 01 
Dogter? 0 2 
lOc.) 3de kind: Ouderdom: __ 
Seun? 0 1 
Dogter? 0 2 
lOd.) 4de kind: Ouderdom: 
Seun? 0 1 
Dogter? 02 
Indien u meer as vier kinders het, sal u asseblief verdere inligting op die laaste 
bladsy van die vraelys verskaf. 
Vrae oor u familie. 
lla) Hoeveel bloedverwande broers het u? 
lIb) Hoeveel bloedverande susters het u? 
llc) Hoeveel van u bloedverwande broers het al kanker gehad? 
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11d) Hoeveel van u bloedverwande en susters het al kanker gehad? 
11e) Hoeveel van u bloedverwande broerslewe nog? 
11£) Hoeveel van u bloedverwande susters lewe nog? 
llg) Het enige en van u bloedverwande ouers al kanker gehad? 
0 1 Ja 
Nee 
llh) Hoe oud was u toe u besef het dat u In risiko geval vir kanker is? 
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Wie het u aangeraai om vir In genetiese toets viroorerflike dermkanker te 
gaan? 
0 1 Myeieidee 
0 2 In Lid van my familie 
0 3 Algemene praktisyn 
0 4 Spesialis 
0 5 Familie dermkanker sister? 
0 6 Ander 
Het u al/n genetiese bloedtoets resultaat vir oorerflike dermkanker gehad? 
0 1 Ja 
0 2 Nee 
0 3 WeetNie 
Vir wie gaan u sien wanneer u siek voel? 
0 1 Algemene praktisyn 
0 2 Klinieksuster / dokter 
0 3 Niemand 
0 4 Ander ------------------
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Mense het verskeie redes hoekom hulle die oorerflike dermkanker genetiese 
toets wil ondergaan of nie. Ons wil graag weet hoeveel elk van die 
volgendefaktore u besluit om vir In genetiese toets te gaan, beinvloed het. 
'n Faktor wat my besluit beinvloed het om vir 'n genetiese toets te gaan, is ..• 
15a.) ... om te weet wat my bloedverwande kinders se risiko is 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
0 4 Nie van toepassing 
15b.) ... om te kan vasstel hoe ek my risiko vir die ontwikkeling van kanker, 
kan verminder 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
15c.) ... om vir die toekoms te beplan 
0 1 Gladnie 
0 2 Effens 
0 3 Baie 
15d.) ... om navorsing te bevorder 
0 1 Gladnie 
0 2 Effens 
0 3 Baie 
15e.) ... om seker te wees van my eie risiko 
0 1 Glad nie 
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0 2 Effens 
0 3 Baie 
15f.) .om In besluit te kan neem oor gesinsbeplanning (om kinders te he of nie) 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
04 Nie van toepassing 
In Faktor wat my besluit kon beinvloed het om nie vir In genetiese toets te 
gaan, is ... 
15g.) ... omdat ek bekommerd was dat ek my versekering mag verloor/nie kon 
kry nie 
01 Glad nie 
0 2 Effens 
0 3 Baie 
0 4 Nie van toepassing 
15h.) ... ek was bekommerd ror die uitwerking van genetiese toetsing op my 
familie 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
15i.) ... ek het geglo dat kanker onvermydelik was 
01 Glad nie 
0 2 Effens 
0 3 Baie 
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15j.) ; .. ek sou dit te moeilik vind om die resultaat emosioneel te kon verwerk 
0 1 Glad nie 
0 2 Effens 
0 3 Baie 
15k.) ... die toetsresultaat sou miskien foutief gewees het 
0 1 Glad rue 
0 2 Effens 
0 3 Baie 
15L.) ... ek het 'n wantroue in modeme medisyne gehad 
Glad rue 
0 2 Effens 
0 3 Baie 
Die volgende vrae is net om uit te vind hoeveel u alreeds weet van gene wat 
oorerflike dermkanker veroorsaak en toestand wat dermkanker voorafgaan). 
Dui asseblief u antwoord aan, volgens 'Waar', 'Vals', of 'Weet Nie'. 
Dermkanker is altyd oorerflik 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
Almal wat In geen vir oorerflike dermkanker het, sal dermkanker kry 
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0 1 Waar 
IJ2 Vals 
0 3 Weet nie 
Iemand wat nie In veranderde oorerflike dermkankergeen het nie, kan nog 
steeds dermkanker kry 
0 1 Waar 
0 2 Vals 
Weetnie 
Daar is meer as een geen wat dermkanker kan veroorsaak 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
Die geen verantwoordelik vir oorerflike dermkanker kan ook die risiko vir 
ander kankers verhoog 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
In Kolonoskopie (die binnekant van die derm word met In spesiale buis 
besigtig) is heel moontlik in staat om dermkanker op te spoor indien dit 
teenwoordig is 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
In Okkultebloed-stoelgangtoets ('n toets wat onsigbare bloed in die stoelgang 
201 
aandui) sal altyd dermkanker opspoor 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
In 'n familie waar 'n geen vir oorerflike dermkanker gevind is, sal die persone 
sonder die geen dieselfde risiko h~ om dermkanker te kry as die algemene 
bevolking 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
Indien iemand Iyk soos, of dieselde persoonlikheid het as, 'n familielid wat 
dermkanker het of gehad het, het hy / sy heel moontlik die geen van daardie 
persoon geerf 
0 1 Waar 
0 2 Vals 
0 3 Weetnie 
Die volgende stellings wil u mening omtrent u vatbaarheid (risiko) vir 
dermkankerbepaal. 
25a) Volgens u mening, in vergelyking met ander mense van u eie ouderdom, 
wat is u kanse om dermkanker te ontwikkel? 
0 1 Baie kleiner 
0 2 Effens kleiner 
0 3 Min of meer dieselfde 
0 4 'n Bietjie groter 
0 5 Baie groter 
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25b) Dui asseblief u kans aan om dermkanker te kry, op 'n skaal van 0 tot 100, 
waar 0 = In 0% of geen kans is, en 100 = 'n 100% kans is, bedoelende dat jy dit 
beslis sal kry. Merk, met 'n kruis, asseblief een van die lyne om jou kans op 
dermkanker aan te dui. 
0% 10 20 30 40 50 60 70 80 90 100% 
Hierdie afdeling handel oor die ondervinding wat u al met kankersiftingstoetse 
gehad het (Toetse vir die vroetydige opsporing van kanker). Merk asseblief die 
blokkie wat volgens u omstandighede die naaste aan reg is. 
26a. Het u al ooit 'n kolonoskopie gehad (die binnekant van die derm word 
met' n spesiale buis ondersoek)? 
01 Nee. Gaan asseblief voort met Vraag 26d 
0 2 Ja 
0 3 Weet nie. Gaan asseblief voort met Vraag 26d 
26b. Indien u ja geantwoord het, het u in die laaste twee jaar 'n kolonoskopie 
gehad? 
0 1 Nee 
0 2 Ja 
0 3 Weet nie 
26c. Indien u ja geantwoord het , was In poliep al ooit tydens een van u 
kolonoskopie~ vewyder ('n poliep is 'n klein, gewoonlik nie-kwaardaardige 
vergroeisel) 
01 Nee 
0 2 Ja 
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0 3 Weetnie 
26d. Het u al ooit In okkultebloed-stoelgangtoets gehad ('n toets vir onsigbare 
bloed in die stoelgang)? 
Nee. Gaan asseblief voort met Vraag 27 
0 2 Ja 
0 3 Weet nie. Gaan asseblief voort met Vraag 27 
26e. Indien Ja, het u die okkultebloed-stoelgangtoets in die afgelope twee jaar 
, gehad. 
0 1 Nee 
0 2 Ja 
Dit sal van hulp wees om te weet watter opsies u sou oorweeg het, indien u 
geentoets aandui dat u die geen vir oorerflike dermkanker besit. 
Hieronder is In Iys van opsies - van hulle mag glad nie op u van toepassing 
wees nie. Hierdie opsies verteenwoordig nie bevestigde metodes vir die 
voorkoming van kanker nie, maar kan met u deur die genetiese berader of 
kliniekdokter bespreek word, oor wat dit behels. Merk asseblief die blokkie wat 
u keuse sou aandui. 
Indien my bloedtoets sou aantoon dat ek die geen vir oorerflike dermkanker 
besit, sou ek die volgende oorweeg ... 
... /n voorkomende kolektomie ('n operasie om die dikderm te verwyder) 
0 1 Nee 
0 2 Ja 
0 3 Weetnie 
0 4 Klaar gedoen/ sal gedoen word 
Dit sal van hulp wees om te weet hoe u geentoets-resultaat u planne vir 
toekomstige opsporing vir dermkanker sou beinvloed. Indien u bloedtoets toon 
dat u weI die geen vir oorerflike dermkanker gedra het , sou u u planne om 
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vir toetse vir die vroetydige opsporing van dermkanker te ondergaan verander 
het? Merk asseblief die blokkie wat die naaste is aan u siening. 
28a. 0 1 Ek sou nie my dermkanker - opsporingtoetse verander nie 
0 2 Ek sou meer gereelde dermkanker - opsporingtoetse ondergaan 
0 3 Ek sou my dermkanker - opsporingtoetse verminder 
0 4 Ek sou my dermkanker - opsporingtoetse stop 
Indien u bloedtoets toon dat u NIE die geen vir oorerflike dermkanker dra nie, 
sou u u planne om dermkankeropsporing toetse te ondergaan, verander? 
28b. 0 1 Ek sou nie my dermkanker - opsporingtoetse verander nie 
0 2 Ek sou meer gereelde dermkanker - opsporingtoetse ondergaan 
0 3 Ek sou my dermkanker - opsporingtoetse verminder 
0 4 Ek sou my dermkanker - opsporingtoetse stop 
Hierdie gedeelte handel oor u siening omtrent dermkanker en dermkanker -
opsporing toetse. Ons wil graag weet tot watter mate u saamstem met elk van 
die volgende stellings. Antwoord asseblief al die vrae selfs a1 het u nog nooit 
dermkankeropsporing toetse ondergaan rue. Merk asseblief die stelling wat die 
naaste is aan u seining is. 
Ek dink mense wat met dermkanker gediagnoseer word, het min kans om die 
siekte te oorleef 
0 1 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
Dermkanker kan genees word indien vroetydig opgespoor 
0 1 Verskil sterk 
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0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
Ek is bekommerd dat dermkanker - opsporing toetse sal aantoon dat ek 
dermkanker het 
0 1 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
Kolonoskopie (die binnekant van die derm word met In spesiaale buis besigtig) 
is In effektiewe manier om dermkanker vroegtydig op te spoor 
0 1 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
0 5 Weet nie 
Dit sal vir my maklik wees om In kolonoskopie te ondergaan 
0 1 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
0 5 Weet nie 
In OkkultebIoed-stoeIgangtoets ('n toets wat onsigbare bIoed in die stoeIgang 
aandui) is In effektiewe manier om dermkanker vroegtydig op te spoor 
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0 1 Verskil sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
0 5 Weetnie 
Dit sal vir my maklik wees om vir In okkultebloed - stoegangtoets te gaan 
0 1 Verski! sterk 
0 2 Verskil effens 
0 3 Effens saamstem 
0 4 Sterk saamstem 
0 5 Weetnie 
In sommige families verhoog die teenwoordigheid van die geen vir oorerflike 
dermkanker ook die risiko om kanker in ander dele van die liggaam te kry. Ons 
wi! graag weet hoe bekommerd u is omtrent die risiko vir ander kankers as 
dermkanker. 
Om vatbaar te wees vir kanker buiten dermkanker ..... 
0 1 ... bekommer my erg 
0 2 ••• bekommer my effens 
0 3 ••. bekommer my glad nie 
Verduidelik asseblief (opsioneel) 
Verskillende mense hanteer stres op verskillende maniere. Hieronder volg vier 
denkbeeldige situasies en ons wi! graag weet hoe u dink u in elk van die 
volgende situasies sal reageer. Lees asseblief elke vraag aandagtig deur en merk 
al die stellings wat beskryf wat u sou doen. 
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Daar moet aan u tande gewerk moet word en u is bang vir die tandarts. Watter 
van die volgende sal u doen? Merk asseblief AL die stellings wat op u van 
toepassing mag wees. 
Ek sou die tandarts vra wat hy presies gaan doen 37a) 0 
37b) 0 Ek sou In kalmeermiddel neem of In drankie drink voor ek gaan 
37c) 0 Ek sou probeer aan aangename herinneringe dink 
37d) 0 Ek sou wi! h~ dat die tandarts vir my moet waarsku wanneer ek 
pyn gaan voel 
37e) 0 Ek sou probeer slaap 
37f) 0 Ek sou al die tandarts se bewegings dophou en luister na die 
gel uid van die boor 
37g) 0 Ek sou die waterstroom vanuit my mond dophou om te sien of 
daar bloed in is 
37h) 0 Ek sou breinspeletjies in my gedagtes wil speel 
U word as gyselaar deur In groep gewapende terroriste in In publieke gebou 
aangehou. Watter van die volgende sal u doen? Merk asseblief AL die stellings 
wat op u van toepassing mag wees. 
38a) 0 Ek sou aIleen gaan sit en soveel dagdroom en fantaseer as wat ek 
kan 
38b) 0 Ek sou op my hoede wees en probeer verhoed om nie aan die 
slaap te raak nie 
3&) 0 Ek sou my lewensverhaal met die ander gyselaars deel 
38d) 0 Indien daar In radio was, sou ek naby probeer bly om na die nuus 





Ek sou probeer om soveel as moontlik te slaap 
Ek sou daaraan dink hoe lekker dit gaan wees om by die huis te 
Ek sou seker maak dat ek weet waar elke moontlike uitgang is 
As gevolg van In groot daling in verkope, is daar In gerug dat verskeie mense in 
u werksdepartement afgedank gaan word. U hoof het In evaluasie van u werk 
van die afgelope jaar ingehandig. Merk asseblief AL die stellings wat op u van 
toepassing mag wees. 
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39a) 0 Ek sou met my medekollegas praat om uit te vind of hulle enige 
iets van my evaluasie af weet 
39b) 0 Ek sou my pligtelys van my huidige beroep nagaan en probeer 
uitwerk of ek aan almal voldoen het 
39c) 0 Ek sou enige argumente of verskille wat ek met my hoof gehad 
het, wat moontlik sy opinie van my mag benadeel het, probeer onthou 
39d)0 Ek sou enige gedagtes van afdanking uit my kop verban 
3ge) 0 Ek sou aan my lewensmaat s~ dat ek my kanse vir afdanking 
liewer nie wi! bespreek nie 
39£)0 Ek sou probeer dink wie van die werknemers in my departement 
deur die hoof gesien word, as die werker wat die swakste werk verrig 
39g) 0 Ek sou aangaan met my werk asof niks besonders gebeur het nie 
40. U is op In vliegtuig, dertig minute vanaf u bestemming wanneer die 
vliegtuig onverwags duik en dan weer stabiliseer. n Kort rukkie daama kondig 
die loods aan dat niks verkeerd is nie, alhoewel die res van die rit onstuimig 
mag wees. U is egter nie oortuig daarvan dat alles in orde is nie. Merk asseblief 
AL die stellings wat op u van toe passing mag wees. 






vliegtuig verskaf word, deeglik deurgaan en seker maak dat ek weet 
waar al die nooduitgange is 
Ek sou oor onbenullighede met my medepassasier gesels 
Ek sou die fliek tot aan die einde kyk, selfs al het ek dit voorheen 
gesien 
Ek sou die lugwaardin roep en vra wat presies die probleem was 
Ek sou In drankie of kalmeermiddel bestel 
Ek sou aandagtig na die enjin luister vir enige ongewone geluide 
ensou die bemanning dophou vir enige ongewone gedrag 
40g) 0 Ek sou met my medepassasier gesels oor wat moontlik verkeerd 
kon wees 
40h)0 Ek sou rustig raak en In boek of tydskif lees of In brief skryf 
41a. Het u enige ernstige stresvolle lewensgebeure die laaste jaar ondervind? 
0 1 Nee. Gaan asseblief voort met Vraag 42. 
0 2 Ja 
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41b. Wat was hierdie lewensgebeure? Omsirkel asseblief die nommer wat op 
u van toepassing is. 
(1) Ouer met kanker gediagnoseer 
(2) Ouer oorlede aan dermkanker 
(3) Broer of suster met dermkanker gediagnoseer 
(4) Broer of suster aan dermkanker oorlede 
(5) Dood van In familielid of vriend aan oorsake buiten dermkanker 
(6) Ekself is gediagnoseer met In nie-kwaadaardige dermkwaal 
(7) Verhuising 
(8) Egskeiding of skeiding van my lewensmaat 
(9) Werksverwante stres 
(10) Ander (spesifiseer assebJief) 
41c. Hoe stresvol was hierdie gebeure vir u die afgelope jaar? Merk asseblief 




20 30 40 50 60 70 80 90 100 
Baie 
Hierdie vraelys is ontwerp om ons te help bepaal hoe u voel. Lees asseblief elke 
item hieronder en merk die een wat die naaste is aan hoe u die afgelope week 
gevoel het. Daar is geen regte of verkeerde antwoorde nie. Moenie te lank oor u 
antwoord dink nie; u onmiddelike reaksie op elke item sal heel moontlik meer 
akkuraat wees as In goed deurdagte antwoord. 
42. Ek geniet nog steeds die dinge wat ek voorheen geniet het. 
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0 1 Beslis sovee1 
0 2 Nie heeltemal sovee1 nie 
0 3 Net In bietjie 
0 4 Omtrent geensins 
43. Ek kan lag en die snaakse kant van dinge insien. 
Net soveel soos voorheen 
0 2 Nie meer heeltemal soveel nie 
Beslis nie meer so vee! nie 
Gladnie 
44. Ek voel opgewek. 
0 1 Glad nie 
0 2 Nie dikwels nie 
0 3 Partykeer 
0 4 Meeste van die tyd 
45. Ek voel asof ek traag geword het. 
0 1 Amper die heeltyd 
0 2 Dikwels 
0 3 Partykeer 
0 4 Nooit 
46. Ek het belangstelling in my voorko~ verloor. 
0 1 Defnitief 
0 2 Ek versorg my nie soveel soos wat ek moet nie 
0 3 Ek mag my dalk nie genoeg versorg nie 
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0 4 Ek versorg my net soveel soos altyd 
47. Ek sien met opgewondenheid uit na dinge. 
0 1 Soveelsoosvoorheen 
0 2 Redelik minder as voorheen 
03 Defnitief minder as voorheen 
0 4 Amper niks 
48. Ek kan 'n goeie boek, radio-of TV-program geniet. 
0 1 Dikwels 
0 2 Partykeer 
0 3 Nie gereeld nie 
0 4 Baie seIde 
'n Verskeidenheid van stellings waarmee mense hulleself beskryf, word 
hieronder gegee. Lees elke stelling en merk dan 'n blokkie om aan te dui hoe u 
PRESIES OP HIERDIE OOMBUK voel. 
Glad nie Ellens Redelik Baie 
49. Ek voel kalm 0 1 0 2 0 3 0 4 
50. Ek voel gespanne 0 1 0 2 0 3 0 4 
51. Ek is onsteld 0 1 0 2 0 3 0 4 
52. Ek voel ontspanne 0 1 0 2 0 3 0 4 
53. Ek voel tevrede 0 1 0 2 0 3 0 4 
54. Ek is bekommerd 0 1 0 2 0 3 0 4 
Hieronder is "n Iys van uitsprake wat detu mense gelewer is omtrent hulle risiko vir 
dermkanker. Merk asseblief 'n blokkie om aan te toon hoe gereeld hierdie uitsprake 
op u van toepassing was gedurende die laaste sewe dae. 
Glad nle Seide Partykeer Dikwels 
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55. Ek het daaraan gedink sonder dat ek wou 01 02 03 04 
56. Ek het myself daarvan weerhou om 01 02 03 04 
ontsteld te raak wanneer ek daaraan 
gedink het of daaraan herinner is 
57. Ek het dit uit my gedagtes probeer hou 01 02 03 04 
58. Ek het moeilik aan die slaap geraak of aan 01 02 03 IJ4 
die slaap gebly a.g.v. beelde en 
gedagtes daaroor wat in my kop gekom het 
59. Ek het met tye sterk gevoelens daaroor gehad 
0 1 02 03 04 
Glad nle Seide Partykeer Dlkwels 
60. Ek het daaroor gedroom 0 1 02 03 04 
61. Ek het probeer om nie daaraan herinner 
te word nie. 01 02 03 04 
62. Ek het gevoel asof dit nie 'n werklikheid was nie 
01 02 03 04 
63. Ek het probeer om nie daaroor te praat nie 01 02 03 04 
64. Beelde het in my gedagtes bly verskyn 01 02 03 04 
65. Ander dinge het gemaak dat ek gedurig 
daaraan dink 0 1 02 03 04 
66. Ek was bewus daarvan dat ek nog baie 
opgekropte gevoelens daaroor het, maar ek het 
nie aandag daaraan gegee nie 01 02 03 IJ4 
67. Ek het probeer om nie daaraan te dink nie 01 02 03 04 
68. Enige herinnering daaraan het gevoelens 
daaromtrent teruggebring 01 02 03 04 
69. My gevoelens was soort van verdoof 0 1 02 03 04 
70. Is daar enige ander sake wat ons nie in hierdie vraelys aangespreek het nie? 
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10.cont. 
10e) 5de kind: Ouderdom: 
Seun? 0' 
Dogter? 0 2 
1 Of} 6de kind: Ouderdom: 
Seun? 
Dogter? 0 2 
10g) 7de kind: Ouderdom: 
Seun? 
Dogter? 
10h) ade kind: Ouderdom: 
Seun? 0' 
Dogter? 0 2 
10i) 9de kind: Ouderdom: 
Seun? 0' 
Dogter? 0 2 
1 OJ) 10de kind: Ouderdom: 
Seun? 0' 
Dogter? 0 2 
KNAP GEDAAN II 
WEEREENS BAlE DANKIE. 
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7.7 Appendix 7: Extract from Research proposal for research 
criteria(l) 
'Investigation of the genetic basis of colorectal cancers in the 
Western and Northern Cape provinces of South Africa' (1) 
'5. RESEARCH PROTOCOL: 
5.1 Patient and family recruitment. and access to archival 
material 
Currently, there are three regions in which a significant degree of cancers have 
been confinned to be due to a common hMLH1 gene mutation; these areas are 
(refer to Figure 1 for geographic location): 
(a) the Hondeklipbaai. Springbok, Port Nolloth triangle (incorporating 
Nababiep. O'Kiep. Steinkopf. Kommagas and Kleinzee). individuals 
have also been identified from villages such as Garies and Upington 
in the northern Cape 
(b) the Wupperthal/Clanwilliam corridor (in the north of the Western Cape 
province). and 
(c) the greater Cape Flats region (from Cape Town, to 
Bellville/Ravensmead, Eersterivier and extending to Maccasar near 
Somerset West). 
5.1.1 Blood relatives (of 'satellite sporadic Individuals' who have already 
been identified with the disease-predisposing mutation), will be contacted 
and infonned of the disorder and their familial risk for the disease and be 
forwarded an Information brochure describing the disorder, with details of our 
research (Appendix 1a/b for current brochure in English and Afrikaans, 
respectively); they will be given the option of participating in the research. 
Participants will be questioned regarding their a ncestral Origins. their medical 
history, particularly regarding signs, symptoms and treatment for the range of 
malignancies a ssociated with HNPCC (Le. Lynch syndrome II) in themselves 
and other blood relatives (Lynch et aI., 1993). A standard questionnaire 
regarding dietary habits and gastrointestinal function will be administered for 
correlation with mutation status and penetrance of disease. 
5.1.2 'New', sporadic Individuals, under 50 years of age, affected with 
co/orectal or one one of the spectrum of HNPCC tumors, Originating from 
the Western and Northern Cape, who present at one of the collaborating 
centres/departments will be recruited for molecular genetic investigations. The 
recruitment protocol will involve infonned consent to collect and use resected 
tissue, as well as 2 X 10 ml peripheral blood samples (Appendix 1c for 
consent/lab DNA fonns). In the absence of fresh resected tissue, archived 
tumour material will be obtained from the collaborating Departments of 
Pathology. With any evidence of a positive family history of the disorder (or as 
a follow-up on detection of a disease-causing mutation in the subject), other 
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members of the subject's family w ill be contacted and recruited as described 
above. 
5.1.3 Archived material: The participating Departments of Pathology/Oncology will 
provide information on material that has been archived over the past 10 years, 
mainly from individuals who presented primarily with colorectal cancer (or the 
Lynch II spectrum, and under the age of 50 years). Appropriate material from 
deceased subjects will be obtained as 10 X 25J.1m sections of paraffin embedded 
tumour tissue from Pathology archives. At the same time, information requested 
under epidemiology below (see section 5.3) will be supplied with each sampling. 
5.2 Molecular Genetic Investigations 
5.2.1 Extent offounder mutation in mixed ancestry population: For consenting patient 
and familial referrals, and for individuals who meet the selection criteria (Lynch 
1111 spectrum of cancers, <50 years of age), 10 ml blood samples (drawn separately 
into two tubes) will be obtained by venepuncture, and processed to DNA using 
standard methods in the laboratory. Archived pathology specimens from patients 
who have undergone surgery for colorectal cancer, and who were under 50 years 
of age at that time, will also be processed to DNA, using standard methods for de-
paraffinization of tissue and isolation of DNA. The DNA from each 
indlviduaVsample will be investigated for the hMLHl mutation identified in the 10 
families previously. The methodology will involve using a set of primers designed 
to amplify the mutated exon within the hMLHl gene through the polymerase chain 
reaction. Restriction digestion using the enzyme Mval, provides a reliable means 
for preliminary testing of large numbers of samples (Ramesar et at, 1999). DNA 
sequencing will be carried out for confirmation. 
5.2.2 Microsatellite instability. Microsatellite instability together with pathology and 
histology is very likely to provide prognostic indication for the subject, while 
providing a pointer to candidate disease-causing genes (Shibata et al., 1993; Jass, 
1998, and see candidate genes under 5.2.3). Investigation of this phenomenon will 
be carried out with tumour and non-tumour tissue of subjects, obtained either 
from Surgery or Pathology. 
5.2.3 Association with candidate genes. In the event of material being available from 
3 or more affected individuals, with a history of coloracta/ cancer (or cancers typical of 
the Lynch II syndromic spectrum, and which do not exhibit the major hMLH1 mutation 
described), a screen of highly polymorphic microsatellite markers (Genome Data Base; 
http//gdbwww.gdb.org) will be carried out to indicate the most likely of the 
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candidate genes hMLH1, hMSH2, hPMS1, hPMS2, hMSH6 (Fishel et al., 1993; Leach 
et al., 1993; Bronner et al., 1994; Nicolaides et al., 1994; Papadopoulos et al., 1994; 
Miyaki et al., 1997) 
Samples triaged out of the initial mutation screen, and material which suggests 
association with a candidate gene, will be processed through a comprehensive 
mutation screen of the candidate genes, which together account for 
approximately 90% of HNPCC. Although single stranded polymorphism 
analysis (Spritz et aI., 1992) has been the method of choice for mutation 
analysis in the applicant's· laboratory for several years, denaturing gradient gel 
electrophoresis and protein truncation testing (Jass, 1998) have been attempted 
and will be used as a suite of methodologies to enhance the detectability of 
DNA changes. 
5.2.4 Genealogical Investigation and extension of families. In relatives of affeded 
individuals know to be mutation positive with disease: Individuals found to be 
negative for the mutation will be Informed of their results, and discharged from 
further investigation. Individuals shown to be mutation positive will be referred 
for gastroenterological followup screening, and questioned for further information 
on at-risk relatives, as far back inter-generation ally as is possible. This will 
require substantial effort and will be facilitated by a genetics nurse with adequate 
training. This endeavour in genealogical tracing wlll help identify possible links 
with other families along the West coast. Older living relatives will be targeted for 
anecdotal information and personal medical histories. 
In 'sporadic' individuals Identified from pathology specimens and from screening 
'sporadic' colorectal cancer patients under the age of 45 years (source: Groote 
Schuur Hospital, Tygerberg Hospital, Kimberly Hospital; private surgeons and 
pathology laboratories). Living, mutation-positive individuals will be contacted 
immediately, for a full familial medical history, endeavouring to establish 
genealogical ties with other families under investigation. Recruitment of family 
members (also of deceased individuals identified through pathology 
specimens), with informed consent, will aid the genealogical expansion of the 
kindred. 
5.2.5 Age/Origin of the disease-associated mutation/so Studies in Finland have shown 
that the majority (approximately 700/0) of coloredal cancers (associated with 
HNPCC) are due to only two mutations in the hMLHl gene (Mouio et al., 1996; 
Nystrom-Lahti et al., 1996). Our Investigations to date show the widespread 
occurrence of a single mutation underlying HNPCC in individuals of mixed 
ancestry deriving from the Northern Cape. 
The material from mutation positive subjects in our preliminary studies, shares a 
minimum haplotype of three micro satellite markers flanking and intemal to the 
hMLH1 gene. This together with a set of 10 markers flanking these markers 
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will be used to estimate age and possible migratory direction of the founder 
phenomenon. The age of the mutation will likely be important in providing a 
reasonable estimate of its dispersal, and its possible role in disease burden; 
furthermore, this will also enable a prediction of the migration into geographical 
regions which have not yet been investigated for the disease and mutation. 
5.2.6 Search for genetic modifier loci. Although there is clear recognition of 
the likelihood of environmental factors which influence the initiation process, 
progression and spread of disease in a predisposed individual there are likely to 
be genetic elements which modify the effect of the primary predisposing 
mutation. The temporal and spatial existence of a common widely spread 
disease-associated mutation is extremely valuable for assessing purported 
biological modifier mechanisms. In this regard, approximately 400 markers 
spread across the human genome will be tested (at intervals of 5-10 cM) with 
approximately 50 subjects who are uniformly mutation carriers and who vary 
with regard to phenotype. The two oldest non-manifesting survivors (>70 yrs of 
age), and material from the youngest affected individual (deceased at 15 yrs of 
age) will form a focal component of the screening panel. Fifty non mutation-
carrying siblings of the 'primary panel' will form the control group for a 
comprehensive screen. It is envisaged that this investigation will be facilitated 
by access to an automated genotyping facility, (which is being acquired by the 
applicant'sRSR laboratory). 
Certain areas of the human genome will be covered with a 'finer screen, e.g. the 
major histocompatability locus on the short arm of chromosome 6 will be 
interrogated for HLA subtypes, which might indicate whether this genomic entity 
has any influence on development and progression of disease. 
5.3 Epidemiology of colorectal cancers. incorporating a 
database/registry for mutation and disease 
correlation 
There is a lack of systematic statistics on cancers, particularly in the Northern 
Cape province. Even in the Western Cape province there is a dirth of cohesive 
information to extract reasonable demographic data. As referred to earlier, 
there is anecdotal and unpublished information suggesting a higher incidence of 
cancers in individuals of mixed ancestry along the west coast of South Africa 
(unpublished data gathered from referrals to Tygerberg Hospital: Albrecht, Smit 
and Mouton, unpublished). This requires further investigation, and will be a 
valuable adjunct to the genetic projects proposed earlier. The current aspect of 
the study is intended to begin with obtaining information in a stepwise manner 
which will ultimately provide basic data on the spatial and temporal variations in 
cancer patterns in the regions, particularly with regard to colorectal and 
associated (Lynch II; Lynch et aI., 1993) cancers 
The project willi nvolve use 0 f a clive a nd passive data collection methods to 
obtain information from clinics, laboratories and the referral hospitals that have 
been mentioned. All patients admitted, and with diagnosis of colorectal and 
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associated Lynch II cancers, wilt be documented, and the database will be 
constructed in close association with the superintendents of these hospitals, 
and relevant specialists. At the same time, the pathology archives of the referral 
hospitals of Groote Schuur, Tygerberg. and Kimberly (which serve the 
catchment population under consideration), will be a sked for specimens from 
patients with colorectal cancer and who were 45 years and under at the time of 
surgery. Contact has already been established with the private pathology 
laboratories which are likely to complement sampling of this catchment western 
seaboard population. An added selector to be invoked in the database 
screening will be area of residence. General practitioners, and physicians along 
the West Cape Coast will also be approached during the course of this study in 
order to provide them with information on the disorder, and to suggest referrals 
from patients meeting the above-mentioned criteria of having colorectal cancer 
and being 45 years of age or younger (at the time of diagnosis or surgery). 
The design of the data forms will be overseen by the Director of the NCR, Dr 
Freddy Sitas, (who will provide registry information as is available on the 
Western Cape and other relevant subregions) and will ensure uniform and 
consistent information collection, which will be admitted to the National cancer 
registry. 
• Information that will be obtained will include: (a) hospital, (b) hospital 
reference number, (c) surname and name of individual, (d) gender, (e) 
date of birth/ age, (f) ethnic group, (g) usual address and contact 
information, (h) date of consultation/ treatment, (i) diagnosis/ disease, G) 
site of disease, (1<) extent/ stage of disease/histological type of disease, (1) 
date of last consultation and dates of various treatments, (m) details of 
treatment! resection, (m) tissue available from, (n) further details, 
including family history. 
The National Cancer Registry (NCR) currently serves the population of South 
Africa in terms of archiving and analysing information on cancers from around 
the country. The northern Cape province has, unfortunately been under-
resourced and has minimal data in the NCR. T he data acquired though our 
investigations will be fed into the NCR, via Dr Sitas. At the same time, however, 
our collaboration with Dr Sitas is based on the NCR providing access to reports 
of cancers submitted to the NCR through private pathologists. This will allow for 
verification and data qualification, and also provide a means of acquiring data 
which is not otherwise easily obtainable. 
Some duplication of feedback from the different specialities and NCR to us is 
inevitable; however careful auditing of information at data entry onto the 
computerised system (currently functional in the applicanfs laboratory on a 
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Microsoft Access platform) will avoid any interference with emerging statistics.' 
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7.8 Appendix 8: Step by step changes to the questionnaire 
Permission to use this instrument is contained in Appendix 2. 
The original Australian Questionnaire (Appendix 2) was converted from the 
original Rich text format with columns (as it was received electronically) to a 
straight- forward word doc. 
This instrument (Appendix 2) was modified to the South African situation in 
English (Appendix 4) and then translated into Afrikaans (Appendix 5). 
The original Australian information sheet was not altered in its content but the 
last paragraph, which was an instruction about posting the questionnaires, was 
altered to suit my research plan for a data collector to be available to answer 
questions and collect the questionnaires at completion (Appendix 6). 
An English consent form was created for this study and translated into 
Afrikaans (Appendix 5 and 6). These (Information sheet and Consent form) 
were incorporated into the English and Afrikaans questionnaire packages. 
The abbreviation 'HNPCC' was changed throughout the questionnaire to 
'Hereditary colon cancer' to make translation manageable. 
Numbering required to be altered throughout the document as additional 
demographic questions were added to the original questionnaire. 
Sociodemographics 
The demographic section changed from Questions 1 to 7 to 1 to 14 
incorporating questions to suit the South African situation. 
was not changed. 
• Original Question 2: What is the highest qualifica~on you have obtained since 
leaving school? 
0 1 No post-school 
0 2 Trade / apprenticeship 
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0 3 Certificate from college / TAPE 
0 4 Diploma (beyond Year 12) 
0 5 Bachelors degree 
0 6 Postgraduate diploma / degree 
0 7 Other 
Altered What standard did you reach at school? 
0 1 Standard 10 (Matric) 
0 2 Standard 9 
0 3 StandardS 
0 4 Standard 7 
05 Standard 6 
0 6 Standard 5 
07 Other 
Original Question 3: Do you speak a language other than English at Iwme? 
0 1 No, only English 
0 2 Yes, Italian 
0 3 Yes, Greek 
0 4 Yes, Chinese 




0 1 No post-school 
is the highest qualification you have obtained tince 
0 2 Trade / apprenticeship 
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0 3 Certificate from college 
0 4 Diploma (beyond Std 10) 
0 5 Bachelors degree 
06 Postgraduate diploma / degree 
0 7 Other 
Original Question 4: What is you' country of birth? 
0 1 Australia 
0 2 United Kingdom 
0 3 Greece 
0 4 Vietnam 
0 5 Lebanon 
0 6 Other 
Altered What is the town of your birth? 
Original Question 5: What is your present marital status? 
01 Never married 
02 Widowed 
03 Divorced 
04 Separated but not divorced 
05 Married or de facto 
Altered What is your present marital status? 




04 Separated but not divorced 
05 Married or married in common law 
Original Question 6. What is your age? 
Age: ___ years 
Altered What is your date of birth? 
• 
These were additional questions added to the South African Questionnaire. The 
reason for adding them was that they might add to socio-economic status thus 
possibly showing a pattern for stress.(70) 
Do you have a strong faith? 
0 1 Yes 
02 No 
Do you have a medical aid? 
0 1 Yes 
0 2 No 
Are you male or female? 
0 1 Male 
0 2 Female 
Question 7 in the original questionnaire is. Do you have children? 
This question was used unchanged as 
was an added 6 point question about family and family members 
who have had cancer. The literature review showed that experience with 
disease was a factor associated with reduced levels of stress (70). In the Petersen 
article on attitudes to colon cancer testing {Petersen, Larkin, et al. 199910: 4971 
she uses a similar set of questions to depict family history and experiences with 
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colon cancer in the family 
were in the original questionnaire as Questions 8,9,10. They 
asked questions about testing for HNPCC. The Australian sample had not yet 
had predictive genetic testing, but this sample group have all received their 
predictive results. The questions were altered to suit their situation Instead of 
asking if they wanted to participate in a predictive testing programme. The 
altered questions were a test to see if they knew they had had predictive genetic 
results for HNPCc. 
After translation a new Question was added 
Have you ever had a predictive genetic ~esult for HNPCC? 
The thought was that Q12 asks 'who referred you to having a test?' and Q14 
asks 'who you go to for clinical help?' It seemed incomplete not to ask if a result 
had been given. 
Genetic risk status' is measured by Question 10 in the original questionnaire 
now ··11 in the altered questionnaire. It is a modified '12 item' scale 
from a previously validated measurement of perceptions of benefits, limitations 
and risks of genetic testing in breast cancer {Lerman, 1996 4953 / id;Lerman, 
1995 4981/id}. The scale has been adapted and piloted in Australia (See 
Appendix 2) to assess the intention to request genetic testing and the acceptance 
of preventative surveillance strategies should a predictive result be gene 
positive for HNPCC. 
The Australians altered the statements to suit their cohort. The Lerman BRCAl 
study has these 12 items: 
Benefits of testing -
~ a) To learn about my children'S risk 
~ b)To know if I need to increase screening 
~ c)To plan for the future 
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);> d)To make surgery decisions 
);> e)To be reassured 
);> £)To make childbearing decisions 
);> Limitations and risks of testing -
);> g)Worried about loosing insurance 
);> h)Concerns about effect on family 
);> i)Don't believe I can prevent getting cancer 
);> j)Couldn't handle it emotionally 
);> k)Test results might not be accurate 
);> I)Don't trust modern medicine 
);> In the Australian questionnaire d) and e) were left out and replaces by; 
To help Research 
To be certain about my risk 
The wording to i) was altered slightly to 
that I believed that cancer was inevitable 
Contrary to the Australian cohort, my sample population had all already 
received their predictive results. The leading statement to Q15 would require 
these individuals to attempt to remember what might have made them decide 
to have themselves tested as well as what might have given them cause to 
hesitate. The leading statement was thus altered. 
Original Question 10 stated 
I A factor which influenced my decision about whether or not to have a gene 
test is ... ' 
Revised Question 15 
A factor which influenced my decision about whether to have a gene test is ... 
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The reason for leaving out' or not' in this leading sentence seemed more direct 
to a sample population who had already made this decision and could now 
comment on why they had made the decision at the time. 
Knowledge 
A Revised Version of a scale, used to measure the knowledge about inherited 
breast cancer and BRCA1 testing, has been integrated into the questionnaire. 
The scale used in the BRCA1 study included items from an instrument used by 
the National Centre for Human Genome Research Cancer Studies Consortium 
(58). 
'Knowledge about colon cancer' is measured with (Original 
questions 11 - 19). The similarities of predictive testing for breast and colon 
cancer have been alluded to in the background. 
Risk perceptions 
Two measures provide for an assessment of the perception of the individual's 
risk of developing colorectal cancer (64). 
(Original Question 20) asks about perceptions of risk for 
developing colon cancer. The medical measurement of risk utilizes family 
history and colonoscopy screening yielding adenomatous polyps (42-44;87). In a 
study measuring' Attitudes toward colon cancer gene testing' (66)it was found 
that risk perception was linked to affected relatives, cancer worry and a 
younger age. These 2 measures will give a baseline of risk perception to which 
screening and health behaviours can be compared. (Objective 2 i.e. cancer risks) 
In the preventive health model (78) Page 144. a broad set of factors which 
influence an individual's decision to take preventative action and this set of 
questions combined to Q 26 and Q 28 also form part of the representation 
section of the Preventative Health Model. 
Attitudes 
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Questions assessing the beliefs about the effectiveness of the surveillance 
methods are included. In addition, individuals will be asked their reasons and 
motivations for accepting or rejecting surveillance (56). 
(Original questions 21 and 22) consists of 3 baseline 
questions about colonoscopic screening to compare attitudes/beliefs about 
other health-related behaviours (Objective 2 - how to prevent development of 
cancer) 
In question 26 - I adenomatous' is removed as having a polyp found on 
colonoscopy is enough. 'Adenomatous' just adds to the difficulty in 
understanding. 
(Original Question 25) . The original wording was 'It would be 
helpful to know what options you would consider should you decide to have a 
gene test and the test result indicate that you carry the gene for HNPCC. 
Below is a list of options, some of which may not be relevant to you. These 
options do not represent proven methods for preventing cancer but may be 
discussed with you by the genetic counsellor or clinic doctor who will explain 
what they involve. Please note your preferences as indicated here in no way 
limit the choices or options when the gene test result is available to you. 
Please tick the box which represents your preferred option.' 
'It would be helpful to know what options you would consider if your gene 
test result indicated that you carry the gene for Hereditary colon cancer. 
Below is a list of options, some of which may not be relevant to you. These 
options do not represent proven methods for preventing cancer but may be 
discussed with you by the genetic counsellor or clinic doctor who will explain 
what they involve. Please tick the box which represents your preferred option.' 
The changes were made to read in the past tense as the research population 
have all had their predictive genetic results. Thus the 'Please note your 
preferences as indicated here in no way limit the choices or options when 
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the gene test result is available to you' section was also removed as it was not 
applicable. 
follows from question 27 in that it also asks the individual to 
contemplate what they may have done differently if they had received a 
different result, as well as what they would possibly change about what they 
had done. 
In the translation to Afrikaans an extra 4th choice was added to the selection. 
The 4th option of 'stopping surveillance' was added. This is what is advised 
when an individual is mutation negative. They know they may request a 
procedure if they are worried but it is not offered as a regular surveillance/ 
screening as in those that are mutation positive. 
(U1~igina1 questions 25 - 35) These questions assess the beliefs 
about effectiveness of surveillance methods and the reasons and motivations for 
accepting/ rejecting screening. An explanatory framework called the 
preventative health model with concepts believed to be important in self 
initiated preventative health behaviour were drawn from the Health belief 
model, the theory of reasoned action and social learning theory (78).These 4 
factors make up a preventative health model which comprises 3 sets of 
variables: 
1. Background factors - sociodemographic info 
2. Representation factors - perceptions with the respect to the 'threat' and 
procedures available to cope with the potential threat 
3. Social influence factors - relationships of individuals with health care 
professionals and social norms reo prevention 
4. Program factors - individual, group, or mass communications 
A shortened version of this model was used in the Australian questionnaire 
and relates to the representation factors. A 4 point Likert- type response was 
used in (78) to describe the variables. 
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(Objective 4 - how genetic testing impacts on medical decision making) 
has an optional open- ended question about attitude toward risk 
of cancer development (Objective 2) 
Psychological and functional health status 
Miller's behaviour style scale has been included as it enables measurement of 
coping in threatening situations and possible responses to these situations 
(56;74). Life event questions are used to assess the possibility of confounding 
effects on psychological outcomes measures. They have been piloted and tested 
for a related study in the Australia study. 
Miller's behaviour style scale is a measure of coping style in 
threatening situations and possible responses to these situations (74). (Objective 
3 psychological health status)(phipps and Zinn: 4997) The coping styles are 
divided into those who seek information (monitors) and those that avoid 
information (blunters). In Questions 37 - 40. The words 'Imaginary scenarios' in 
the introduction to the scale is self explanatory, thus the words 'imagine 
vividly' were left out as it did not change the meaning and would be easier to 
translate. 
3 Components (a, band c) asking if the respondents had had a) a 
stressful life event in the last year b) if 'yes' in a) what was the event. They have 
a choice of 10 specifics and c) a Ukert scale asking how stressful the event was 
for them on a scale of 0 (not stressful) to 100 (very stressful) 
Impact on Medical Decisions 
These questions make up a depression scale from the 
hospital anxiety and depression scale (HADS) (103). This is a rating scale that 
has been designed specifically for patients with physical illness. It has 14 items 
divided into 2 subscales, 7 for anxiety and 7 for depression with somatic items 
excluded. Only the depression scale has been used. 
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is the Spielberger State -Trait Anxiety Inventory (ST AI- State 
Short version) that is included as a measure for situational 
anxiety. Objective 3 psychological health status. (56;86). 
is an 'intrusion and avoidance' subscale of the Impact of 
Events Scale (IES) (61;61;83). In this study the' stressor' is the concern of being 
at risk for colon cancer. The IES has 2 subscales. 1 x is an 'intrusion subscale 
which refers to ideas, images and feelings or bad dreams that intrude into every 
day thoughts' (Ref Esplen, MJ Journal of psychometric research pg. 429) and the 
other avoidance refers to I consciously recognised avoidance of certain ideas, 
feelings or situations.' The intrusion scale has 7 items (score range 0 - 35) higher 
score indicating more reported intrusion and 8 items for the avoidance scale (0 -
40) with the higher score indicating a more reported avoidance' 
Items are scored by frequency of their occurrence. 
This is an open-ended question allowing the participant to air any 
views not covered in the questionnaire that they may feel strongly about. 
The abbreviation 'HNPCC' throughout the original questionnaire was then 
changed to hereditary colon cancer. In the context of the questionnaire all the 
individuals had received predictive results for HNPCC and understood it to be 
a hereditary form of colon cancer. It would then make translation into 
Afrikaans easier as well as easier to understand. 
7.8.1 Mter Piloting: 
~ The numbering in had to be altered to suit data capture. 
The numbering in questionl0 had to be altered to suit data capture. This was 
noted after the pilot. Each child had to be captured as a separate entity e.g. lOa 
for '1st child' and lOb for '2nd child' etc. 
Question 11 required renumbering as it was found to be too difficult to add to 
the data so each potential answer was given a separate allocation thus changing 
11 a -11£ to 11 a -11 h 
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In question 11 and 15h the piloted Afrikaans translation' Vrae oor u gesin' was 
used as a description for the set of questions. This was changed to ' Vrae oor jou 
familie' as the meaning of I gesin/, in Afrikaans, implied a more nuclear family 
whereas 'familie' was more in line with the meaning of 'your wider family' 
which is what the question is about. 
» Translated words or phrases required altering to make the meaning 
more descriptive e.g. 
The tense of statements was altered to the past tense as it was felt that it 
would make the subjects realise that they were being asked to remember 
why they agreed to enter the predictive genetic testing programme. 
Words were added to make statements more clear and in some cases more 
polite. 
Instructions were clarrified 
In questions lla to llg and question15a the word 'bloedverwande' (translated 
directly means 'blood relative') was added to each question as it was realised 
that in the South African context using only the words 'brothers' and 'sisters' 
could have had a different meaning to our population, hence 'bloedverwande' 
was added to make the meaning clearer. 
In question 15 the words 'Oorerflike Kolonkanker' (Inherited Colon Cancer) in 
the intro were changed to' oorerflike dermkanker'. It was felt that the term 
'derm' was more explicit and simple to understand than 'kolon' . 
In question 15 the wording in the Afrikaans translated leading statements were 
slightly re--arranged to flow more easily from' In Faktor wat my besluit om vir 
'n genetiese toets te gaan, beinvloed het, is .. ,' to n Faktor wat my besluit 
beinvloed het om vir In genetiese toets te gaan, is .. ,'. This change was made 
after the pilot test. 
For questions 15g to 151 the tense in these statements and the leading statements 
was changed after the pilot was done. The present tense was used in the piloted 
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Afrikaans questionnaire as a direct translation from the original Australian 
questionnaiJf. After changing the leading statement to suit the research 
subjects, who had all had predictive results, it was felt that the change of tense, 
to the past tense, would make the subjects realise that they were being asked to 
remember why they agreed to enter the predictive genetic testing programme. 
It was felt that it would not change the meaning of the set of questions but 
would make the subjects feel that the questions were specifically suited to them. 
Number15 was used twice in the piloted questionnaire. All questions from 15 
onwards were renumbered. 
In question 20 the word' verantwoordelik' was added to the statement. It was 
felt that it made the meaning of the Afrikaans statement more clear. 
In question 23 the 'persone' was added to the statement to make the sentence 
more simple to understand and more polite instead of 'die'. 
The Likert scale line in question 25 b was marked with percentages to choose 
from. The instructions were then altered to explain what to do. 
Question 26 uses the word 'kankersiftingstoetse' as the Afrikaans translation for 
'cancer -screening tests'. This was not well understood in the pilot. An 
explanation of 'toetse vir die vroetydige opsporing van kanker' was added. 
The work 'boksie' was used in the pilot questionnaire but changed to 'blokkie' 
as the word seemed more correct. 
Question 26c. 'It was felt that clarification needed to be given about having 
answered 'yes' or 'no' in 26a so 'Indien u ja ge-antwoord' was added to this 
question. 
Question 27. The work 'boksie' was used in the pilot questionnaire but changed 
to 'blokkie' as the word seemed more correct. 
Question 27. The leading statement was changed to the past tense after the pilot 
to make the statement more pertinent to the research subjects. The word' sal' 
was replaced with' sou' . 
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In the pilot Question 28 and 31 the word' skandering' was used to translate the 
word 'screening 'but it was replaced with 'opsporing'. 1lis was at the request 
of one of the pilot subjects who asked 'what skandering was?' In the responses 
'skanderingsessies 'was replaced with dernkanker-opsporingtoetese' 
Question 36. The word 'besit' was replaced with 'teenwoordigheid'. The word 
'teenwoordigheid' created a 'presence of the gene' rather than 'besit' which had 
'ownership' qualities to it. . A spelling mistake was corrected in the word 
, dermkanker' . 
Question 37 - 41. The leading statement for the next 4 questions explains that 
'four imaginary scenarios are described'. In the pilot the words' opgemaakde 
situasies' was used but it was decided after the pilot that' denkbeeldige 
situasies' was more in line with the original meaning. 
Question 37. Initially in the pilot a direct translation of the words was used. 
English - 'Vividly imagine that you are afraid of the dentist and have to get 
some dental work done', Afrikaans -'U is bang vir die tandarts en dat daar aan 
u tande gewerk moet word'. After the pilot the wording was re-arranged so 
that the Afrikaans sounded better. Post pilot Afrikaans - 'Daar moet aan u 
tande gewerk moet word en u is bang vir die tandarts'. 
The Likert scale line in question 41c was marked with percentages to choose 
from. The instructions were then altered to explain what to do, Question 41 
asked about stressful life events in the last year. This was left out of Question 
41c in the pilot. It was re - added after the pilot, 
In the leading statement to questions 55 - 69 the word 'vatbaarheid' was used in 
the pilot as a translation for' at risk' but changed to ' risiko'. It was felt that this 
word was used before in the questionnaire and understood. 
In the pilot question 57 the word 'ban' was used as a translation for 'remove', It 
was replaced with 'hou'. It was decided that 'Ban' was not suitable in this 
instance. 
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In question 69 the word 'afgestomp' was used as a translation for the word 
'numb' but, after the pilot, 'verdoof' was used, as it was a better match. 
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7.9 Appendix 9: Answers to data set questions 
Hi.. ... Below are the responses 
The excel file entitled IQues data 11 is compiled of the numbers from the 
questionaire IAppendix 3 no 31. The yellow colums are the ones I have questions 
about. 
1. Column B = date on the front page. Is this format OK? .. 
2. 3 = What should I enter if a question is not answered? 
3. Colum M Ques. 10 a = There are 2 answers per question. An age and a tick 
box. Does one record the age in writing? Eg. twenty two to differentiate 
from 121 from the tick box. Is this format of recording this OK? 
4. Column w Ques lla. Answer is a number of people. Doe I use Number 2 or 
two here? ~If_ 
5. Column AD Ques. llh. The individual had completely misunderstood the 
qU4estilon and answer. What do I enter? 
6. 
7. Column BI Ques 26e. This uestion had an option to skip. What should I 
enter? 
8. Column BU - This is an area where can explain their choice in Ques. 36. 
Where do I write this? 
9. Column BV quest 37a. Quest 37 a - h is a section in which they could choose 
more thal1 one. Iputastar to represent the answer chosen. Is this OK 
_;.!I~.~~"J 
10. Column Ques 41b. One individual chose more than one answer. I thought 
should allocate the colums to accomadate this eg 41b (1), 41b (2) etc and 
use a star as in ques 37 
Thank you so much 
Ursula Algar 
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7.10 Appendix 10: Itinerary for a preparatory West Coast 
Colonoscopic surveillance trip 
Sunday 29 July 2003 
Collect car at the airport 
Monday 28 July 2003 
Depart: Cape Town 
See patients in: Clanwilliam 12h00 - 16hOO 
Drive to Wuppertal- Booked @ soetbekkie 027 4923410 
Tuesday 29 July 2003 
See patients in: Wuppertal 09hOO - 12hOO 
Drive to Vredendal/ Lutzville. 
See patients in: Lutzville 14.30 - 16hOO 
Booked Marina Visagie - Komkans farm 027 642 4015 
Wednesday 30 July 2003 
Drive to Okiep. 
See patients in: Okiep 12h00 -16hOO 
Booked @ Okiep Hotel 027441 000 
Thursday 31 July 2003 
See patients in: Okiep, Springbok 08hOO -12hOO 
See patients in: Steinkopf 14hOO - 16hOO 
Booked @ Okiep Hotel 027 441 000 
Friday 1 August 2003 
See patients in: Kommagas, Hondeklipbaai, Kleinsee 
Saturday 2 August 2003 
See patients in: Kleinsee, Port Nolloth 
Sunday 3 August 2003 
Monday 4 August 2003 
Arrival of Prof. Raj Ramesar (Department of Human genetics) 
See patients in: Kleinsee, Port Nolloth, Okiep 
Booked accommodation @ Okiep Hotel 027 441 000 
Tuesday 5 August 2003 
See patients in: Okiep, Kammieskroon, Nourivier 
Booked accommodation @ Okiep Hotel 027 441 000 
Wednesday 6 August 2003 
See patients in: Springbok/ Okiep 
Arrive back in Cape Town 
Thursday 7 August 2003 
Drop car at Newlands depot by 8 am 
237 
Summary 
DATE PLACE · IND. PREP QUEST. GIVEN 
SEEN GIVEN 
28 JULY 03 CLANWILLIAM 6 6 8 
29 JULY 03 WUPPERTAL 12 8 30 
29 JULY 03 LUTZVILLE 7 5 0 
30 JULY 03 GARIFS 2 0 1 
30 JULY 03 KHARKHAMS 1 0 0 
31 JULY 03 OKIEP 6 7 7 
1 AUGUST 03 KOMMAGAS 17 16 19 
1 AUGUST 03 HONDEKLIPBA 3 2 4 
AI 
2 AUGUST PORT NOLLOTH 3 11 13 
4 AUGUST KLEINSEE 2 1 1 
4 AUGUST STEINKOPF 7 4 0 
5 AUGUST KAMMIEKROON 7 2 0 
5 AUGUST NOURIVIER 12 5 0 
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7.11 Appendix 11: Ethics Clearance cerificate 
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12 March 2003 
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Gastrointestinal Clinic 
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Research Ethics Committee 
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